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1.1 Breast cancer incidence and prevalence
Breast cancer is a disease in which malignant (cancer) cells form in the tissues of the 
breast. Usually, it starts off in the inner lining of the milk ducts or the lobules that supply 
them with milk. A malignant tumor can grow into surrounding tissues or spread to other 
parts of the body [1]. In 2008, at the start of our study, breast cancer was the most frequent 
cancer among women around the world with an estimated 1.38 million new cancer cases 
diagnosed (23% of all cancers) and accounting for 458,000 deaths a year [2]. In general, 
the incidence rate of breast cancer in economically developed countries is higher than in 
developing countries; however the case fatality rate is higher in developing countries, which 
indicates the more unfavorable survival [3]. In Indonesia, data from the 90s showed that 
breast cancer was the second most frequent cancer next to the cervical cancer among 
women, however, recent data shows that breast cancer has emerged as the most frequent 
cancer and the leading cause of death [4-5]. The breast cancer incidence rate per 100,000 
people is 36.2 and the mortality rate is 18.6; both numbers are increasing [6]. A review 
study of cancer epidemiology in the South East Asian countries suggested that poorer 
survival among Indonesian breast cancer patients is largely due to late presentation of the 
disease [7]. This condition is compounded by lack of facilities for early detection and also 
poor access to primary treatment [8-9]. 
1.2 Detection and diagnosis of breast cancer
To detect and diagnose that a patient has breast cancer, the physicians may use the following 
procedures or tests: (1) Clinical breast exam (i.e. the physicians carefully examines the 
breasts and arm pits to check for signs of disease, such as lumps or anything else that 
seems unusual, (2) Mammogram (i.e. an x-ray of the breasts), (3) Ultrasound exam (i.e. a 
procedure in which high-energy sound waves (ultrasound) are used to make a picture of 
the breast tissues), (4) Magnetic Resonance Imaging (i.e. a procedure that uses magnet 
and radio waves to make a series of detailed pictures of the breast), (5) Blood chemistry 
exam (i.e. a procedure in which a blood sample is checked to detect possible abnormalities 
of certain substances released into the blood by organs and tissues in the body as a sign 
of disease), and (6) Biopsy (i.e. the removal of cells or tissues of the breast; these tissues 
are examined under a microscope by a pathologist to check for signs of cancer) [1]. 
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1.3 Breast cancer treatment
In developed countries, most women come to the hospital with an early stage of breast 
cancer and they will have surgery as the main treatment [10]. However, as the majority 
of patients in Indonesia (60%-70%) are diagnosed at advanced stages (III and IV) and 
approximately 35% of them have metastasized [11-13], most patients receive combination 
treatment. Based on the protocol written by The Indonesian Society of Surgical Oncology, 
the treatment of breast cancer includes two types of therapy; the first is local therapy and 
the second is systemic therapy. Local therapy is intended to treat a tumor at the site without 
affecting the rest of the body; examples of local therapy are surgery and radiation therapy. 
Systemic therapy refers to drugs that spread throughout the body to eliminate or slow the 
growth of cancer cells. This type of therapy includes chemotherapy, hormonal therapy and 
molecular targeting therapy (biology therapy) [14]. The treatment plan is dependent on 
tumor size, degree of differentiation of the tumor and the presence of axillary metastases. 
Each type of therapy can be applied separately or in combination across time. 
Survival rates are often used to indicate the outcome of the breast cancer treatment. 
According to the American Cancer Society’s report, the 5-year survival rate (i.e. the 
percentage of patients who live at least 5 years after being diagnosed with breast cancer) 
for patients with stage I = 88%, stage IIA = 81%, stage IIB = 74%, stage IIIA = 67%, stage 
IIIB = 41%,  stage IIIC = 49%, and stage IV = 15% [15]. In the USA, the mortality rate 
is gradually decreasing which has been attributed to the advancement of breast cancer 
treatment. Women’s survival has improved by approximately 13% since the mid-1970s [16]. 
However, in Indonesia and also other developing countries the mortality is still increasing 
[3]. It has been suggested that besides the late presentation of the disease, patient’s non-
adherence to treatment is also an important factor attributed to ineffective breast cancer 
treatment in developing countries [17]. 
1.4 Psychosocial aspects of breast cancer
As cancer is a chronic and frequently terminal disease, receiving a breast cancer diagnosis 
can be one of the most threatening negative events women ever experience. Women who 
are diagnosed with breast cancer are faced with multiple stressors throughout their illness 
trajectory. Current cancer care has been improved a lot by the advancement in medical 
treatment programs. Women are generally provided with information about the details of 
their cancer diagnosis and prognosis and they are also involved in the decision-making 
process related to treatment. Still, women may experience several mental and behavioral 
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disturbances as an adverse effect of breast cancer diagnosis and treatment. A review study 
about behavioral symptoms in patients with breast cancer and survivors found that the 
most common mental and behavioral disturbances related to breast cancer were fatigue, 
sleep disturbance, depression, and cognitive impairment [18]. Previous literature reported 
that one third to 45% of cancer patients reported significant psychological distress [19]. 
In Western and Asian women with breast cancer, anxiety and depression are the most 
prevalent psychological problems. The prevalence of anxiety ranges from 21.1% to 29% [20-
23], whereas the prevalence of depression ranges from 4.5% to 37% [24]. Previous studies 
have found that anxiety and depression are associated with several negative outcomes, 
namely: poor adherence to medical recommendation [25] and low quality of life [22, 26]. 
Besides psychological distress, women with breast cancer have also reported the 
following psychosocial issues: fear of recurrence, changes in body image and sexuality, 
intrusive thoughts about illness and existential concerns regarding mortality [27]. As these 
problems may lead to serious mental health issues, it is important to assess patient needs, 
distress, concerns, and the social context in which care is delivered. 
1.5 Non-adherence to treatment
In general, the term adherence refers to the extent to which a patient’s behavior coincides 
with medical advice [28], such as filling prescriptions, taking medication appropriately, 
attending follow-up appointments, and executing behavioral modifications. Many 
health providers prefer to use the term adherence instead of compliance because it is 
non-judgmental and describes a statement of fact rather than of blame of the patient, 
prescriber, or treatment [29]. In the context of chronic disease, which needs long-term 
therapy, the World Health Organization (WHO) defines non-adherence as the extent to 
which a person’s behavior – taking medication, following a diet, and/or executing lifestyle 
changes, corresponds with agreed recommendations from a health care provider [30]. 
As the term non-adherence covers a broad range of behaviors, Levinsky & O’Donohue 
elaborated that non-adherence to treatment may appear in several forms, namely: (1) not 
initiating a recommended treatment, (2) not attending or coming late to appointments, (3) 
not completing behavioral recommendations, (4) not taking medication as prescribed, and 
(5) terminating the treatment prematurely [31]. 
A meta-analysis study of 569 published empirical studies about patient adherence 
to medical recommendations found that the rate of non-adherence ranged from 11.7% to 
34.5%, with an overall average non-adherence rate of 24.8%. People with HIV disease, 
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arthritis, gastrointestinal disorders or cancer reported higher adherence rates, whereas 
people with pulmonary disease, diabetes or sleep disorders reported lower adherence rates. 
In cancer patients, the non-adherence rate is 20.9% [32]. Specifically, in the breast cancer 
population, a previous study among Malaysian breast cancer patients found that 29% of 
patients were non-adherent to chemotherapy and 13% of patients were non-adherent to 
radiotherapy [33], whereas a study among Canadian breast cancer patients found that 22% 
of patients discontinued adjuvant endocrine therapy within 2 years [34] . To the best of our 
knowledge, the adherence rate in the Indonesian breast cancer population is not known, 
however previous cancer studies found a considerable non-adherence rate. For example, a 
study in childhood leukemia found that 25% of patients refused or abandoned therapy [35]. 
Another study in retinoblastoma patients found that 31.5% of patients temporarily refused 
medical treatment, whereas 18.2% of patients refused treatment permanently [36]. 
Non-adherence to treatment has been found to have several serious consequences, 
including poor clinical outcomes, higher (re)hospitalization rates and increased health care 
costs [37]. A meta-analysis study found that patients with high adherence to the overall 
treatment regiment were 26% more likely to have a good clinical outcome than patients with 
low adherence [38]. A study among Indonesian retinoblastoma patients found that patients 
who had initially refused therapy but had later been readmitted to the hospital (temporary 
refusal) had significantly lower survival rates than patients who had not refused therapy. 
In addition, temporary-refusal was also found to be highly associated with progression of 
tumor stage [36]. While data about the direct and indirect health care costs related to non-
adherence in Indonesia are not yet available, the U.S. health care system has reported that 
annual direct costs are approximately $100 billion and that annual indirect costs exceed 
$1.5 billion in lost patient earnings and $50 billion in lost productivity [39]. 
1.6 Factors related to non-adherence to treatment
Over the last several decades, experts of health, behavioral and social sciences have 
investigated the prevalence of non-adherence to medical recommendations and its 
underlying factors. Experts have suggested a comprehensive approach to the non-adherence 
phenomenon due to its multidimensionality and complexity. The ecological model suggests 
that poor adherence does not only concern patients, but also involves several other levels 
of factors, i.e. micro-level (health care provider and social support), meso-level (health care 
organization), and macro-level (health policy) [37]. Although health care systems, therapy-
related problems, economic and logistic concerns are important factors in adherence, poor 
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adherence to medical recommendations is a behavioral problem at root [40]. Therefore, 
patients’ psychosocial characteristics may influence their adherence in both direct and 
indirect ways [41]. A conceptual review and synthesis study about common psychosocial 
factors underlying adherence in breast cancer treatment differentiated potential factors into 
two groups, namely, cognitive variables and socio-emotional variables [40]. Both groups, 
which are studied in this thesis, are elaborated below:
1.6.1 Cognitive variables
Breast cancer knowledge. Commonly, cognitive aspects refer to women’s knowledge about 
breast cancer which is assumed to have some influence on their adherence to treatment. 
Although there is only limited literature that examined the association between knowledge 
and treatment adherence, poor knowledge about risks for cancer, treatments and outcomes 
of treatments has been known to be associated with poor adherence to screening programs 
[42-45]. Breast cancer knowledge has been assumed to have a positive effect to patients’ 
survival. In long-term survival patients, better knowledge about breast cancer may stimulate 
early consultation and may lead to early average stage of presentation which may result in 
a longer survival [46]. A study among breast cancer patients found that better knowledge 
was a predictor of greater adherence to lymphedema risk management recommendations 
[47].
Illness perceptions. The Common Sense Model of Illness Cognition assumes that 
patients respond to symptoms and signs of illness by forming cognitive and emotional 
representations of the illness on the basis of concrete and abstract sources of information 
available to them [48]. This model suggests that illness perceptions will have an effect 
on patients’ coping behaviors and psychological outcomes, including adherence [49]. 
These perceptions consists of eight dimensions, namely, (1) consequences, the perceived 
consequences of the illness on the patient’s life; (2) time line, the perceived duration of the 
illness; (3) personal control, the perceived personal control over the illness; (4) treatment 
control, how much the patient thinks treatment helps to control the illness (5) identity, 
symptoms that the patient attributes to the illness; (6) illness concern, how much the patient 
worries about his/her illness;  (7) coherence, how well the patient understands his/her illness; 
and (8) emotional representation, how much the patient is emotionally affected by his/her 
illness [50]. A review study of patients’ illness perceptions and medication adherence found 
that having more positive perceptions about the duration of the illness and consequences 
on the overall quality of life or functional capacity, having stronger beliefs in their personal 
and treatment control over their illness, having less worries about their condition and being 
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less emotionally affected by the illness were positively associated with better adherence, 
whereas having better or poor understanding of their illness was not associated with 
adherence to medication [51].
Health locus of control. Locus of control (LOC) has been suggested as a potential 
predictor of better adjustment to cancer [52-53]. The concept of LOC originally comes 
from Rotter’s Social Learning Theory and is defined as a person’s belief about the location 
of controlling forces in their life, either internal or external [54]. Wallston and colleagues 
[55]  developed the Health Locus of Control (HLC) concept to examine an individual’s 
generalized expectations about where the control over his or her health resides. Individuals 
with an internal HLC believe that what happens to their health condition results from their 
own actions, whereas individuals with an external HLC believe that their health condition is 
controlled by external forces, such as chance, doctors, powerful others. Later, Wallston and 
colleagues developed the God locus of health control concept which refers to individuals’ 
beliefs about God’s control over their health [56]. Associations between HLC, adherence 
and non-adherence behaviors have been investigated in chronically ill patients. Although 
internal HLC was assumed to be positively associated with better adherence, previous 
studies showed mixed results. For example, some studies among diabetes patients have 
found that internal HLC was associated with better adherence to medication [57-58], 
whereas others found no association between internal HLC and adherence to medication 
[59-60]. Conversely, a study that investigated breast cancer patients who were intentionally 
non-adherent (e.g. choosing not to take their medication) and who were not intentional 
non-adherent to medication (i.e. forgetting to take their medication) found no evidence that 
a high belief in external HLC (i.e. chance) was associated with poor adherence [61].  
Satisfaction with cancer information. The provision of sufficient and adequate 
information is one of the main elements of supportive care in cancer treatment. A review 
study about information provision among cancer survivors found that patients who were 
satisfied with the information provided by health professionals had a better quality of life 
than dissatisfied patients [62]. However, previous studies on information provision among 
cancer patients found that the information supplied by health care providers frequently 
does not meet patients’ individual informational needs [63-65], which may lead to patients’ 
dissatisfaction. Previous studies that examined the association between satisfaction with 
information and adherence found that patients who were satisfied were more likely to 
comply with medical recommendations and treatments [66-67].  
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1.6.2 Socio-emotional variables
Psychological adjustment. Women with breast cancer may not only experience psychological 
distress at the time of diagnosis, but also years after disease diagnosis and treatment 
[68]. Previous studies have found that patients’ psychological distress is associated with 
treatment non-adherence. For example, a study among adolescent cancer patients found 
that depression is positively associated with non-adherence [69]. A review study about risk 
factors for noncompliance with medical treatment found that the non-adherence rate in 
depressed cancer patients is had 3 times higher than in non-depressed patients [25]. 
Socio-demographic and economic status. Although previous literature showed 
inconsistent associations between socio-demographic and economic status and non-
adherence to medical recommendations, low socioeconomic status may have a stronger 
influence on patients’ health behaviors in developing countries. For example, financial 
problems may put patients in the dilemma between continuing cancer treatment and 
fulfilling other priorities, such as children’s education expenses. Moreover, a review study 
about inequalities in health care use in developing countries showed significant differences 
in treatment provision by health-care providers and subsequent differences in treatment 
outcome between patients with different socio-economic status [70]. Sabaté [30] summarized 
several factors that have been reported to be associated with adherence, namely: poor 
socioeconomic status, poverty, illiteracy, low level of education, unemployment, lack of 
effective social support networks, unstable living conditions, long distance from a treatment 
centre, high cost of transport, high cost of medication, changing environmental situations, 
culture, and misconceptions about illness and treatment.
1.7 This thesis
1.7.1 Aims and research questions
The main aim of this thesis was to identify possible psychosocial risk factors for non-
adherence to treatment and for poor psychological adjustment in Indonesian women 
with breast cancer. When required, Indonesian versions of the measurement instruments 
concerned were developed and validated. 
The research questions of this thesis are as follows:
Concerning non-adherence:
•	 What	 are	 the	 self-perceived	 reasons	 for	 delay	 in	 seeking	 help	 and	 non-adherence	 to	
treatment in Indonesian women with breast cancer? (Chapter 2)
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•	 Which	 psychological	 factors	 are	 associated	 with	 non-adherence	 to	 treatment	 in	
Indonesian women with breast cancer? (Chapter 6)
Concerning psychological adjustment:
•	 Is	the	Indonesian	version	of	Distress	Thermometer	valid?	(Chapter	3)
•	 Is	the	health	locus	of	control	of	Indonesian	women	with	breast	cancer	different	than	of	
healthy women? (Chapter 4)
•	 Is	health	locus	of	control	associated	with	anxiety	and	depression	in	Indonesian	women	
with breast cancer? (Chapter 4)
•	 How	satisfied	are	 Indonesian	women	with	breast	 cancer	with	 the	 information	 they	
received from health care professionals? (Chapter 5)
•	 What	 is	 the	 relation	 between	 illness	 perceptions	 and	 quality	 of	 life	 in	 Indonesian	
women with breast cancer? (Chapter 5)
1.7.2 Outline of the thesis
The thesis is structured as follows. Chapter 2 presents our qualitative study about 
psychosocial and cultural factors of non-adherence in Indonesian women with breast 
cancer. Chapter 3 explores psychological distress in women with breast cancer and 
presents the validation of the Indonesian version of the Distress Thermometer, as well as 
the cut-off score to be applied in the Indonesian cancer population. The study in chapter 4 
investigates the difference in health locus of control between Indonesian women with breast 
cancer and healthy women, and assesses its associations with anxiety and depression. In 
chapter 5 women’s satisfaction with cancer information is examined and its association with 
illness perceptions and quality of life is also discussed. Chapter 6 presents the quantitative 
study of psychological factors associated with non-adherence to treatment in Indonesian 
women with breast cancer. This thesis concludes with a general discussion of the findings 
in Chapter 7. Implications for clinical practice and future research are presented as well.
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Abstract
Objective: The aim of this study was to explore reasons for delay in seeking medical help and 
non-adherence to treatment in Indonesian women with breast cancer. 
Methods: Semi-structured interviews were conducted by purposive sampling, using 
a consecutive sample of 50 breast cancer patients who were treated at the Outpatient 
Surgical Oncology Clinic of Hasan Sadikin Hospital in Bandung, Indonesia. Interviews were 
recorded, transcribed verbatim and coded using qualitative software. Codes were merged 
into main themes that were subsequently mapped onto the study’s aim.
Results: Eight main themes concerning reasons for delay in seeking medical help and 
treatment non-adherence emerged, namely: lack of awareness and knowledge, cancer 
beliefs, treatment beliefs, financial problems, emotional burden, severe side effects, 
paternalistic style of communication and unmet information needs.
Conclusion: This study has identified several modifiable psychosocial and cultural factors 
related to delay in seeking help and non-adherence to treatment in breast cancer patients. 
We suggest that the provision of extensive information through media campaigns, treatment 
decision aids, and caregiver and patient education are needed to change the illness 
behaviors of Indonesian breast cancer patients.
Keywords: Breast cancer, psychosocial factor, non-adherence, Indonesia.
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Introduction
Breast cancer is the most frequently occurring cancer and the leading cause of death 
among Indonesian women. The incidence rate per 100,000 people is 36.2 and the mortality 
rate is 18.6; both numbers are increasing [1-3]. Although the incidence of breast cancer in 
Indonesia is lower than in developed countries, the mortality rate is higher [4]. Similar to 
other low- and middle- income countries, poorer survival among breast cancer patients is 
largely due to late presentation of the disease. This condition is compounded by lack of 
resources for diagnosis and treatment [5-6]. Previous breast cancer studies in Indonesia 
found that about 60%-70% of patients had come to the hospital when the disease was 
already in advanced stages (III and IV) and 35% of them were metastasized [7-9].
In addition to a delay in seeking medical help, non-adherence to treatment has been 
recognized as a factor that leads to unfavorable outcomes among breast cancer patients. The 
World Health Organization (WHO) defines adherence as a multi-dimensional phenomenon 
which is determined by the interplay of five dimensions, namely: (a) social and economic 
factors (e.g. poor socioeconomic status, low level of education, cost of medications); (b) 
health care system-related and health care team-related factors (e.g. poorly developed 
health services, poor medication distribution systems); (c) condition-related factors (e.g. 
severity of symptoms, level of disability); (d) therapy-related factors (e.g. the immediacy of 
beneficial effects, side-effects, duration of treatment); and (e) patient-related factors (e.g. 
self-efficacy, knowledge, treatment beliefs and perceived barriers to adherence) [10]. Non-
adherence to treatment may appear in the following forms: (1) not initiating a recommended 
treatment, (2) not attending or coming late to appointments, (3) not completing behavioral 
recommendations, (4) not taking medication as prescribed, and (5) terminating the treatment 
prematurely [11]. A study in the USA found that early discontinuation and non-adherence 
to adjuvant hormonal therapy was associated with increased mortality [12]. Up until now, 
the general adherence rate in Indonesian cancer population is not known. However, one 
study in childhood leukemia found that 25% of patients refused or abandoned therapy [13]. 
A study in retinoblastoma patients found that 31.5% of patients temporarily refused medical 
treatment, whereas 18.2% refused treatment permanently [14].
Factors that are allegedly associated with adherence have been investigated in several 
Western countries. Demographic factors such as higher income and education have been 
found to be associated with a higher level of adherence, whereas age and gender were not 
associated [15]. In addition to demographic factors, psychosocial and cultural factors have 
also been recognized as potential predictors of adherence in developing countries. The 
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lack of breast cancer awareness, social taboos of cancer, misconceptions about cancer 
treatment and strong beliefs in traditional treatment were identified as main barriers to 
achieve early diagnosis and effective treatment of breast cancer in developing countries 
[16]. 
Each culture has its own system of beliefs, perceptions and ideas about health and 
illness [17], which affect people’s response to their illness. People’s beliefs about their illness 
and medication have been found to be related to treatment adherence [18-19]. Marked by 
a high degree of religious, cultural and social diversity, Indonesia provides a unique socio-
cultural environment which influences people’s perceptions, attitudes and behaviors in daily 
life [20]. Previous studies about treatment refusal in retinoblastoma patients and childhood 
leukemia patients found that psychosocial factors such as beliefs about the incurability of 
cancer, belief in alternative treatments and dissatisfaction with health-care providers were 
frequently reported by patients as reasons for non-adherence [13-14]. To the best of our 
knowledge, qualitative research that systematically explores the psychosocial and cultural 
factors for non-adherence in Indonesian women with breast cancer patients has never 
been conducted.
The aim of this qualitative study was to explore reasons for delay in seeking help and 
non-adherence to treatment in Indonesian women with breast cancer. Identifying modifiable 
psychosocial and cultural factors influencing people’s illness behavior is important to 
determine the focus of a future interventions to increase help-seeking and non-adherence 
to treatment in Indonesia.
Methods
Participants
This study was part of a larger quantitative study in which the potential determinants of non-
adherence to treatment in Indonesian breast cancer patients were studied (in preparation). 
Due to the lack of prior knowledge about predictors of delay in seeking help and non-
adherence to treatment in Indonesian patients, we decided to apply purposive sampling by 
recruiting consecutively 50 participants at the outpatient surgical oncology clinic of Hasan 
Sadikin Hospital (HSH) in Bandung, Indonesia between April-June 2010. This version of 
purposive sampling was chosen to obtain a sample with clear information concerning the 
criteria of seeking medical help and treatment non-adherence from their medical records. 
Inclusion criteria were (a) age >18 years, (b) diagnosis of breast cancer, (c) and adequate 
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command of the Indonesian language. Patients were ineligible if they had any major 
psychiatric disorder as assessed by their physician or if they were too ill. 
Procedure
This study was approved by the Indonesian Medical Ethical Committee and the Board of 
Directors of HSH. A member of the administration staff of HSH identified eligible patients, 
explained the study purpose to them and asked for their initial consent to participate. One 
week later, the interviewers met with the patients who were willing to participate, asked 
them to sign a consent form and scheduled the interviews. The interviewers conducted 
semi-structured interviews in the clinic waiting room while participants waited for their 
appointment. We set a convenience place in the corner of the room outside hearing distance 
of other patients to provide privacy.
Data Collection and Analysis
This study followed the principles of the Grounded Theory which consists of systematic 
guidelines for gathering, synthesizing, analyzing and conceptualizing qualitative data to 
construct a theory grounded in the data from which it was developed [21]. This approach 
was chosen given the lack of prior knowledge about non-adherence in the Indonesian 
culture. To obtain good quality data we conducted semi-structured interviews to explore 
patients’ experiences during their diagnosis and treatment. Interviews were conducted by 
seven master students in clinical psychology who first received a two-day interview training 
by two clinical psychologists. The training included instruction, demonstration, role-play and 
feedback. The trainees received information about the medical and psychological aspects 
of breast cancer, as well as information about the study and the semi-structured interview. 
Each interviewer was supervised by the first author during their first interview and received 
feedback afterwards.
Firstly, participants were asked about their demographic characteristics and back 
ground, including age, gender, marital status, education level, employment status, insurance 
status and family history of breast cancer. Afterwards, participants were interviewed on 
the following topics: knowledge of the disease, perceived disease severity, information 
provided by the patient’s physician, use of health services and alternative treatment, 
attitudes towards western and traditional medicine particularly in relation to the patient’s 
disease, the perceived benefits of, and barriers to, treatment and non-adherence to medical 
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recommendations. The semi-structured interviews took an average of 30-45 minutes and 
all interviews were transcribed verbatim by the master students.
To determine the delay in seeking help and uptake of treatment we adopted a 
three-month interval as our gold standard, since there is strong evidence that a delay in 
presentation of symptomatic breast cancer of three months or more is associated with 
lower survival [22-23]. We defined delay in seeking help if the period from the first breast 
symptom to the first medical consultation was >3 months; and delay in uptake of treatment 
if the period between the first diagnosis and the first admission at HSH was >3 months. 
Treatment non-adherence was defined if patients were absent from two or more consecutive 
treatment sessions at HSH [24].   
We used a thematic analysis that refers to the principles of the Grounded Theory [25]. To 
achieve data analysis consistency, we used a qualitative software program ATLAS.ti version 
5.2 [26]. The interview results were first typed in Word files and saved as plain text and 
subsequently the documents were assigned as a hermeneutic unit in the ATLAS.ti package. 
The first author coded the transcripts using open coding, after which codes obtained during 
the analysis were compiled into categories that covered all relevant information. Finally the 
categories were merged into main themes that were subsequently mapped onto the study’s 
aim. The codes, categories and themes were discussed regularly with the second author 
until agreement on the themes was reached. Frequencies and percentages of patients 
mentioning a theme were calculated and typical citations were noted.
Results
A total number of 54 patients were approached. Fifty patients agreed to be interviewed and 
four patients declined to participate because they were too ill to be interviewed. As shown 
in table 1, the participants’ ages ranged from 34 to 65 years. Thirty-nine participants had 
received junior high school or lower education. Forty-four participants were married and 
the rest were widows. The majority of the participants were housewives or unemployed. 
Thirty-two participants had advanced cancer (stages TNM III and IV) and 48 participants 
had undergone chemotherapy. Sixteen participants had a family history of breast cancer. 
Forty-six participants had health insurance provided by the government to poor people, 
whereas the other women financed their own medical expenses.
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Table 1. Demographic and clinical characteristics of study participants
Variable n (%)
Age range
30-39 16 (32%)
40-49 18 (36%)
50-59 13 (26%)
60-69 3 (6%)
Marital Status
Married 44 (88%)
Never married 0 (0%)
Divorced 0 (0%)
Widowed 6 (12%)
Education (yrs)
None 3 (6%)
Elementary school (1-6) 23 (46%)
Junior high school (7-9) 13 (26%)
Senior high school (10-12) 11 (22%)
College (> 13) 0 (0%)
Employment
Housewife/unemployed 42 (84%)
Laborer/irregular job 7 (14%)
Private employee 1 (2%)
Stage of cancer 
1 0 (0%)
2 18 (36%)
3 29 (58%)
4 3 (6%)
Treatment
Surgery 35 (70%)
Chemotherapy 48 (96%)
Radiotherapy 16 (32%)
Residency 
Bandung 10 (20%)
Outside Bandung 40 (80%)
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Place of the first diagnosis
District Hospital 40 (80%)
Hasan Sadikin Hospital 10 (20%)
Health insurance 
Yes 46 (92%)
No 4 (8%)
Family history of breast cancer
Yes 16 (32%)
No 34 (68%)
Delay in seeking help, treatment delay and treatment 
non-adherence
Thirty-five participants had delayed in seeking help, with the time of delay ranging from 4 
to 24 months, except for the four participants (P.8, P.17, P.28 and P.49) who had delayed 
for 4 years, 10 years, 3 years and 15 years, respectively. The median duration of delay 
was 7 months. The majority had an advanced stage of cancer when they visited a doctor 
or a hospital. After receiving a cancer diagnosis, twenty-one participants had delayed 
treatment uptake at HSH with the time of delay ranging from 4 to 24 months, except for the 
two participants who had delayed for 4 years. The median time of treatment delay was 6 
months. Ten participants reported that they had missed two or more consecutive treatment 
sessions during their treatment at HSH.
Factors related to treatment non-adherence
We constructed a theoretical model to describe factors related to delay in seeking medical 
help and non-adherence to treatment (Figure 1). Eight themes emerged from our data; 
these themes were categorized into 3 clusters, namely: (1) factors related to patients (lack 
of awareness and knowledge, cancer beliefs and treatment beliefs), (2) factors related to 
treatment (financial problems, emotional burden and severe side effects), and (3) factors 
related to patient-health provider relationships (paternalistic style of communication and 
unmet information needs). In the rest of this section we will elaborate the eight main 
themes.
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Factors related to patients
Lack of awareness and knowledge
Most of the participants had not intentionally delayed seeking medical treatment. They had 
not been aware of the breast cancer risks due to limited knowledge. The majority of the 
participants had received only junior high school or lower education and also reported 
a lack of information provision about breast cancer in rural areas. Lack of breast cancer 
knowledge was the reason that many participants underestimated the severity of their 
disease, also because its symptoms had not hindered their daily activities. Even when 
the participants had already undergone the treatment program at HSH, some of them had 
poor knowledge about breast cancer. For example, one participant said “I don’t know what 
exactly the cause of my breast cancer is. I think it is because I wore my bra too tight. It may 
have irritated my breast skin and after a long period that developed into cancer” (P.36).
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Cancer beliefs
The majority of the participants described breast cancer as a dangerous, deadly and 
incurable disease. These cancer fatality beliefs were based on stories and breast cancer 
experiences of their relatives and neighbors or on media sources, such as magazines and 
newspapers. “This disease is very dangerous; I have seen my relatives and my neighbor 
who had breast cancer. They did not recover and finally died” (P.39). Some participants 
described breast cancer as a shameful disease because it threatened their womanhood 
and affected their identity as a wife or mother. They tended to hide and avoid discussing 
their illness with other family members. In addition, some participants believed that cancer 
could be passed down in the family. “I heard from people that if the mother has cancer now, 
tomorrow the children will have it too” (P.19). Moreover, some participants believed that 
their cancer was beyond their control because God determined their fate. They seemed to 
surrender and accepted their illness because they believed that an individual’s faith cannot 
be changed and their illness is divine and aimed at testing their faith. “This cancer is my 
destiny; I just have to be patient, accept my condition and try to seek a treatment, but only 
God can heal” (P.13).
Treatment beliefs
The majority of participants perceived medical treatment of cancer involving frightening 
medical procedures, particularly surgery. Moreover, they perceived surgery as a painful 
treatment causing the loss of an essential organ. They described surgery as a process 
where a person is brought unconscious to an operating room with doctors wearing special 
clothes proceeded to use frightening operation tools. This fear of surgery was also a 
common reason to delay their treatment at HSH. “When the doctor said that I got cancer 
and I had to be operated immediately in HSH, I was shocked because I was really afraid of 
surgery. I decided not to come to HSH until I was ready for it” (P.40).
In addition to fear and misconceptions about medical treatment, we found that the 
majority of the participants had a strong belief in traditional healers. This belief seemingly 
influenced participants’ treatment decisions; they perceived the traditional healer as an 
alternative solution for their health problem or as a complement to medical treatment. 
In the current study, many participants had consulted traditional healers, such as herbal 
therapists, acupuncturists and spiritual therapists. Most participants consulted a traditional 
healer after they had received a breast cancer diagnosis in a district hospital. Several 
reasons accounted for their decision to consult a traditional healer, namely: recommendation 
from their husband or relatives, healers provided treatment without surgery, affordable 
 33
consultation fee and transportation costs, and a holistic care approach. Some patients 
preferred traditional healers because they not only focus on patients’ physical symptoms, 
but also on their feelings. “I was really afraid of surgery, it was not wrong to try another 
treatment such as herbal medicine and another method of traditional treatment which were 
more comfortable for me” (P.5).
Factors related to treatment
Financial problems
Most of the participants reported that the high cost of medical treatment was a main 
factor influencing their decision to undergo medical treatment at the referral hospital. In 
the current study, most people who had limited financial resources had been advised to 
apply for government health insurance to cover their medical expenses. Nevertheless they 
still had difficulty in paying their transportation, accommodation and logistical expenses. 
Moreover, a majority of participants reported that they came to the hospital accompanied 
by one to three family members which increased their financial burden. “Although all 
medical treatment cost were covered by the government insurance, I had to wait until I had 
enough money to pay transportation, food and another expense for me and my family who 
accompanied me, because the distance from my home is quite far” (P.30).
Emotional burden
The long duration of cancer treatment led to more psychological burden. Many participants 
worried about the uncertain outcome of the treatment and this influenced their cancer 
curability beliefs in the some extent. Some participants expressed their fear of death; they 
were worried that the treatment could not cure their cancer and that their body would only 
suffer more due to the disease and the side effects of treatment. “Sometimes, I was really 
worried about my treatment effectiveness. I had to be optimistic that my cancer can be 
cured, however side effects often ruined my optimism. I am afraid that my body cannot 
handle this cancer anymore and I will die shortly” (P.26). In addition, some participants felt 
despair and guilt towards their husband and children because their treatment was time and 
energy consuming and reduced their ability to function as a wife and mother. 
Severe side effects
A large number of participants expressed that severe side effects were among the reasons 
they missed their treatment schedule. The majority of participants reported that the side 
effects of chemotherapy were the most burdensome for them. Of the side effects mentioned, 
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most included pain, fatigue, nausea, dizziness, loss of appetite, sleep disturbance and 
hair loss. “I had to undergo chemotherapy and the side effects were very uncomfortable. 
I felt pain, fatigue, nausea and dizziness that limited my daily activities. Sometimes, I was 
thinking about not keeping to my chemotherapy schedule due to those side effects” (P.3).
Factors related to patient-health provider relationships 
Paternalistic style of doctor-patient communication
The majority of participants perceived that doctors have higher status than patients. They 
reported having a non-assertive style of communication during consultations with doctors 
to show respect and avoid conflict. Some of them felt inferior to the doctors because they 
came from a rural area and had low education. Many participants who wanted to know 
more about breast cancer causes and their treatment procedure never dared to ask the 
doctor for more information. “I am a low educated person and come from a rural area; I just 
follow the doctor’s advice for my health and I do not dare to ask anything” (P.22)
Unmet information needs
Participants had obtained information about diagnosis and treatment from the doctors 
in the hospital. Most information had been delivered orally and written information was 
seldom provided. Some participants reported that information provided by doctors during 
consultations did not meet with their needs or expectation because the information was 
scant or unclear. The gap between needed and provided information appeared to have 
affected participants’ understanding and treatment adherence. Almost all participants 
reported having received information about the tests they had to undergo for diagnosis 
and the side effects of the treatment, however only a few of them received clear information 
about the positive effects of the treatment. Moreover, some patients did not know the 
detrimental consequences of missing or postponing their treatment program. “The doctor 
just asked me to follow the entire treatment program and explained its possible side effects, 
such as hair loss, blackened skin on fingers, nausea, fatigue, dizziness, eating and sleeping 
disturbance” (P.21). 
Discussion
This study is the first study exploring reasons for delay in seeking treatment and non-
adherence to treatment in Indonesian women with breast cancer. The results of this 
qualitative study suggest eight main factors related to delay in seeking treatment and 
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non-adherence to treatment, namely: lack of awareness and knowledge, cancer beliefs, 
treatment beliefs, financial problems, emotional burden, severe side effects, paternalistic 
style of communication and unmet information needs.
Lack of breast cancer awareness and inadequate knowledge about signs and 
symptoms of breast cancer seem to influence women’s ability to recognize breast cancer 
symptoms, disease severity and the necessity of seeking medical help. This finding is 
in accordance with previous studies in other developing countries which found that lack 
of awareness and knowledge is an essential predictor of delay in presentation of breast 
cancer [16, 27-29]. Several problems may contribute to this lack of knowledge, such as 
lack of health awareness and education, limited health education programs, particularly 
in rural or isolated areas and insufficient information provided by the health care providers 
[16, 30-31]. Currently, printed material (e.g. leaflets and brochures) and electronic sources 
(e.g. website) with breast cancer information are being provided by the Indonesian Cancer 
Foundation. However, these sources of information appear not to have achieved an 
optimal impact due to lack of dissemination and lack of Internet access, particularly in 
rural areas. Several programs could be introduced to improve breast cancer awareness 
and knowledge that may contribute to lowering the number of delay in seeking medical 
help. The use of media campaigns, such as public service announcements on television, 
radio and newspapers, have been found to be an effective way to improve breast health 
knowledge, to teach women how to conduct breast self-examination and to increase breast 
health practices [32]. 
Perceptions and beliefs about symptoms, disease and health determine how individuals 
understand and respond to their illness [33-34]. In the present study, some women believe 
that cancer is incurable, that cancer is a shameful disease and can be passed down to 
their family members. Similar perceptions have been found in South Asian women with 
breast cancer living in the UK and Canada [33, 35]. These beliefs seem to influence their 
perception of the necessity to seek medical help and to start their treatment in the referral 
hospital. Likewise, a study in Malaysian women found that negative perceptions of breast 
cancer were the main reason for delay in the presentation of breast cancer [29].
Indonesians are well-known for their religiosity [36]; religion and spiritual background 
also seem to influence women’s perceptions and responses toward their illness. Women’s 
faith in God influences their attitude toward their illness and either encouraged or discouraged 
them to seek medical help. A majority of women felt that their faith in God helped them to 
face their cancer. Peek, Sayad, & Markwardt [37] and Barton-Burke, Barreto, & Archibald 
[38] argued that religion and spirituality can be resources that help patients cope with their 
Ch
ap
te
r 2
36 
illness and alleviate their fear about future health uncertainty and death. However, some 
women showed less motivation to fight their cancer and tended to resign themselves to 
their fate. This finding is in accordance with a breast cancer study in Iran [39] and supports 
another argumentation that reliance on God to cure cancer may discourage women from 
seeking medical care [40].  
In regard to treatment beliefs, some women had negative perceptions of Western 
breast cancer treatment, resulting in medical mistrust. In contrast, many women had a 
great belief in traditional healers. Women used traditional therapy as an alternative solution 
for their health problem or as a complement to medical treatment. There is ample evidence 
from previous studies describing that a strong belief in a traditional healer influences 
patients’ behavior and treatment decisions [16, 29, 41-42]. One explanation might be 
that traditional therapies are less expensive than ‘Western-type’ medical care, treatment 
without surgery and do not require expensive travel because traditional healers can be 
found locally. Furthermore, cultural and religious beliefs may persuade people to choose 
traditional therapies. For example, Moslem patients tend to consult traditional healers who 
offer Islamic consultation and treatment.  Our study suggests that women may also prefer 
traditional healers because they are not only focused on patient’s physical symptoms, but 
also on patient’s feelings. Up till now, there has been no registration system for traditional 
healer practices in Indonesia. This condition limits the possibility for dissemination of breast 
cancer information to traditional healers. Such information could encourage them to refer 
their patients to the hospital immediately when they recognize breast cancer symptoms. 
Moreover, there is a fierce competition between traditional healers and evidence-based 
medicine, which is even fought in television-advertisements. We feel that advocating 
the integration of traditional healing into medical health care should be regulated by the 
government to prevent conflicts and rejection.
Previous studies in developing countries found that financial problems are the main 
barrier to achieving effective early diagnosis and breast cancer treatment [16, 29, 43], and 
this was also an important factor in the current study. Not only women from developing 
countries worry about the costs of cancer treatment, Western women also perceived that 
medical treatment for breast cancer as expensive [42]. Although medical costs were covered 
by the government health insurance, patient adherence to treatment was still influenced by 
financial difficulties in paying transportation costs to the hospital, accommodation and other 
logistical costs, which is similar to previous studies in child leukemia and retinoblastoma 
patients [13-14]. 
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The long duration of treatment and its side effects lead to uncertainty about treatment 
effectiveness in women. Patients who reported having severe side effects were more likely 
to miss their treatment because they were too ill to come to the hospital or felt that the side 
effects were worse than cancer itself. A previous study in child leukemia patients also found 
that severe side effects were one of the main reasons for treatment abandonment [13]. In 
addition, women’s uncertainty about the effectiveness of their treatment may lead to higher 
distress. High distress is known to be associated with high levels of non-adherence [44]. The 
majority of the participants were married and many reported that the severe side effects 
limited their role-functioning as a mother and wife. Inability to perform their role as mother 
and wife for a long period often elicited feelings of guilt towards husband and children.
Optimal doctor-patient communication is essential to achieve good medical services. 
However, in Indonesia several barriers to effective communication appear to exist. Women 
do not assert themselves in the presence of doctors; they feel inferior and do not dare to 
ask for further information about their disease and treatment. A study on doctor-patient 
communication in Southeast Asia found that a paternalistic style is common in Indonesia. 
Doctors and patients are not prepared for a participatory style of communication and the 
high patient load in health care centers might exacerbate this [45]. Moreover, having lower 
education and coming from rural area seem to amplify women’s inferior attitude towards 
doctors during consultations. Similarly, a previous study about client communication 
behaviors in East Java and Lampung found that less educated patients experienced a greater 
social distance from the health service providers due to their limitation in understanding 
technical information [46]. 
Information provision by health professionals should ideally match patients’ needs. In 
the present study, most information about cancer diagnosis and treatment was delivered 
orally. Some participants reported that they received too little or too complicated information. 
The gap between needed and provided information appeared to have affected participants’ 
understanding and belief about treatment efficacy, which may decrease their treatment 
adherence. Llewellyn, Horne, McGurk, & Weinman [47] suggest that cancer patients who 
are not satisfied with the amount and content of the information received before treatment 
are more likely to be unsure about their treatment, suffer more symptoms and perceive the 
consequences of the illness to be greater.  
Several limitations of the current study should be considered. Firstly, the majority of the 
participants were married, housewife/unemployed and had lower education level, because 
HSH is a referral hospital for patients with government insurance for poor people. These 
demographic characteristics seem to have substantially influenced women’s perceptions 
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and beliefs about financial burden, motherhood role, and disease and/or treatment. As we 
used purposive sampling, limiting ourselves to patients in the HSH, our sample cannot be 
considered to be representative of the general population of breast cancer patients. We 
lack patients, for instance, who went for treatment abroad or those who never visited the 
hospital for treatment. However, it is probably a good representation of the patients at HSH 
because of the consecutive patient inclusion. Therefore, our findings need to be confirmed 
in women in the general breast cancer population. Secondly, delay time and adherence 
rate were obtained retrospectively through participants’ self report which may have caused 
recall bias. Thus, a prospective study is needed to ascertain participants’ delay and non-
adherence rate. 
In conclusion, this study has identified several modifiable psychosocial and culture-
related barriers to seeking medical help and adherence in breast cancer patients. We 
argue that not only financial support is needed to reduce non-adherence in Indonesia, but 
also extensive information provision through media campaigns and the use of treatment 
decision aids. Women undergoing breast cancer treatment seem to be burdened by severe 
side effects of treatment suggesting that education for cancer professionals, such as in-
hospital training about communication and symptom management for physicians and 
health professionals may be needed. The factors identified in this study present ample 
opportunities for future research, which may contribute to important understanding of illness 
behavior among cancer patients. Better understanding and knowledge of such factors is 
not only useful for physicians working in Asian countries, but also for physicians working 
with Asian populations in Western countries.
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Abstract
Purpose: This study aims to translate the Distress Thermometer (DT) into Indonesian, test 
its validity in Indonesian women with breast cancer and determine norm scores of the 
Indonesian DT for clinically relevant distress. 
Methods: First, the original version of the DT was translated using a forward and backward 
translation procedure according to the guidelines. Next, a group of 120 breast cancer 
patients who were treated at the Outpatient Surgical Oncology Clinic in Hasan Sadikin 
Hospital in Indonesia completed a standard socio-demographic form, the DT and the 
Problem List, the Hospital Anxiety and Depression Scale (HADS) and the WHO Quality of 
Life (WHOQOL-BREF).
Results: Receiver operating characteristic (ROC) curve analyses identified an area under 
the curve = 0.81 when compared to the HADS cutoff score of 15. A cutoff score of 5 on 
the DT had the best sensitivity (0.81) and specificity (0.64). Patients who scored above 
this cutoff reported more problems in the practical, family, emotional, spiritual/religious and 
physical domains (30 out of 36 problems, p-value<0.05) than patients below the cutoff score. 
Patients at advanced stages of cancer experienced more emotional and physical problems. 
Patient’s distress level was negatively correlated with overall quality of life, general health 
and all quality of life domains. 
Conclusions: The DT was found to be a valid tool for screening distress in Indonesian 
breast cancer patients. We recommend using a cutoff score of 5 in this population.
Keywords: Distress Thermometer, validation, quality of life, breast cancer, Indonesia.
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Introduction
In Indonesia, cancer incidence has an estimated number about 300,000 cases per year [1]. 
However, only 10% of these cases are treated in the health care system as the majority 
of these people do not seek medical help due to several factors, such as strong beliefs in 
traditional healers, fear and denial, and cultural taboos [2-3]. As one of the ten identifiable 
main diseases causing death in Indonesia [4], the diagnosis of cancer and its treatment 
often causes considerable psychological distress in patients. It has been recognized and 
reported in previous studies that 20-40% of cancer patients experience a significant level 
of distress [5-6]. Breast cancer is the primary cancer in Indonesia and its incidence and 
mortality rate is increasing [7]. Previous findings have shown that women with breast cancer 
experience psychological distress [8], even years after disease diagnosis and treatment 
[9]. Patients’ distress is associated with a number of negative outcomes, including low 
adherence to treatment recommendation [10], poor satisfaction with care [11] and poor 
quality of life [12]. 
Similar to developed countries [13-14], distress among cancer patients often goes 
unrecognized by health care professionals in Indonesia. The ratio between the amount of 
health care professionals and cancer patients is still far from ideal in Indonesia. Data from 
506 Government Hospitals in Indonesia showed that in average there are only 14 General 
Practitioners and 16 Specialists per hospital [4]. This condition may lead to several practical 
issues, including limited consultation time. In addition, a paternalistic style of doctor-
patient communication and patients’ unassertiveness are quite common in Indonesia [15]. 
These factors may also cause consultations to be focused primarily on physical aspects of 
cancer. 
The National Comprehensive Cancer Network (NCCN) states that distress should be 
recognized, monitored, documented and treated promptly at all stages of the disease and 
in all settings [16]. Considering the high patients load and the unbalanced ratio between 
patients and health care professionals in Indonesia, there is an urgent need for a short 
and effective screening tool to detect distress among patients. Ideally, such a tool should 
be able to assess distress across the physical, psychological, social and spiritual domains 
[17]. As current screening tools are long and burdensome for patients to complete, there is 
a need for a brief, valid and easy to complete measure of distress in this population. 
In order to meet this demand, the NCCN has developed the Distress Thermometer 
(DT) which is a single item that asks the patients to rate their distress using a visual 
analogue scale. It is accompanied by the Problem List (PL) that asks patients to identify 
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any of 36 issues that have been a problem for them in the past week. The DT is very brief, 
easy to administer and it uses a word for psychological problems with non stigmatizing 
connotations, namely distress [16]. This tool was initially developed by the NCCN and many 
studies have reported that the DT is an effective screening tool for detecting distress among 
various medical conditions, such as prostate carcinoma [18], bone marrow transplantation 
[19], lung cancer [20], breast cancer [8] and mixed site cancer [21]. The NCCN suggests 
that a score of 4 or higher on the DT indicates a clinically significant distress level [16]. 
Some validation studies using the Hospital Anxiety and Depression Scale (HADS) found 
the same cutoff score of 4 [22-24], whereas other authors found that a cut off score of 5 [25-
28] best distinguished distressed patients from non-distressed ones. Most studies found 
that DT scores above the cutoff are correlated with emotional, family and physical problems 
as measured by the Problem List. However, results on spiritual and religious concerns are 
inconclusive [21-23]. 
The Distress Thermometer has been successfully translated from English into several 
languages, such as Arabic [29], Dutch [30], Japanese [25], Korean [23], Turkish [24] and 
Italian, Spanish and Portuguese [27], but it has not yet been used in Indonesian cancer 
patients. Therefore, this study aims to translate the DT into Indonesian, test its validity 
in Indonesian women with breast cancer by comparing it with a well-established distress 
measure, i.e. the HADS, and to determine norm scores of the Indonesian DT for clinically 
relevant distress. The other aim was to establish the validity of the DT by examined its 
associations with the Problem List scores, socio-demographic and clinical characteristics, 
and quality of life. 
Methods
Participants
Consecutive sampling was used to recruit 120 women with breast cancer from the outpatient 
surgical oncology clinic at Hasan Sadikin Hospital (HSH) Bandung in two phases. The 
first group of 50 patients was recruited between April-June 2010; the second group of 70 
patients was recruited between June-October 2011, due to logistical reasons. Inclusion 
criteria were age >18 years, first diagnosis of breast cancer and adequate command of the 
Indonesian language. Patients who had been treated by psychiatrists were excluded from 
the study.   
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Ethics statement
The study was approved by the Indonesian medical ethical committee and the Board of 
Directors of Hasan Sadikin Hospital. All samples were obtained with written informed 
consent reviewed by the ethical board.  
Procedures
This validation study was part of a larger investigation in which the correlates of non-
adherence behavior in Indonesian breast cancer patients were explored. After receiving 
written permission from the NCCN, we used the forward and back translation method to 
translate the DT, since this method is the most frequently recommended and used method 
in translation guidelines for cross-cultural studies [31]. One of the authors of this study (A.I) 
who is a clinical psychologist translated the DT from English into the Indonesian language; 
the back translation into English was carried out by an English language teacher (J.H) who 
is a Native American who speaks the Indonesian language fluently and who has been living 
in Indonesia for 6 years. Upon completing the translation, a linguist (A.C) examined the 
original English version and the back translation version of the DT to assess the significance 
of any discrepancies. After some discussions with A.C, we finalized the Indonesian version 
of the Distress Thermometer.
A member of the administration staff of HSH identified eligible patients, explained the 
study purpose to them and asked for their initial consent to participate. One week later, those 
who wanted to participate were approached by one of the research assistants before their 
next visit to their physician. Ten master´s students in clinical psychology were trained as 
research assistants and were supervised by S.S (clinical psychologist) and A.I. The research 
assistant provided further information about the study and instructions on how to fill in the 
questionnaires. After informed consent had been obtained, participants filled in the DT, the 
HADS, the World Health Organization Quality of Life (WHOQOL-BREF) and a demographic/
background data form. Participants filled out the questionnaires in the waiting room before 
their consultations. Ten of the participants were illiterate, but they were able to speak and 
understand the Indonesian language. In these cases, the research assistants read both the 
informed consent form and the questionnaires out loud. After the participants signed the 
informed consent form, the research assistants helped them to fill in the questionnaires.
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Measures
Socio-demographic and medical status.
A standard socio-demographic form was used to collect self-report data on age, marital 
status, education level, employment status, insurance status and family history of breast 
cancer. The patients’ medical status, such as type and stage of cancer as defined by the 
TNM stadium classification system [32], type of treatment and time since diagnosis were 
obtained via a medical chart review. 
Distress Thermometer (DT). 
The DT is a 1-item, self-report measure of psychological distress developed by the NCCN 
[16]. Patients are asked to rate their distress in the past week on an 11-point visual analogue 
scale ranging from 0 (no distress) to 10 (extreme distress). Afterwards, patients are asked 
to fill in the Problem List (PL) that accompanies the visual image of the DT to check whether 
or not (yes/no) they experienced any of the problems listed during the previous 7 days. 
The PL version used in this study consisted of 36 problems that were grouped into five 
categories, namely practical problems, family problems, emotional problems, spiritual/
religious concerns and physical problems. The PL aims to better define the nature of the 
problems which possibly cause the reported distress. To assess its association with the DT 
scores, the total amount of problems checked was calculated (range 0-36).   
Hospital Anxiety and Depression Scale (HADS).
The HADS is a 14-item self-report questionnaire that has been developed to assess 
psychological distress in people with medical illness [33]. It consists of 2 subscales; one 
subscale consists of 7 items to measure anxiety (HADS-A) and one subscale consists of 
7 items to measure depressive symptoms (HADS-D). Respondents are asked to indicate 
which of 4 options (rated 3-0) best describes their feelings during the previous week, which 
results in a maximum score of 21 on each subscale. The sum scores of the two subscales 
can be added up to a total score (HADS-T). The HADS has been widely used to validate 
the DT because of the similarity in their conceptual background [18, 22-27, 30, 34-35]. 
The HADS is available in the Indonesian language, but has not yet been psychometrically 
validated in Indonesian patients and cut-off scores for clinically relevant symptoms are not 
yet available. Therefore, in the present study we used the global cutoff score of the HADS 
total (>15) that in studies elsewhere distinguished best between people with and without 
clinically significant emotional distress [36-37]. Factor analysis of the Indonesian version 
 49
of the HADS demonstrated a two factor solution in good accordance with the HADS-A 
and HADS-D subscales, except for item 3: I feel cheerful and item 4: I feel as if I am 
slowed down. The solution accounted for 45% of variance. Both subscales were found to 
be internally consistent, with values of Cronbach’s coefficient (alpha) being 0.77 and 0.74, 
respectively.
World Health Organization Quality of Life (WHOQOL-BREF).
The WHOQOL-BREF was developed as an abbreviation of the WHOQOL-100 to provide a 
short form quality of life assessment [38] It was developed by the WHO through a multicentre 
field trial situated within 23 countries. This tool is a self-report questionnaire which consists 
of 26 items, each item representing one facet of life that is considered to have a contribution 
to a person’s quality of life. Twenty-four items measure four broad domains, namely physical 
health (e.g. mobility, pain and discomfort; 7 items), psychological health (e.g. body image 
and appearance, negative feelings, self esteem; 6 items), social relationships (e.g. personal 
relationships, social support; 3 items) and environment (e.g. financial resources, health and 
social care, physical environment; 8 items). Two other items measure the overall perception 
of quality of life and general health. The WHOQOL-BREF employs a 5-points scale (1 to 5) 
with a higher score indicating a higher level of self-perceived quality of life. The WHOQOL-
BREF is available in a validated Indonesian version [39]. 
Data Analysis
We used the Statistical Package for Social Science (SPSS 17.0) for data analysis. The 
mean score, the standard deviation, the median score and the frequency distribution of 
the DT were explored using descriptive statistical analysis. The concurrent and convergent 
validity of the DT with the HADS and the WHOQOL-BREF were examined by Pearson’s 
correlation coefficient analyses. Receiver operating characteristic (ROC) analysis was used 
to identify the optimal DT cutoff score for distinguishing whether a patient experiences 
clinically significant distress as defined by the HADS. The Area Under the Curve (AUC) was 
used to estimate the overall discriminative accuracy of the DT cutoff score relative to the 
established cutoff score of the HADS >15. We used a qualitative guideline for interpreting 
AUC values by Hosmer and Lemeshow [40], namely AUC=0.50 as an indication that the 
test has no discrimination, AUC<0.70 as an acceptable discrimination, AUC<0.80 as a good 
discrimination and AUC<0.90 as an excellent discrimination. ROC curves were used to 
show the trade-off between the sensitivity (true-positive rate) and specificity (true-negative 
rate) for every possible cutoff score of the DT. 
Ch
ap
te
r 3
50 
To explore the association between the DT cutoff score and the Problem List, the 
demographic variables and the clinical variables, Chi-square analyses were conducted for 
categorical variables and t-test analyses were conducted for continuous variables. The association 
between the DT and the total score in the PL was explored by Pearson’s correlation coefficient; 
associations between the DT cutoff scores and individual items in the PL were explored by the 
Chi-square analyses.
Results
Demographic and clinical characteristics 
A total of 120 patients participated in this study. The response rate was 91%. Twelve out 
of 132 women approached declined to participate because they were too ill to fill in the 
questionnaires. As shown in Table 1, the mean age of the women in this sample was 
approximately 45.5 years of age (range; 28-66). Most of the participants were married 
(84%). The majority of the participants had middle school or lower education (i.e. 49% had 
elementary school, 20% had junior high school and 8% had no education). Seventy-three 
percent of the participants (73%) were housewives or unemployed. The mean number of 
months since diagnosis was 21.5 (SD=20.3, range= 1-120 months). More than half of the 
study participants (52%) were in the disease stages III or IV. Fifty-six percent underwent 
mastectomy, 83% underwent chemotherapy and 23% underwent radiotherapy.  Ninety-three 
percent of the participants had health insurance provided by the government to poor people 
(e.g. Jakesmas, ASKES, Gakin and Gakinda) and only 7% financed their own medical 
expenses. Twenty-five percent of the participants had a family history of breast cancer.
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Table 1. Demographic and clinical characteristics of study participants
Variable n (%)
Age (M±SD) 45.5 ± 8.04
Marital Status
Married 101 (84%)
Single 2 (2%)
Divorced 0 (0%)
Widowed 17 (14%)
Education (highest)
None 10 (8%)
Elementary school 59 (49%)
Junior high school 24 (20 %)
Senior high school 21 (18 %)
College or university 6 (5%)
Employment
Housewife/unemployed 88 (73%)
Laborer/irregular job 25 (21%)
Private employee 2 (2%)
Government officer 5 (4%)
Months since diagnosis (M±SD) 21.5 ± 20.3
Range (months) 1-120
Current stage of cancer 
1 3 (3%)
2 54 (45%)
3 46 (38%)
4 17 (14%)
Treatment
Mastectomy 67 (56%)
Chemotherapy 99 (83%)
Radiotherapy 28 (23%)
Health insurance 
Yes 112 (93%)
No 8 (7%)
Family history of breast cancer
Yes 30 (25%)
No 90 (75%)
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Average score on the DT and the Problem list
The average score of the patients on the DT was 4.7 (SD = 2.6). The most frequent problems 
checked in descending order in the practical domain were insurance/financial (60%), 
transportation (48%), housing (32%), work/school (24%) and child care (21%). The most 
frequently checked problems in the family problems category were: dealing with children 
(14%), the ability to have children (11%) and dealing with a partner (11%). In the emotional 
problems category, the most frequently checked problems were worry (81%), sadness 
(80%), fears (54%), depression (41%), nervousness (41%) and loss of interest in usual 
activities (33%). Eleven percent of the patients checked the item about spiritual/religious 
concerns. The ten most frequently checked problems in the physical problems category 
were pain (71%), fatigue (68%), nausea (55%), sleep (52%), getting around (51%), tingling 
in hands/feet (51%), eating (41%), appearance (36%), memory/concentration (36%) and 
skin dry/itchy (36%). 
Establishment of a DT cutoff score
The Pearson’s correlation coefficient between the DT scores and the HADS total was 0.58 
(p<0.01); the correlation coefficients between the DT and the HADS-Anxiety and the HADS-
Depression scales were 0.58 (p<0.01) and 0.48 (p<0.01), respectively. Using the HADS 
cutoff score of 15 as the criterion, sixty-two women (52%) were identified as experiencing 
clinically significant distress. The ROC analysis obtained the AUC of 0.81 (SE=0.04; 
95%CI=0.73-0.88; p<0.001) (Figure1). This AUC value indicates an excellent discrimination. 
Table 2 lists the Sensitivity, Specificity, Positive predictive values and Negative predictive 
value on each the DT cut-off point. A cutoff score of 5 on the DT optimally identified 81% 
of the HADS cases (sensitivity) and 64% of the HADS non cases (specificity) with positive 
and negative predictive values of 70% and 76%, respectively. Of those screened positive 
by the DT, 30% would be false positives and of those screened negative by the DT 24% 
would be false negatives. 
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Figure 1. Receiving operation characteristic (ROC) curve of Distress Thermometer scores versus 
Hospital Anxiety and Depression Scale cutoff scores. 
Table 2. Sensitivity, Specificity, Positive and Negative predictive values on each the 
Distress Thermometer cut-off point.
Cut-off point Sensitivity Specificity Positive 
predictive 
value
Negative 
predictive 
value
0/1 0.98 0.11 0.51 0.88
1/2 0.95 0.21 0.56 0.80
2/3 0.92 0.40 0.62 0.82
3/4 0.90 0.50 0.66 0.83
4/5 0.81 0.64 0.70 0.76
5/6 0.52 0.91 0.86 0.64
6/7 0.42 0.95 0.90 0.60
7/8 0.24 0.98 0.94 0.54
8/9 0.15 1.00 1.00 0.52
9/10 0.10 1.00 1.00 0.51
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Associations between the DT cutoff score and the Problem List 
items
The DT scores were statistically significantly correlated with the Problem List total score 
(r=0.47, p<0.01). In the practical problems category (p<0.05), the DT cutoff score was 
significantly associated with four problems (i.e. child care, housing, insurance/financial 
and work/school), and was not associated with transportation. The DT cutoff score was 
significantly associated with each of the problems in the family problems category (p<0.05). 
Patients who scored above the cutoff experienced more problems in dealing with children, 
dealing with their partner and the ability to have children. In the emotional problems 
category (p<0.05), the DT cutoff score was significantly associated with five problems (i.e. 
depression, nervousness, sadness, worry and loss of interest in usual activities), and was 
not associated with fears. Patients who scored above the cutoff experienced more spiritual/
religious concerns (p<0.05). Finally, in the physical problems category (p<0.05), the DT cutoff 
score was significantly associated with 17 out of 21 problems (i.e. appearance, bathing/
dressing, breathing, changes in urination, constipation, diarrhea, eating, fatigue, feeling 
swollen, fever, indigestion, memory/concentration, mouth sores, nose dry/congested, pain, 
sexual and skin dry/itchy), and was not associated with four other problems (i.e. getting 
around, nausea, sleep and tingling in hand/feet).
Demographic and clinical characteristics associated with the DT 
cutoff score and the Problem List items
Marital status and insurance status were excluded in the Chi-square analyses, as some 
categories did not fulfill the minimum number of expected observations. We found that 
women with a score below the DT cutoff score of 5 did not differ significantly from women 
at or above the DT cutoff score of 5 on age, time since diagnosis, education, employment 
status and family history of cancer. However, we found a significantly difference in stage of 
cancer (X² = 3.90, df = 1, p= 0.048). Women with a score > 5 were more likely to be at an 
advanced stage of cancer. 
We found several significant associations between the PL-scores and the demographic 
and clinical characteristics. The advanced cancer patients (stage III or IV) had higher 
PL-total scores (t=-3.32, p<0.001), more emotional problems (t=-3.55, p<0.001) and 
more physical problems (t=-2.62, p<0.01) than the stage I or II cancer patients. Age was 
negatively correlated with physical problems (r=-0.21, p<0.05) and the PL-total scores (r=-
0.182, p<0.05). PL scores were not associated with marital status, employment status, 
family history of cancer and time since diagnosis.
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The DT and the HADS correlations with the WHOQOL-BREF scores 
Table 3 shows the correlation coefficients of distress and quality of life. The DT, the HADS 
total, the HADS Anxiety and the HADS Depression scores were significantly negatively 
correlated with overall quality of life, general health and all quality of life domains. 
Table 3. Association between distress and quality of life 
DT HAD-A HAD-D HADS-T
Overall quality of life -0.36** -0.40** -0.32** -0.39**
General health -0.43** -0.44** -0.31** -0.41**
Physical health domain -0.45** -0.45** -0.53** -0.54**
Psychological domain -0.55** -0.55** -0.53** -0.59**
Social relationships domain -0.22* -0.29** -0.38** -0.35**
Environment domain -0.31** -0.30** -0.36** -0.36**
DT: Distress Thermometer; HAD-A: HAD Anxiety subscale score; HAD-D: HAD Depression subscale 
score; HADS-T: Hospital Anxiety and Depression Scale total score.
*Correlation is significant at the 0.05 level (2-tailed).
 **Correlation is significant at the 0.01 level (2-tailed).
Discussion
In this study, we examined the validity of the DT and its screening efficacy in detecting 
distress in Indonesian cancer patients. Our results showed that the Indonesian version of 
the DT has concurrent validity with the HADS, which is a well-established screening tool 
for distress. A cutoff score of 5 on the DT yielded optimal sensitivity and specificity. Patients 
who had a score above the cutoff score of 5 experienced more problems in the practical, 
family, emotional, spiritual/religious and physical domains than women with DT scores 
below this cut off score. Also, they were more likely to be at an advanced stage of cancer. 
Finally, distress as measured with the DT was found to be negatively correlated with overall 
quality of life, general health and all quality of life domains which establish the convergent 
validity of the Indonesian version of the DT. 
The ROC analysis comparing the DT scores with the well-established HADS cutoff 
score of 15 obtained an AUC which indicates a good discrimination. Using the DT cutoff 
score of 5, eighty-one percent patients were identified correctly as being distressed and 
64% identified correctly as not being distressed which is comparable to the result of the 
meta-analysis study by Mitchell [41]. This evidence shows that the DT has a screening 
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efficacy for distress in Indonesian breast cancer patients. The current Distress Management 
Guidelines from the NCCN recommend that a DT score of 4 or higher indicates that a 
patient has a clinical significant level of distress and should be referred to a psychosocial 
care team [16]. However, we obtained a sensitivity of 90% and a specificity of 50% at a 
cutoff score of 4, resulting in a large proportion of patients incorrectly being identified as 
experiencing clinically significant distress. Considering the lack of health care professionals 
in Indonesia, we believe that it is more appropriate to use the cutoff score of 5 which 
yielded an optimal combination of sensitivity and specificity, to avoid a large number of false 
positive cases being diagnosed. Patients who may not require further intervention may 
feel burdened by further screening procedures. Moreover, false positive screening leads 
to higher health care costs and an increased need for health professionals. The DT cutoff 
score of 5 found in this study corresponds with the cutoff score found by other validation 
studies using the HADS [25-27, 34-35]
Patients who had significant distress were more likely to report more problems in the 
practical, family, emotional, spiritual/religious and physical domains. Interestingly, patients 
who had clinically significant distress were more likely to experience spiritual/religious 
concerns which is similar to the results of a study conducted in Korea [23]. In contrast, 
most studies conducted in Western countries found that clinically significant distress was 
not associated with spiritual/religious concerns [20, 22, 24], or only weakly related [34]. The 
significant correlation between high distress and spiritual/religious concerns is possibly 
due to the fact that Indonesian people are religious and have a strong belief in God. Many 
people rely on God to heal their disease. We hypothesize that people who do not feel any 
change in their illness will be more convinced their cancer as the will of God and they 
cannot change their destiny which in turn might trigger higher levels of distress. 
Results of studies on associations between distress and socio-demographic and 
clinical characteristics in cancer patients are inconsistent [42]. In the present study, high 
distress was only found to be associated with stage of cancer, but not with other socio-
demographic or clinical characteristics. This finding is in concordance with previous 
studies that were also unable to find significant associations between the DT and socio-
demographic and clinical characteristics [18-19, 23-24, 27, 43]. Our finding that distress is 
associated with lower overall quality of life, general health and all quality of life domains is 
in line with the studies by Skarstein et al.[12] and Ozalp et al.[24], and further proves the 
validity of the Indonesian version of the DT.
The Problem List scores were associated with several demographic and clinical 
characteristics in the expected direction, suggesting that the Indonesian version of the 
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Problem List is also a valid tool. Advanced cancer patients experienced more emotional 
problems and physical problems than patients at an early stage of cancer, and younger 
patients experienced more physical problems. These results are in line with previous 
studies results [44-45].
Several limitations of this study should be noted. Firstly, we used only breast cancer 
patients as our sample. Furthermore, we conducted this study at HSH which is a referral 
hospital that provides health services to the poor people. Therefore, the majority of the study 
participants had middle to low socio-economic and educational level. However, demographic 
and clinical characteristics of the patients (e.g. mean age, education level, marital status 
and stage of cancer) were similar to previous studies in Indonesian breast cancer patients 
[46-47]. Multi-center studies with a larger sample of various patient groups are needed to 
be able to extrapolate these results of the present study to other patient groups. Secondly, 
all measures used were self-rating questionnaires. Nevertheless, we included ten illiterate 
participants and they were helped to fill out the questionnaires. This may have led to some 
bias. Thirdly, the HADS Indonesian version has only been linguistically validated by the 
MAPI Institute which may have lead to some cultural bias. However, the basic psychometric 
examination results indicated that the HADS Indonesian version can be considered as a 
good instrument in terms of factor structure and internal consistency. Since the Geriatric 
Depression Scale, which is an instrument that is similar to the HADS has been shown to 
have the same optimal cut off point in both Western and Asian countries [48], we used the 
general HADS cutoff score suggested for Western countries in our study. Finally, this study 
examined the validity of the DT, but further research is required involving oncologists and 
nurses to confirm the feasibility of its use in daily care practice.  
Bearing these limitations in mind, our findings suggest that the Indonesian version of 
DT could be used as a screening tool in daily cancer care in Indonesia. As the DT is brief 
and easy to administer, it might be an acceptable tool for oncologists in Indonesia. The 
NCCN suggests that early detection and treatment of distress leads to better adherence to 
treatment, better communication and prevents severe anxiety and depression [6]. According 
to our findings, cancer patients who experience distress above the DT cutoff score of 5 
should be referred to a psychologist or another health professional to manage their distress 
and get appropriate treatment of their main distress sources as indicated in the PL. The use 
of the DT in daily cancer care in Indonesia may help oncologists to prevent potential severe 
psychological problems in cancer patients and provide additional interventions to patients 
who need it. Our results suggest that patients in an advanced stage of cancer should be 
given priority for psychological intervention. Such interventions are often part of medical 
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psychology. Given that the field of medical psychology is new in Indonesia, we recommend 
its development by psychological faculties with academic hospitals in order to be able to 
provide adequate psychological resources to patients and doctors. 
Our study did not only confirm the validity of the DT in Indonesian population, but 
also showed specific associations with several problems in the problem list. We found that 
women with breast cancer in Indonesia, most of whom are very religious, have different 
sources of distress than breast cancer patients in Western countries. In this respect, our 
study sheds light on cultural factors explaining cancer-related distress, thereby generating 
knowledge that is not only useful for physicians working in Asian countries, but also for 
physicians working with Asian populations in Western countries.
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Abstract 
The aims of this study were to assess whether Indonesian women with breast cancer 
have higher external Health Locus of Control (HLC) than healthy women, and to explore 
the association between HLC and symptoms of anxiety and depression. In this study, 120 
consecutive women with breast cancer were recruited at the outpatient surgical oncology 
clinic at the Hasan Sadikin Hospital in Bandung. One hundred and twenty two healthy 
women were recruited from the Bandung area. A standard demographic form, Form C of the 
Multidimensional Health Locus of Control, as well as the Hospital Anxiety and Depression 
Scale and patients’ medical records were used. Data were analyzed using descriptive 
statistics, t-test, Pearson’s correlation, MANOVA and multiple linear regressions. Women 
with breast cancer had higher scores on all external HLC subscales, i.e. chance, doctor, 
powerful others and God, and lower internal HLC compared to healthy women. High God 
LHC scores were associated with a high level of anxiety (β=0.21, p<0.05), whereas none 
of the HLC subscales were associated with depression. Our results suggest that women 
with breast cancer tend to have high external HLC, while healthy women tend to have high 
internal HLC.  A strong belief in an external source of control, i.e. God, might be negatively 
associated with patients’ emotional adjustment. Further research is needed to give an 
insight into the direction of this association.
 
Keywords: Health locus of control; anxiety; depression; breast cancer; Indonesia
 65
Introduction
Breast cancer is a serious health condition among women worldwide. In 2008, approximately 
1.38 million new  cases were diagnosed and approximately 458,000 deaths were recorded 
both in developed and developing countries [1]. Receiving a breast cancer diagnosis is a 
life threatening negative event and potentially causes considerable psychological problems. 
Women who are diagnosed with breast cancer are faced with multiple stressors throughout 
their illness trajectory, such as having a biopsy, awaiting diagnosis, having surgery, 
experiencing treatment side effects, anticipating the possibility of cancer metastasizing, 
coping with financial, family and social problems and facing the risk of recurrence and/or 
death. The most prevalent psychological problems among women with breast cancer are 
anxiety and depression. The reported prevalence of anxiety ranges from 21.1% to 29% 
[2-5], whereas the prevalence of depression ranges from 4.5% to 37% [6]. 
Locus of control (LOC) has been suggested as a potential predictor of a better 
adjustment to cancer [7-8]. The concept of LOC derives from Rotter’s social learning theory 
and is defined as a person’s belief about the location of controlling forces in their life, either 
internal or external [9]. In particular, Wallston, Wallston, Kaplan, & Maides [10] developed the 
Health Locus of Control (HLC) concept to examine an individual’s generalized expectations 
about where the control over his or her health resides. Individuals with an internal HLC 
believe that what happens to their health condition results from their own actions, whereas 
individuals with an external HLC believe that their health condition is controlled by external 
forces, such as chance, doctors, powerful others and God [11]. 
For several years, studies on HLC have focused on internal HLC, recognized as the 
most logical HLC dimension related to better health outcomes and emotional adjustment 
[12]. However, results have been mixed. For example, a study among cancer and chronic 
pain patients found that lower internal HLC predicted higher depression [13]. On the other 
hand, a study among breast cancer patients did not find any direct relationship between 
HLC and depression and anxiety [14]. Until  now, studies in the Indonesian population have 
also produced mixed results [15-16]. 
Wallston and Wallston [17] have suggested that in medical situations where only a 
little personal control is possible, patients are more likely to be reliant on external sources of 
control, such as doctors or powerful others (e.g. family), than on internal sources. Evidence 
from previous studies found different HLC orientations between healthy persons and 
physically ill persons. Healthy college or adult samples tended to have a higher internal 
HLC and a lower external HLC, whereas chronically ill patients (e.g. chronic obstructive 
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pulmonary disease, hypertension and cancer) tended to have higher external HLC [18]. 
High external HLC among chronically ill patients may have advantages for their emotional 
adjustment, as patients who do not try to control their condition, may be able to minimize 
their level of frustration. For example, a study among cancer chemotherapy patients who 
received progressive muscle relaxation and/or biofeedback training to alleviate the side 
effects of treatment found that patients with a high external HLC showed greater improvement 
on measures such as pulse rate, blood pressure and depression than patients with a high 
internal HLC [19].
 Luszczynska and Schwarzer [20] have suggested that culture and religion might 
affect the average level of HLC  scores and that some dimensions might play a more 
prominent role in some cultures. They speculated for example, that internal HLC might be 
associated with better health behaviors in countries that are individualistic than in  countries 
that are collectivistic [20-21]. A study about cultural variation in HLC among Caucasian, 
Asian and Afro-Caribbean women found that Asian women had higher scores on chance 
and powerful others HLC than other groups. Moreover among Asian women, being highly 
religious seemed to explain some of their higher scores [22]. Indonesian people are known 
to be highly influenced by their religion in relation to  their health and illness behavior [23-
24]. Thus, it is relevant to consider Indonesian patients’ views in the context of their belief 
that God is a source of control over their health condition. 
To the best of our knowledge, only a few systematic studies have been conducted in 
Indonesia evaluating HLC and its association with psychological problems, such as anxiety 
and depression. None of these studies included God as a perceived source of control over 
a person’s health condition. Therefore, the aims of the present study were: (a) to assess 
whether Indonesian women with breast cancer have a higher external HLC than Indonesian 
healthy women, and (b) to explore the association of HLC and anxiety and depressive 
symptoms in Indonesian women with breast cancer.
Methods
Study design and participants
This study used a cross-sectional design. One hundred and twenty consecutive women 
with breast cancer were recruited at the outpatient surgical oncology clinic at Hasan 
Sadikin Hospital (HSH), Bandung in two phases. The first group of 50 patients was recruited 
between April-June 2010; the second group of 70 patients was recruited between June-
October 2011, due to logistical reasons. Eligible patients were aged over 18 years, had a 
first diagnosis of breast cancer, were able to provide informed consent, had no psychiatric 
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treatment history, and had an adequate command of the Indonesian language. As HSH is 
a referral hospital for patients with government insurance for poor people, the majority of 
patients were middle to low socio-economic status. The healthy group was recruited from 
a selected area in Bandung (i.e. Maleer urban village). This area was chosen because 
the women’s socio-demographic characteristics were similar to the patient group and also 
for pragmatic reasons. We consecutively included 122 healthy women between February 
and March 2012. Population registration records were used to select the healthy women 
sample. Women were eligible if they were aged over 18 years, were free of chronic disease, 
were able to provide informed consent, and had an adequate command of the Indonesian 
language.
Measurements
The study included a socio-demographic status form and measures of HLC, anxiety 
and depression symptoms. For this study, a self-report form was developed to obtain 
participants’ socio-demographic data on age, marital status, insurance status, education 
level, employment status and religion. The patients’ medical status, including type of cancer, 
time since diagnosis, stage of cancer and type of treatment was obtained via a medical 
chart review from HSH.  
The C form of the Multidimensional Health Locus of Control (MHLC) scales [25] was 
used to assess participants’ feelings of control over their illness or disease. It was designed 
as a generic medical-condition-specific measurement of locus of control that could easily 
be adapted for use with any medical condition. It consists of one Internal scale and three 
External scales: (1) chance, (2) doctors, and (3) powerful others. In this study, the word 
‘condition’ was substituted with ‘cancer’ for the patients and ‘health condition’ for the healthy 
women. This instrument consists of 18 items using a 6-point Likert format, ranging from 
1 = ‘strongly disagree’ to 6 = ‘strongly agree’. A higher score is indicative of a stronger 
belief in that type of control. In conjunction with the MHLC scales, we used the God Locus 
of Health Control Scale (GLHC) [11] to assess individuals’ beliefs about God’s control 
over their health. The scale has the same format as the MHLC. After obtaining the written 
permission of the authors, we prepared the Indonesian version of the MHLC scales through 
the forward- and back-translation method. Firstly, the first author of this paper translated 
the questionnaire from English to Indonesian, and then a Native American who speaks the 
Indonesian language fluently translated it back into English. Secondly, a linguist compared 
the original English version and the back-translation of the questionnaire to assess the 
significance of any discrepancies. After discussing any possible discrepancies, consensus 
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was achieved and the Indonesian version of the MHLC scales was finalized. The Cronbach’s 
alpha for each subscale of the Indonesian version of the MHLC in the current sample is as 
follows: internal HLC=0.62, doctors HLC=0.60, powerful others HLC=0.48, chance=0.56 
and God HLC=0.77). For content validity, the items within both scales were scrutinized by 
three psychologists, who agreed that the items were valid. 
 In order to measure anxiety and depression symptoms, the Hospital Anxiety and 
Depression Scale (HADS) was included [26]. This scale has been known to be an effective 
screening measure for symptoms of anxiety and depression in a medical population [27-28]. 
It is a 14-item self-report measure that has two subscales; the HADS-A subscale consists 
of 7 items to measure anxiety, and the HADS-D subscale consists of 7 items to measure 
depressive symptoms. Respondents are asked to indicate which of 4 options (rated 3-0) 
best describe their feelings during the previous week. The scores range from 0 to 21 on 
each subscale, a higher score indicating higher anxiety and depression. The Indonesian 
version of the HADS has been linguistically validated by the MAPI Institute.
Procedures
The Indonesian Medical Ethical Committee and the Board of Directors of HSH approved 
the study material and procedure concerning patient participation for compliance with the 
ethical guidelines. This study was also approved by the Head of Maleer urban village. For 
women with breast cancer sample, a member of the administrative staff of the surgical 
oncology clinic identified and approached eligible patients during a regularly scheduled 
consultation and reported those who consented to a research assistant arranging an 
appointment during their next visit. Data collection was conducted by 10 Master’s students in 
clinical psychology who had been trained as research assistants and who were supervised 
by two clinical psychologists. The research assistants provided the patients with further 
information about the study, instructions on how to fill in the questionnaires and a survey 
packet. The packet included a letter that described the study, an informed consent form, 
the socio-demographic form, the MHLC scales and the HADS. Participants completed the 
questionnaires in the waiting room while they were waiting for their consultation with the 
physicians for their treatment. There were seven illiterate participants in this study. In these 
cases, the research assistants read the questionnaires aloud and helped the participants 
to fill in the questionnaires. 
For the healthy sample, data collection was conducted by two Community Association 
staff members. They identified eligible women, approached them personally to join the study, 
and arranged an appointment at their home. The Community Association staff provided the 
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participants with a survey packet consisting of written information about the study purpose, 
the socio-demographic form and the MHLC scales. First, participants were asked to read 
the information about the study and the questionnaire instructions. Afterwards they were 
asked to fill in the socio-demographic form and the MHLC scales. Each participant received 
a small gift for their participation. 
Data Analysis
For data analysis, we used the IBM® SPSS® Statistics version 20. Descriptive statistics 
were used to describe participants’ demographic and clinical characteristics. Differences 
in demographic characteristics between women with breast cancer and healthy women 
were analyzed by t-tests. To explore the association between demographic and clinical 
characteristics and MHLC scores, Pearson’s correlation coefficients were performed for 
continuous variables and t-test analyses were performed for the categorical variables. 
Marital status (married vs. other), education level (junior high school or lower education 
vs. senior high school or higher), employment status (housewife/unemployed vs. other), 
health insurance status, stage of cancer (stage 1 or 2 vs. stage 3 or 4), treatment type 
(Mastectomy vs. no mastectomy, Radiotherapy vs. no radiotherapy and Chemotherapy vs. 
no chemotherapy), and family history of cancer were treated as dichotomous variables. 
Multivariate analysis of variance (MANOVA) was used to evaluate differences between 
women with breast cancer and healthy women on MHLC subscales scores. Multiple 
linear regression analyses were conducted to test the association between anxiety and 
depression and MHLC scores. We analyzed anxiety and depression as the dependent 
variables and Internal, Chance, Doctors, Powerful others and God subscale scores as the 
independent variables.  
Results
Demographic and clinical characteristics
Women with breast cancer ranged in age from 28 to 66 years (M =45.52, SD = 8.04), 
and the healthy women ranged in age from 20 to 80 years (M =45.14, SD = 12.60). The 
difference in age between the two groups was not significant. The groups were also 
comparable regarding their marital status, education level and employment status. The 
groups were significantly different in relation to insurance status; the majority of women 
with breast cancer had health insurance whereas only a minority of healthy women did. 
A summary of the demographic and relevant clinical characteristics of the participants is 
presented in Table 1. 
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Table 1. Demographic and clinical characteristics of study participants
Variable Breast Cancer Patients
n (%)
Healthy Women
n (%)
Age (M±SD) 45.52 ± 8.04 45.14 ± 12.60
Marital Status
Married 101 (84%) 100 (82%)
Single 2 (2%) 3 (2%)
Widowed 17 (14%) 19 (16%)
Education
None 10 (8%) 0 (0%)
Elementary school 59 (49%) 44 (36%)
Junior high school 24 (20 %) 31 (25%)
Senior high school 21 (18 %) 39 (32 %)
College or university 6 (5%) 8 (7%)
Employment
Housewife/unemployed 88 (73%) 101 (83%)
Laborer/irregular job 25 (21%) 4 (3%)
Private employee 2 (2%) 14 (12%)
Government officer 5 (4%) 3 (2%)
Religion
Islam 120 (100%) 122 (100%)
Others 0 (0%) 0 (0%)
Health insurance 
Yes 112 (93%) 23 (19%)
No 8 (7%) 99 (81%)
Months since diagnosis (M±SD)  21.5 ± 20.3 Na
Stage of cancer 
1 3 (3%) Na
2 54 (45%) Na 
3 46 (38%) Na 
4 17 (14%) Na 
Treatment
Mastectomy 67 (56%) Na 
Chemotherapy 99 (83%) Na 
Radiotherapy 28 (23%) Na
Family history of breast cancer
Yes 30 (25%) Na
No 90 (75%) Na
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Association between demographic and clinical characteristics and 
health locus of control
Level of education was associated with internal and chance HLC in both sample groups, 
women with breast cancer who had junior high school or lower education had higher 
chance HLC scores (t=3.67, p=0.001), and healthy women who had junior high school 
or lower education had lower internal HLC (t=-3.02, p=0.003) and higher chance HLC 
(t=3.03, p=0.003). In women with breast cancer, time since diagnosis was significantly 
negatively correlated with God LHC scores (r=-0.23, p<0.05). No other demographic or 
clinical characteristic was significantly associated with HLC. 
Health locus of control in breast cancer patients and healthy women
Table 2 shows the means, standard deviations, range and MANOVA results of women with 
breast cancer and healthy women on the MHLC scales and the HADS scores, whereas 
table 3 shows Pearson’s coefficient correlations of the MHLC subscales. There were 
significant differences in HLC orientations between women with breast cancer and healthy 
women. Women with breast cancer had significantly lower scores on internal HLC (F=4.09, 
p<0.05), higher chance HLC (F=60.53, p<0.01), higher doctors HLC (F=42.80, p<0.01), 
higher powerful other HLC (F=61.49, p<0.01), and higher God LHC (F=72.59, p<0.01) than 
healthy women.  
Table 2. Means, standard deviations, range and MANOVA results of breast cancer patients 
and healthy women on the MHLC scales and the HADS scores
Measure Breast Cancer patients
n=120
Healthy Women 
n=122
Mean SD Min-
Max
Mean SD Min-
Max
df F p-
value
Internal 25.16 4.24 13-34 26.30 4.56 13-36 1 4.088 <0.05
Chance 25.03 3.91 15-31 20.28 5.46 8-30 1 60.532 <0.01
Doctor 15.08 1.93 4-18 13.07 2.75 6-18 1 42.798 <0.01
Powerful 
others 
11.98 2.54 6-17 9.24 2.90 3-18 1 61.487 <0.01
God 27.76 4.13 12-36 21.60 6.78 9-35 1 72.593 <0.01
HAD-A 8.13 3.62 0-19 - - -
HAD-D 6.59 3.69 0-15 - - -
HAD-A:  Hospital Anxiety and Depression-Anxiety subscale score; 
HAD-D:  Hospital Anxiety and Depression-Depression subscale score 
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Table 3. Correlations of the MHLC scales, Anxiety and Depression
Measure Breast Cancer patients Healthy Women
1 2 3 4 5 1 2 3 4 5
Internal (1) - 0.34** 0.23* 0.18* 0.22* - 0.09 0.37** 0.01 0.01
Chance (2) 0.34** - 0.12 0.43** 0.39** 0.09 - 0.11 0.20* 0.43**
Doctor  (3) 0.23* 0.12 - -0.01 0.13 0.37** 0.11 - 0.05 0.08
Powerful
others (4)
0.18* 0.43** -0.01 - 0.25** 0.01 0.20* 0.05 - 0.35**
God  (5) 0.22* 0.39** 0.13 0.25** - 0.01 0.43** 0.08 0.35** -
HAD-A 0.09 0.14 -0.014 0.19* 0.23* - - - - -
HAD-D 0.02 0.15 -0.01 0.14 0.12 - - - - -
HAD-A:  Hospital Anxiety and Depression-Anxiety subscale score; HAD-D:  Hospital Anxiety and Depression-Depression 
subscale score 
*Correlation is significant at the 0.05 level (2-tailed).
 **Correlation is significant at the 0.01 level (2-tailed).
Association between health locus of control, anxiety and depression
Table 4 shows multivariate linear regression analyses results evaluating the association 
between HLC, anxiety and depression adjusted for patients’ education level. God LHC 
was found to be the only HLC orientation associated with anxiety (β=0.21, p<0.05). No 
significant association between HLC orientations and depressive symptoms were found.
Table 4. Standardized betas of multivariate linear regression analyses evaluating HLC, 
anxiety and depression.
HADS-A HADS-D
Internal HLC 0.06 -0.05
Chance  HLC -0.01 0.04
Powerful others  HLC 0.13 0.09
God   HLC 0.21* 0.07
HAD-A:  Hospital Anxiety and Depression-Anxiety subscale score; 
HAD-D:  Hospital Anxiety and Depression-Depression subscale score 
*p< 0.05  corrected for educational level
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Discussion
The present study is among the first to explore HLC among women with breast cancer 
and healthy women in the Indonesian population. Women with breast cancer had higher 
external HLC (chance, doctors, powerful others and God) and lower internal HLC than 
healthy women. God LHC was the only HLC belief that explained a significant amount 
of the variance of anxiety, whereas none of HLC orientations was related to depressive 
symptoms. Several associations between patients’ characteristics and HLC were found. 
A strong belief that God has control over their cancer was more common in patients with 
shorter time since diagnosis. Education level was related to a high chance HLC in both 
women with breast cancer and healthy women. 
The findings of the current study show that women with breast cancer tend to attribute 
their illness to external sources of control, namely: physicians, significant others, chance and 
God. On the other hand, healthy women tend to have high internal HLC which indicates that 
they believe their health condition resulted from their own behaviors and capabilities. This 
finding is in line with what has been found in the previous Western literature suggesting that 
high beliefs in external sources of control is common in chronically ill patients and breast 
cancer patients [17, 29-30], whereas healthy people are more likely to have an internal 
health locus control [18]. One possible explanation for this finding is related to the nature 
of cancer and its treatment process. The perceived uncontrollable nature of cancer and 
the uncertainty of treatment outcomes might reduce patients’ beliefs in personal control 
over their illness. In addition, the majority of patients involved in the current study are in an 
advanced stage of cancer requiring long-term cancer treatment. This situation may lead to 
an increased belief in external forces among patients, i.e. the doctor, powerful others (e.g. 
family members), chance and God in the determination of their health condition. 
In line with previous research [8, 14, 31], our results indicate that a HLC among 
women with breast cancer is not necessarily associated with emotional adjustment. Only 
high God HLC was related to higher level of anxiety. This result is in concordance with a 
previous study among Rheumatoid Arthritis and Systemic Sclerosis patients that found high 
God HLC was associated with poor emotional adjustment [11]. Levenson [32] interpreted 
chance HLC as a belief in an unordered and random nature of the world, whereas powerful 
others HLC was interpreted as a belief in the basic order and predictability of the world 
giving potential control over one’s life outcomes. Although we did not find any significant 
relationship between a strong belief in doctors and powerful others HLC and patients’ 
emotional adjustment, we did find that patients who attributed their health condition to God 
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(which could also be considered to be an unpredictable source of control), was associated 
with a higher anxiety level. Another explanation might be that high anxiety leads to a greater 
belief in God’s control over one’s health.  
In the current study, several associations between HLC orientations and patients’ 
demographic characteristics were found. The God HLC showed a modest negative 
association with time since diagnosis. This finding indicates that newly diagnosed patients 
are more likely to attribute control over their illness to God than other patients. A review 
study about religion and coping with serious medical illness suggested that when people 
become physically ill they tend to rely on religious belief and practice which may reduce the 
sense of helplessness and maintain hope [33]. In addition, we found a strong association 
between education and chance and internal HLC. Lower educated patients tended to have 
a stronger belief in chance than higher educated patients, whereas lower educated healthy 
women tended to have lower internal and higher chance HLC than higher educated healthy 
women. These findings are in concordance with previous studies from Western and Eastern 
countries [18, 34]. In contrast to a study by Wallston and colleagues [11] that found God 
HLC was negatively correlated with level of education, our results suggest that both women 
with breast cancer and healthy women have a high God LHC regardless of their level of 
education.
This current study has several limitations. First, the design is cross-sectional; therefore 
we could not evaluate the causality between HLC, anxiety and depression. Second, 
the Indonesian version of the MHLC scales used in the current study has not yet been 
validated in an Indonesian population. We found suboptimal Cronbach’s alpha values in 
several subscales. Issues regarding to the reliability of the translation of the MHLC has 
not only occurred in the Indonesian version, but also in the Chinese version of the MHLC 
that found suboptimal Cronbach’s alpha values in several subscales (internal HLC=0.52, 
doctors HLC=0.51, powerful others HLC=0.44 and chance HLC=0.66) [35]. Theoretically, 
Cronbach’s alpha is related to the test length; therefore, the poor alpha value in the Powerful 
others subscales may be attributed to the small number of items in the subscales (n=3). 
The finding that the 6-item subscales have also suboptimal alpha value may be attributed 
to cultural factors. The research assistants reported that some patients interpreted Chance 
HLC items as statements about their destiny or fate. For example, the Indonesian term for 
fate is ‘nasib’, which refers to something that has been determined by God for each individual 
and no one else knows about it. Consequently, differences in understanding may have led 
to the variability of participants’ responses. Schmitt [36] argues that there is no sacred level 
of acceptable level of alpha and in certain cases measures with low levels of alpha may 
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still useful for the interpretation. Nunnally [37] stated that in the early stages of research, 
the reliability coefficients of 0.60 or 0.50 may be considered sufficient. Nevertheless, we 
suggest that our results should be interpreted with caution and a full validation study of the 
Indonesian version of the MHLC scales is highly recommended before future research is 
undertaken.        
In conclusion, Indonesian women with breast cancer tend to have high external HLC 
attributing control of their illness to their doctors, to powerful others, to chance, and to God. 
On the other hand, healthy women tend to have high internal HLC over their health condition. 
Our findings suggest that believing that an external source of control, i.e. God, controls the 
course of one’s breast cancer may be associated with poorer emotional adjustment in 
Indonesian breast cancer patients. Interviews or longitudinal studies might give an insight 
into the direction of this association.
Clinical implications
The implication of the current study findings for clinical practice is that knowledge on patients’ 
HLC can help cancer care professionals’ to presume patients’ emotional adjustment problem 
during their illness trajectory. Another implication is that assessing patient’s HLC can help 
tailor psychological support to their specific needs.
Ch
ap
te
r 4
76 
References
1 Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM: Estimates of worldwide burden of cancer 
in 2008: Globocan 2008. Int J Cancer 2010;127:2893-2917.
2 Zabora J, BrintzenhofeSzoc K, Curbow B, Hooker C, Piantadosi S: The prevalence of psychological 
distress by cancer site. Psychooncology 2001;10:19-28.
3 Montazeri A, Jarvandi S, Haghighat S, Vahdani M, Sajadian A, Ebrahimi M, Haji-Mahmoodi M: Anxiety 
and depression in breast cancer patients before and after participation in a cancer support group. 
Patient Educ Couns 2001;45:195-198.
4 Osborne RH, Elsworth GR, Hopper JL: Age-specific norms and determinants of anxiety and depression 
in 731 women with breast cancer recruited through a population-based cancer registry. Eur J Cancer 
2003;39:755-762.
5 So WK, Marsh G, Ling WM, Leung FY, Lo JC, Yeung M, Li GK: Anxiety, depression and quality of life 
among chinese breast cancer patients during adjuvant therapy. Eur J Oncol Nurs 2010;14:17-22.
6 Massie M J, Lloyd-Williams M, Irving G, Miller K: The prevalence of depression in peopole with cancer; 
in Kissane D W, Maj M, Sartorius N (eds): Depression and cancer. Singapore, John Wiley & Sons, Ltd, 
2011, pp 1-36.
7 Bettencourt BA, Talley AE, Molix L, Schlegel R, Westgate SJ: Rural and urban breast cancer patients: 
Health locus of control and psychological adjustment. Psychooncology 2008;17:932-939.
8 Watson M, Pruyn J, Greer S, van den Borne B: Locus of control and adjustment to cancer. Psychol Rep 
1990;66:39-48.
9 Rotter JB: Generalized expectancies for internal versus external control of reinforcement. Psychol 
Monogr 1966;80:1-28.
10 Wallston BS, Wallston KA, Kaplan GD, Maides SA: Development and validation of the health locus of 
control (hlc) scale. J Consult Clin Psychol 1976;44:580-585.
11 Wallston KA, Malcarne VL, Flores L, Hansdottir I, Smith CA, Stein MJ, Weisman MH, & Clements, 
P.J. : Does god determine your health? The god locus of health control scale. Cognitive Therapy and 
Research 1999;23:131-142.
12 O’Hea EL, Moon S, Grothe KB, Boudreaux E, Bodenlos JS, Wallston K, Brantley PJ: The interaction of 
locus of control, self-efficacy, and outcome expectancy in relation to hba1c in medically underserved 
individuals with type 2 diabetes. J Behav Med 2009;32:106-117.
13 Arraras J. I, Wright S. J, Jusue G, Tejedor M, Calvo J.I: Coping style, locus of control, psychological 
distress and pain-related behaviours in cancer and other diseases. Psychology, Health & Medicine 
2002;7:181-187.
14 Naus MJ, Price EC, Peter MP: The moderating effects of anxiety and breast cancer locus of control on 
depression. J Health Psychol 2005;10:687-694.
15 Iskandarsyah A: Correlation between health locus of control and depression in patients with kidney 
disease in r.A habibie hospital: Faculty of Psychology. Bandung, Bandung Islamic University, 2004, 
Bachelor thesis. 
16 Wahyuningtyas H A: Differences of depression level tendency between internal locus of control on 
people with sle (systemic lupus erythematosus) and external locus of control on the people with sle 
 77
in rsud dr. Soetomo surabaya: Faculty of Psychology Surabaya, Airlangga University, 2009, Bachelor 
thesis.  
17 Wallston KA, Wallston BS: Who is responsible for your health: The construct of health locus of control; in 
G. Sanders &, Suls J (eds): Social psychology of health and illness. Hillsdale, N.J, Lawrence Erlbaum & 
Associates, 1982, pp 65-95.
18 Wallston KA, & Wallston BS: Health locus of control scales; in Lefcourt H (ed) Research with the locus 
of control construct. New York, Academic Press, 1981, vol 1, pp 189-241.
19 Burish TG, Carey MP, Wallston KA, Stein MJ, Jamison RN, Lyles JN: Health locus of control and chronic 
disease: An external orientation may be advantageous. Journal of Social and Clinical Psychology 
1984;2:326-332.
20 Luszczynska A, Schwarzer R: Multidimensional health locus of control: Comments on the construct and 
its measurement. J Health Psychol 2005;10:633-642.
21 Hofstede G: Culture consequences: Comparing values, behaviors, institutions, and organizations across 
the nations. Thousand Oaks, CA, Sage Publications, 2001.
22 Wrightson KJ, Wardle J: Cultural variation in health locus of control. Ethn Health 1997;2:13-20.
23 Rahmah H, Hatthakit U, Chunuan S: Religiosity and health status in middle aged male muslims in 
indonesia. Thai J Nurs Res 2008;12:220-230.
24 Yuniarti KW, Dewi C, Ningrum RP, Widiastusi M, Asril NM: Illness perception, stress, religiousity, 
depression, social support, and self management of diabetes in indonesia. Yogyakarta, Universitas 
Gadjah Mada, 2010. 
25 Wallston KA, Stein MJ, Smith CA: Form c of the mhlc scales: A condition-specific measure of locus of 
control. J Pers Assess 1994;63:534-553.
26 Zigmond AS, Snaith RP: The hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361-
370.
27 Ibbotson T, Maguire P, Selby P, Priestman T, Wallace L: Screening for anxiety and depression in cancer 
patients: The effects of disease and treatment. Eur J Cancer 1994;30A:37-40.
28 Herrmann C: International experiences with the hospital anxiety and depression scale--a review of 
validation data and clinical results. J Psychosom Res 1997;42:17-41.
29 Bourjolly JN: Locus of control among black and white women with breast cancer : A preliminary study. J 
Psychosoc Oncol 1999;17:21-31.
30 Bremer BA, Moore CT, Bourbon BM, Hess DR, Bremer KL: Perceptions of control, physical exercise, 
and psychological adjustment to breast cancer in south african women. Ann Behav Med 1997;19:51-
60.
31 Cvengros JA, Christensen AJ, Lawton WJ: Health locus of control and depression in chronic kidney 
disease: A dynamic perspective. J Health Psychol 2005;10:677-686.
32 Levenson H: Differentiating among internality, powerful others, and chance.; in Lefcourt H M (ed) 
Research with the locus of control construct. New York, Academic Press, 1981, pp 15-63.
33 Koenig HG, Larson DB, Larson SS: Religion and coping with serious medical illness. Ann Pharmacother 
2001;35:352-359.
34 Morowatisharifabad MA, Mahmoodabad SS, Baghianimoghadam MH, Tonekaboni NR: Relationships 
between locus of control and adherence to diabetes regimen in a sample of iranians. Int J Diabetes Dev 
Ctries 2010;30:27-32.
Ch
ap
te
r 4
78 
35 Ip WY, Martin CR: The chinese version of the multidimensional health locus of control scale form c in 
pregnancy. J Psychosom Res 2006;61:821-827.
36 Schmitt N: Uses and abuses of coefficients alpha. Psychological Assessment 1996;8:350-353.
37 Nunnally J C: Psychometric theory. New York, McGraw-Hill, 1967.
 79
Cha
pter
 5
Satisfaction with information and its 
association with illness perception 
and quality of life in Indonesian 
breast cancer patients
Published:
Iskandarsyah A, de Klerk C, Suardi DR, Soemitro MP, Sadarjoen 
SS, Passchier J. Support Care Cancer. 2013 Jun 18. [Epub ahead 
of print]
80 
Abstract
Purpose: The aims of this study were to assess the level of satisfaction with the information on 
illness and treatment among breast cancer patients, to explore its association with patients’ 
illness perceptions and quality of life, and to provide recommendations for improvement of 
the information provided.
Methods: Seventy breast cancer patients at the Outpatient Surgical Oncology Clinic in Hasan 
Sadikin Hospital in Indonesia were recruited consecutively in a cross-sectional study design. 
They completed a demographic form, the Satisfaction with Cancer Information Profile, the 
Brief Illness Perception Questionnaire, and the World Health Organization Quality of Life
Results: A considerable number of breast cancer patients (41–86 %) were dissatisfied with 
the amount and content of the information they received, particularly on the information 
about access to patient support groups and the impact of their treatment on long-term 
quality of life. The majority of patients were dissatisfied with the amount of written information 
provided. Patients who were satisfied with the type and timing of information received had 
stronger beliefs in personal control (β=−0.30, p<0.05), lesser concerns about their health 
condition (β=−0.47, p<0.01), and better understanding of their illness (β=−0.27, p<0.05), 
and were less emotionally affected by their illness (β=−0.27, p<0.05). In addition, the 
satisfied patients had a more positive perception of their general health (β=0.31, p<0.05) 
and better psychological health condition (β=0.33, p<0.05).
Conclusions: Satisfaction with the information provided is associated with better health 
outcomes, including more positive illness perceptions. This study appears to highlight 
the importance of providing adequate and sufficient information that meets the needs of 
patients.
Keywords: Satisfaction with information, illness perceptions, quality of life, breast cancer, 
Indonesia
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Introduction
Cancer is a chronic and frequently terminal disease. In 2008, approximately 12.7 million new 
cancer cases and 7.6 million cancer deaths were reported worldwide [1]. In Indonesia, breast 
cancer is the most prevalent cancer among women with an incidence rate of 36.2 and a 
mortality rate of 18.6 per 100,000 people [2]. Although  advances in current breast cancer 
treatment  have been found to improve women’s survival by approximately 13% in Western 
countries [3], the female breast cancer mortality rate in Indonesia is still increasing [4].  
In addition to the provision of appropriate medical treatment, cancer services should 
provide sufficient and adequate information about the disease and its treatment. The 
provision of information is one of the main elements of supportive care during their illness 
trajectory [5]. However, literature on the nature of the information provided to cancer patients 
suggests that the information supplied by health care providers frequently does not meet 
the needs of individual patients [6-9]. For example, a qualitative study among Indonesian 
women with breast cancer found that many patients reported  having received too little or 
unclear information from their physicians, particularly the information about the chances 
of cure and treatment process [10]. Although most cancer patients want to obtain basic 
information about diagnosis and treatment, not all patients want extensive information at 
every stage of their illness [11]. Providing information that matches the needs of the patients 
will lead to higher satisfaction among patients as this information appears to be associated 
with better illness perception and better health-related quality of life [12-14].
The illness perception concept has been recognized as an important factor associated 
with psychological outcomes in persons with physical illness [15]. This concept is based on 
the Common Sense Self-Regulation Model by Leventhal et al. [16]. This model assumes 
that patients respond to symptoms and signs of illness by forming cognitive and emotional 
representations of the illness on the basis of concrete and abstract sources of information 
available to them. The patients’ interpretation of that information is the first step in the 
process of coping with their illness and help seeking [15]. A recent study involving 4,446 
cancer survivors in the Netherlands found that satisfaction with information obtained was 
associated with more positive illness perceptions, except for personal control [13].
Quality of life is another important endpoint of research and clinical practice among 
cancer patients that seems to be associated with satisfaction with information. The 
concept of quality of life comprises a broad range of aspects including the perceptions 
a person has about his/her physical health, psychological state, level of independence, 
social relationships, personal beliefs and their relationship to the salient features of the 
environment [17]. Information on the quality of life can make a substantial contribution 
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to the health care providers’ understanding of the patients’ experiences of their cancer 
treatment [18]. A review study among cancer survivors concluded that satisfaction with 
information was positively associated with quality of life [19].
To date, only a little information is known about patient satisfaction with information in the 
Southeast Asian population of cancer patients, such as that in Indonesia. Therefore, the aims of 
this study were to assess breast cancer patients’ level of satisfaction with information on illness 
and treatment, to explore its associations with patients’ illness perceptions and quality of life, and 
to provide recommendations for improvement of the information provision. We hypothesized that 
satisfied patients would report more positive illness perceptions and higher quality of life. 
Methods
Participants
This study was part of a larger investigation in which psychosocial functioning of Indonesian 
breast cancer patients was explored. Seventy consecutive breast cancer patients were 
recruited from the outpatient surgical oncology clinic at Hasan Sadikin Hospital (HSH) 
Bandung from June until October 2011. The inclusion criteria were (a) age >18 years, (b) 
first diagnosis of breast cancer, and (c) an adequate command of the Indonesian language. 
Patients who had psychiatric treatment history were excluded from the study.   
Procedures
This study was approved by the Indonesian Medical Ethical Committee and the Board of 
Directors of HSH. A staff member from the surgical oncology clinic who handled patient 
administration identified eligible patients, approached patients to participate in the study and 
asked for their initial consent. Patients who agreed to participate were approached by one of 
the research assistants to arrange an appointment before the next visit to their physician. Data 
collection was conducted by ten master´s students in clinical psychology who were trained as 
research assistants and were supervised by SS (clinical psychologist) and AI (first author). 
The research assistants obtained informed consent and provided detailed information about 
the study and instructions on how to fill in a demographic form and the questionnaires: the 
Satisfaction with Cancer Information Profile (SCIP), the Brief Illness Perception Questionnaire 
(BIPQ), and the World Health Organization Quality of Life (WHOQOL-BREF). Participants 
filled in the questionnaires while they waited for consultation with the physicians for their 
treatment in the waiting room. Seven of the participants were illiterate, but they were able 
to speak and understand the Indonesian language. In these cases, the research assistant 
helped the participants by reading items aloud and filling in their responses.
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Measures
Socio-demographic and medical status
A standard socio-demographic form was used to collect self-report data on age, marital 
status, education level, employment status, insurance status, and family history of breast 
cancer. The patients’ medical status, including type and stage of cancer, type of treatment, 
and time since diagnosis, were obtained via their medical records.
Satisfaction with Cancer Information Profile (SCIP) 
The SCIP is designed to assess patient satisfaction with cancer information and comprises 
two subscales [14]. SCIP-A Satisfaction with the amount and content of information consists 
of 14 items about unwanted effects (items 1, 2, 3, 4 and 5), long-term effects (items 6, 9, 
10, 11, 12 and 13) and social/financial support (items 7, 8 and 14). Patients are asked to 
rate each item using the following response scale: ”too much”, “about right”, ”too little” and 
”none wanted”. Patients who rate the items with either ‘about right’ or ‘none wanted’ are 
given the score of 1, whereas patients who rate the items with either ‘too much’ or ‘too little’ 
are given score of 0. A subscale total score is obtained by summing the score for each item. 
The total score ranges from 0 to 14, with high scores indicating a high degree of satisfaction 
with the amount and content of the information received. SCIP-B Satisfaction with type 
and timing of information received consists of seven items about the format and timing of 
the information. Patients are asked to rate each item on a 5-response scale that ranged 
from “very satisfied”=5 to “very dissatisfied”=0. The total subscale score ranges from 7 to 
35, with higher scores indicating higher levels of satisfaction with the type and timing of 
information. This instrument was translated to produce an Indonesian version using the 
forward and back translation method. Forward translation was conducted by the first author 
(AI) and backward translation was conducted by a bilingual native English speaker (JH). 
A linguist (AC) examined the original English version and the back translation version of 
the SCIP to assess the significance of any discrepancies and after some revisions, the 
Indonesian version of the SCIP was finalized. The reliability coefficient for the Indonesian 
version of the SCIP is good (SCIP-A α= 0.77 and SCIP-B α= 0.81).
Brief Illness Perception Questionnaire
The BIPQ is a shortened version of the Illness Perception Questionnaire-Revised which 
was developed to obtain a very short and simple measure of illness perception [20]. The 
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BIPQ consists of eight items using a linear 0-10 response scale and one causal scale. Five 
of the items assess cognitive illness representations, namely, item 1, consequences (the 
perceived consequences of the illness on the patient’s life); item 2, timeline (the perceived 
duration of the illness); item 3, personal control (the perceived personal control over the 
illness); item 4, treatment control (how much the treatment can help to control the illness); 
and item 5, identity (symptoms that the patient attributes to the illness). Two of the items 
assess emotional representations, namely, item 6, concern (how much the patient worries 
about his/her illness) and item 8, emotions (how much the patient is emotionally affected 
by his/her illness); and one item (item 7) assesses how well the patient understands his/her 
illness (coherence). The causal representation is assessed by an open-ended response 
item, which asks patients to list the three most important causal factors in their illness (Item 
9). In statistical analyses, response scales of items 3, 4, and 7 were reversed to obtain 
the same response directions with the other five items. A higher score indicates a more 
threatening view of illness. Item 9 was excluded from the analyses because of the variety 
of responses. This instrument was translated to produce an Indonesian version using the 
same procedure as the one used to translate the SCIP. 
World Health Organization Quality of Life (WHOQOL-BREF)
The WHOQOL-BREF is a brief self-report quality of life assessment developed by the WHO 
group in 24 international field centers [21]. This instrument consists of 26 items, each item 
representing one aspect of life that is considered to contribute to a person’s quality of 
life. Twenty-four items measure four broad domains: domain 1, physical health (7 items); 
domain 2, psychological health (6 items); domain 3, social relationships (3 items); and 
domain 4, environment (8 items). Two other items measure the overall perception of quality 
of life and general health. The WHOQOL-BREF employs a 5-point scale (1 to 5) with a 
higher score indicating a higher level of self-perceived quality of life. The Indonesian version 
of the WHOQOL-BREF is available and has been validated [22]. 
Statistical analysis
Descriptive statistics were used to describe demographic and clinical characteristics of 
the study participants, the SCIP, the BIPQ, and the WHOQOL-BREF scores. Associations 
between demographic and clinical variables and the SCIP, the BIPQ, and the WHOQOL-
BREF scores were analyzed by the Pearson’s correlation coefficients for continuous 
variables and t-tests for the categorical variables. The following demographic and clinical 
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variables were dichotomized: marital status (married vs. other), education level (junior high 
school or lower education vs. senior high school or higher), employment status (housewife/
unemployed vs. other), ethnic group (Sundanese vs. other), health insurance status 
(insured vs. not insured), stage of cancer (stage 1 or 2 vs. stage 3 or 4), treatment type 
(Mastectomy vs. no mastectomy, Radiotherapy vs. no radiotherapy, and Chemotherapy 
vs. no chemotherapy), and family history of cancer (yes vs. no). Associations among the 
SCIP, the BIPQ, and the WHOQOL-BREF scores were explored by Pearson’s product 
moment correlation coefficient and Spearman’s rank order correlation. Multiple regression 
analyses were performed to investigate the association between the two subscales of the 
SCIP, with the BIPQ and the WHOQOL-BREF scores controlled for demographics and 
clinical characteristics which were correlated with dependent variables. In the multivariate 
regression analyses, employment status, educational level, and time since diagnosis were 
entered in the first block and the two SCIP subscales were entered in the second block, 
whereas the eight domains of illness perception, overall quality of life, general health, and 
the four domains of quality of life scores were the dependent variables. We applied an alpha 
value of 0.05 on the 14 regression analyses. A Bonferroni correction for 14 tests would 
require a nominal alpha of 0.004. However, with our sample size of 70, this conservative 
value would unduly raise the type II error. Therefore, and also given the pioneer character 
of the present study in this population, we decided to maintain an alpha value of 0.05. All 
analyses were conducted using the IBM® SPSS® Statistics version 20.
Results
Demographic and clinical characteristics
The response rate was 91%. Seven out of 77 patients approached declined to participate 
because they were too ill to fill in the questionnaires. The mean age of participants was 
45.6 years (SD=7.88, range=28-66). Fifty-eight (81%) participants were married and forty-
six (66%) participants were unemployed/housewife. The majority of the participants had a 
lower level of education (Junior high school=16% and Elementary school=51%) and seven 
(10%) had no education. Fifty-five (79%) of participants had Sundanese ethnic origin and 
fifteen (21%) participants had others ethnic origin (i.e. Javanese and Minang Kabau). Almost 
half of participants had advanced stages of cancer (stage III=23% and stage IV=20%). The 
mean number of months since diagnosis was 22.6 (SD=19.7; range= 1-84 months). Ninety-
four percent of the participants had health insurance provided by the government to poor 
people. Demographic and clinical variables are summarized in Table 1.
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Table 1. Demographic and clinical characteristics of study participants.
Variable n (%)
Age (M±SD) 45.60 ± 7.88a
Marital Status
Married 57 (81%)
Single 2 (3%)
Widowed 11 (16%)
Education (highest)
None 7 (10%)
Elementary school 36 (51%)
Junior high school 11 (16 %)
Senior high school 10 (14 %)
College or university 6 (9%)
Employment
Housewife/unemployed 46 (66%)
Laborer/irregular job 18 (26%)
Private employee 1 (2%)
Government officer 5 (7%)
Ethnicity
Sundanese 55 (79%)
Other 15 (21%)
Months since diagnosis 
(M±SD)
22.6 ± 19.7a
Range (months) 1-84b
Current stage of cancer
1 3 (4%)
2 37 (53%)
3 16 (23%)
4 14 (20%)
Treatment modality
Mastectomy 32 (46%)
Chemotherapy 51 (73%)
Radiotherapy 12 (17%)
Health insurance 
Yes 66 (94%)
No 56 (80%)
a Values are presented as M±SD
b Number of months
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Patients’ satisfaction with information
Table 2 shows means, standard deviations, and ranges of the SCIP, the BIPQ and the 
WHOQOL-BREF scores. Satisfaction with the amount and content of information scores 
were positively skewed with scores ranging from 0 to 13 (mean=5.24, median=5, SD=3.33), 
whereas satisfaction with the type and timing of information scores were normally distributed 
with scores ranging from 14 to 33 (mean=22.80; SD=4.12).
Table 2. Means, standard deviations and range of the SCIP, the BIPQ and the WHOQOL-
BREF scores.
Measure Breast Cancer patients
n=70
Mean SD Min-
Max
Satisfaction with the amount and content of information 5.24 3.33 0-13
Satisfaction with the type and timing of  information 22.80 4.12 14-33
Illness perception
Consequences 6.19 2.49 0-10
Timeline 5.43 2.12 0-10
Personal control 3.46 2.16 0-8
Treatment control 1.69 1.94 0-7
Identity 5.29 2.43 0-10
Illness concern 6.93 2.34 1-10
Coherence 4.37 2.64 0-10
Emotional representation 5.51 2.56 0-10
Overall quality of life 3.06 0.66 1-5
General health 2.93 0.94 1-5
Physical health 11.77 2.13 7-16
Psychological health 12.69 2.17 8-17
Social relationships 13.11 1.63 9-18
Environment 11.45 1.66 8-15
In regard to the amount and content of information, we found that a considerable 
number of patients (41%-86%) reported that they received insufficient information regarding 
several aspects related to their illness and treatment. Table 3 shows the information aspects 
and proportion of patients who reported that they received too little information, based 
on the SCIP-A items. Most patients were dissatisfied with the information about social/
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financial support, namely, access to patient support groups, how treatment may influence 
their ability to work and how to ask for possible financial support.
Table 3. Proportion of patients who reported to have received ‘too little’ information on 
the SCIP-A.
SCIP-A item Number of 
patients (%)
Subscale 1 : Unwanted effects
Whether your treatment interferes with other medicines you 
may be taking
54 (77%)
What the risks of your experiencing complications are 43 (61%)
What you should do if you experience unwanted side effects 39 (56%)
What the risks of your experiencing side effects are 31 (44%)
Whether the treatment has any unwanted side effects 29 (41%)
Subscale 2: Long-term effects
How your treatment may impact on your quality of life over the 
next year 
54 (77%)
How long you expect recovery to take 46 (66%)
How you may expect to feel immediately after treatment 45 (64%)
The long term impact of treatment on functioning (daily 
activities)
42 (60%)
The effect of treatment on your appearance 37 (52%)
Whether you may need further treatment in the future 35 (50%)
Subscale 3: Social/financial support
Patient support groups for you and your partner 60 (86%)
The effects of treatment on your ability to work 50 (71%)
Who to ask/where to go for possible financial support 48 (69%)
Table 4 shows means and standard deviations of the SCIP-B items, i.e. satisfaction 
with the type and timing of information. We found that participants were satisfied (SCIP-B 
item score > 3) with the usefulness of the information provided (mean=3.60), the amount 
of verbal information (mean=3.46), the usefulness of information for their partner/family 
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(mean=3.40), the understandability of the information given to them (mean=3.32), the 
timing at which they received the information (mean=3.13) and the detail of information 
provided (mean=3.13). However, participants were dissatisfied with the amount of written 
information provided (mean=2.77).  
Table 4. Means and standard deviations of the SCIP-B items scores.
SCIP-B item Mean (SD)
The usefulness of the information to you 3.60 (0.87)
The usefulness of the information to your partner/family 3.40 (0.87)
The amount of written information supplied 2.77 (0.76)
The amount of verbal information supplied 3.46 (0.81)
The timing at which you received information 3.13 (0.88)
The detail of the information given to you 3.13 (0.93)
How understandable the information was to you 3.31 (0.84)
Demographic variables related to the SCIP, the BIPQ, and the WHOQOL-
BREF scores
None of demographic and clinical characteristic was significantly associated with the SCIP 
scores; however several associations were found with the BIPQ and the WHOQOL-BREF 
scores. The time since the diagnosis was negatively correlated with the illness concern 
aspect of illness perception (r= -0.24, p<0.05), and positively correlated with physical 
health (r= 0.25, p<0.05), psychological health (r= 0.27, p<0.05) and environmental (r= 
0.26, p<0.05) domains of quality of life. Participants who were housewives/unemployed 
had higher scores on identity (t=2.568, p=0.01) and the illness concern (t=2.159, p=0.04) 
aspect of illness perception, and had lower scores on physical health domain of quality of 
life (t=-2.116, p=0.04) compared to participants who worked irregularly or had a permanent 
job. Participants with middle school or lower education had higher scores on coherence 
aspect of illness perception (t=2.452, p=0.02) and had lower scores on the environment 
domain of quality of life (t=-2.854, p=0.01) than participants with higher education. 
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Association between satisfaction with cancer information, illness 
perception, and quality of life 
Table 5 shows the Pearson’s product moment correlation coefficients and Spearman’s rank 
order correlation coefficients that describe the magnitude and directions of the bivariate 
associations between patients’ satisfaction with information, illness perceptions, and quality 
of life. Satisfaction with the amount and content of information scores was only negatively 
correlated with the emotional representation aspect of illness perception (r=-0.25, p<0.05). 
Patients who felt less emotionally affected by the illness were more likely to have higher 
levels of satisfaction with the amount and content of information received. Satisfaction 
with the type and timing of information scores was negatively correlated with personal 
control (r=-0.24, p<0.05), illness concern (r=-0.36, p<0.01), coherence (r=-0.25, p<0.05) 
and the emotional representation aspect of illness perception (r=-0.33, p<0.01). Patients 
who perceived that they had a high personal control over their illness, less worries about 
their illness, and better understanding about the illness, and felt less emotionally affected 
by the illness were more likely to have higher levels of satisfaction with the type and timing 
of information received. Satisfaction with the type and timing of information scores was also 
positively correlated with the psychological health domain of quality of life (r=0.26, p<0.05), 
which means that patients who had higher levels of satisfaction with information were more 
likely to have better psychological health. 
Table 5. Pearson’s correlations between the SCIP, the BIPQ and the WHOQOL-BREF 
scores.
Measure SCIP-A SCIP-B
SCIP-A (Satisfaction with the amount and content of 
information)
- 0.45**
SCIP-B (Satisfaction with the form and timing of information) 0.45** -
Illness perception
Consequences -0.08 -0.05
Timeline -0.12 -0.02
Personal control -0.01 -0.24*
Treatment control -0.08 -0.21
Identity -0.08 -0.10
Illness concern -0.09 -0.36**
Coherence -0.09 -0.25*
Emotional representation -0.25* -0.33**
 91
Overall quality of life 0.20 a 0.18 a
General health 0.15 a 0.23 a
Physical health -0.04 -0.03
Psychological health 0.12 0.26*
Social relationships 0.22 0.16
Environment 0.15 0.07
*Correlation is significant at the 0.05 level (two-tailed); **Correlation is significant at the 0.01 level 
(two-tailed).
a  Spearman’s rank order correlation coefficient
Table 6 shows multivariate regression analyses results in evaluating the SCIP scales 
with the BIPQ and the WHOQOL-BREF scales. Satisfaction with the type and timing of 
information explained a significant amount of the variance of personal control (β=-0.30, 
p<0.05), illness concern (β=-0.47, p<0.01), coherence (β=-0.27, p<0.05) and emotional 
representation (β=-0.27, p<0.05) of illness perception, the general health (β=0.31, p<0.05) 
and psychological health aspect (β=0.33, p<0.05) of quality of life. On the other hand, 
satisfaction with the amount and content of information did not significantly explain the 
variance of illness perception and quality of life. 
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Discussion
Our results show that a considerable number of patients were dissatisfied with the 
information that was provided. In regard to the amount and content of the information, 
many patients were dissatisfied with the information about social/financial support, namely; 
access to a patient support group, how treatment may influence the ability to work and 
how to ask for possible financial support. In regard to the type and timing, the majority 
of patients were dissatisfied with the amount of written information provided. None of the 
demographic and clinical characteristics were associated with patient satisfaction with 
cancer information. Patients who were satisfied with the type and timing of information had 
stronger beliefs in their personal control over their illness, less worries about their condition, 
and a better understanding of their illness and were less emotionally affected by the illness. 
Patients who were satisfied with the type and timing of information had also a more positive 
perception of their general health and psychological health condition. However, satisfaction 
with the amount and content was not associated with any illness perception or quality of 
life aspects.    
Although the importance of sufficient information provision has been recognized, the 
current sample seems to be less satisfied with the information provided by their physicians 
compared to a Western sample. In the Western sample, more than half of the participants 
reported are satisfied, with only two out of fourteen aspects being dissatisfied of the 
information provided,  namely, where to go for financial advice (64 out of 82 patients; 78%) 
and information about patient support groups (43 out of 82 patients; 52%) [7], whereas in 
the current sample there were 11 out of 14 aspects of information that patients reported 
being dissatisfied with by more than half of participants. The majority of Indonesian patients 
were dissatisfied with the information about social/financial support either because it was 
not provided or they received too little information. This finding is similar to the previous 
studies among head and neck cancer, colorectal cancer and endometrial cancer patients 
in Western countries that found a considerable number of patients who were dissatisfied 
with the information about access to patient support groups and other services [7, 23-24]. 
One possible explanation for this finding might be the busy setting and the unbalanced ratio 
between doctors and patients in the Indonesian health care services which results in a short 
consultation time [25]. Doctors seemed to focus their information on the physical aspect of 
illness and treatment. Therefore, although several patient support groups exist (e.g. the 
Indonesian Palliative Community/Masyarakat Paliatif Indonesia), the information about 
patient support groups is rarely provided. The improvement of information provision about 
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access to patient support groups is obviously needed, as social support has been known 
to be associated with better adjustment to cancer, better quality of life, less treatment side 
effects, less sense of isolation and alienation, and less psychological distress [26-28]. 
In the social/financial support aspect, the study showed that many patients were also 
dissatisfied with the information about long-term effects, in particular, how the treatment 
may impact on their long-term quality of life. Previous studies in Eastern countries found that 
doctors were more likely to limit their information about cancer diagnoses and prognoses 
because they assumed that full disclosure may have negative effects on the outcome of 
treatment or evoke serious psychological problems [29-31]. We assume that the same 
applies in Indonesia.
 With regard to the type and timing of information, most of the patients were dissatisfied 
with the amount of written information. This finding corroborates the results of our qualitative 
study in which patients reported that most of the information was delivered orally by the 
physicians, whereas written information was seldom provided [10]. Although the need for 
written information may vary among patients, written information seems to be the most cost 
effective and fruitful information source in complementing verbal information. The provision 
of written information will be helpful to increase patient’s knowledge, to empower patients, 
and to help patients to be able to “ask the right questions” during a consultation session 
[32]. We suggest that the lack of written information provision in the current Indonesian 
oncology setting can be improved by the provision of clear, concise, easy to understand, 
and attractive leaflets. 
In general, our findings show that patients who are satisfied with the received 
information had more positive illness perceptions than people who were less satisfied, which 
is in concordance with the previous studies among cancer patients in the Netherlands and 
UK [13-14]. The present study found that people who were satisfied with the information 
provided had stronger beliefs in personal control over their illness, less worries about their 
condition, and a better understanding of their illness, and were less emotionally affected 
by the illness. According to the Common Sense Self-Regulatory Model, patients form 
cognitive and emotional representations of the illness by comparing their own ideas and 
information received [15]. Therefore, misconceptions about their illness and inappropriate 
information provision can lead to a maladaptive response to the illness. The provision of 
appropriate and adequate information for the patients prior to treatment can help patients 
to reformulate their illness perceptions which will enable them to have a better adjustment 
during and after treatment [33]. In regard to the quality of life, patient satisfaction with the 
type and timing of information was associated with better perceptions about their general 
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health and psychological health condition. These findings show that patient satisfaction with 
information is associated with illness perceptions; however, it may have only a minor effect 
on the patients’ quality of life. 
This study has several limitations. First, the cross-sectional design used in this study 
limits the possibility to establish a causal association between satisfaction with cancer 
information, illness perceptions and quality of life. The reverse causal relationship (i.e. 
negative illness perceptions which lead to lower levels of satisfaction with information) may 
be possible too. For example, a randomized controlled follow-up study found that patients’ 
illness perception before consultation predicted patient satisfaction with the consultation [34]. 
In contrast, a prospective study showed that satisfaction with information before treatment 
was predictive of health related-quality of life 6–8 months after the end of treatment [23]. 
Second, the number of tests related to the small sample size (n=70) may lead to a limited 
statistical power. Post-hoc power analyses based on the number of tests yielded powers 
in the range of 0.47 and 0.83 for the significant analyses. One outcome (i.e., the negative 
correlation between satisfaction with the form and timing of information received and 
illness concern) had a power over 0.80 which is generally accepted as sufficient. Lastly, 
we conducted this study at HSH which is a referral hospital that provides health services 
to patients who have middle to low socio-economic status. Therefore, larger samples of 
various patient groups are needed to extrapolate the findings of the present study to other 
Indonesian patient groups. 
Our findings suggest that many Indonesian breast cancer patients are dissatisfied 
with the information they receive, particularly the information on access to patient support 
groups and written information. Satisfaction with the type and timing of information is 
associated with more positive illness perceptions, better perception of general health, and 
psychological health. However, longitudinal studies are needed to determine whether there 
is a support for these findings.
Practice implications
Although the Indonesian version of the SCIP used in the present study is the first adaptation 
based on a single sample of breast cancer patients, it shows a good reliability and is easy to 
be administered. Therefore, this measure could be used as a screening tool in daily cancer 
care and helpful in designing tailored information provision for breast cancer patients in 
Indonesia. Nevertheless, further research is needed to evaluate the psychometric properties 
of the SCIP which include a larger sample of various cancer patient groups. 
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Provision of concise and clear information about illness and treatment for the 
patients is a fundamental principle of care. However, many breast cancer patients reported 
dissatisfaction with the provision of information, which suggests an alarming gap between 
the provision of information and the needs of individuals. This situation leaves room for 
improvement and intervention. Provision of clear, concise, and easy to understand written 
information (e.g. leaflets) prior to treatment can be a cost-effective and efficient source 
of information, supplementing the verbal information provided in the busy setting of the 
oncology clinic in Indonesia.
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Abstract
Objective: The aim of the present study was to test the association between potential 
psychosocial factors and non-adherence to treatment in Indonesian women with breast 
cancer. 
Methods: Seventy consecutive breast cancer patients who were treated at the Outpatient 
Surgical Oncology Clinic in Hasan Sadikin Hospital in Indonesia were recruited. They 
completed a demographic form, the non-adherence questionnaire, the Breast Cancer 
Knowledge Test, the Brief Illness Perception Questionnaire, the Multidimensional Health 
Locus of Control Scales, the Satisfaction with Cancer Information Profile and the Distress 
Thermometer. 
Results: Seventeen (24%) out of seventy patients reported that they had delayed initiating 
treatment at the hospital, and nine (13%) out of seventy patients had missed two or 
more consecutive treatment sessions. In the bivariate analyses, we found no significant 
differences on any of the psychological variables between patients who delayed initiating 
treatment and those patients who did not, whereas patients who had missed two or more 
consecutive sessions had lower satisfaction with the type and timing of information provided 
and more negative illness perceptions than patients who had not missed their sessions. 
In multivariate regression analyses, consulting a traditional healer before diagnosis was 
associated with treatment delay (β=1.27, p=0.04). Poorer perceptions of illness (β=0.10, 
p=0.02) and whether a traditional healer had been consulted after diagnosis (β=1.67, 
p=0.03) were associated with missing treatment sessions.
Conclusions: Having negative illness perceptions was associated with missing treatment 
sessions, whereas consulting a traditional healer was a risk factor for treatment delay and 
missed treatment sessions. 
Keywords: Breast cancer, psychosocial factor, non-adherence, Indonesia.
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Introduction
Breast cancer is the most frequently diagnosed cancer among women both in developed 
and developing countries [1]. However, the mortality rate in developing countries is higher 
than developed countries due to the more favorable survival rate in developed countries 
[2]. A review study of cancer epidemiology in South East Asian countries found that late 
presentation at the hospital for treatment was the major problem related to lower survival 
rates among women with breast cancer in Indonesia [3]. In addition, poor adherence to 
treatment is considered to be an important factor contributing to higher mortality rates in 
developing countries [4].
In general, the term adherence refers to the extent to which patients follow the 
instructions they are given for prescribed treatments [5]. More specifically, Levinsky & 
O’Donohue elaborated that non-adherence to treatment may appear in several forms, 
namely: (a) not attending or coming late to appointments, (b) delay or not initiating a 
recommended treatment, (c) not completing behavioral recommendations, (d) not taking 
medication as prescribed, and (e) terminating the treatment prematurely [6]. A recent 
meta-analysis study about patient adherence which involved 569 published studies found 
an average non-adherence rate of 25% and a non-adherence rate of 21% for cancer 
patients [7]. Specifically among breast cancer population, previous studies found about 
16%-32% of patients delayed initiating treatment [8-9], and approximately 30% of patients 
discontinued therapy early [10]. In Indonesia, the general non-adherence rate among the 
cancer population is not yet known. However, previous studies reported a considerable 
non-adherence rate. For example, we found in a retrospective study in fifty breast cancer 
patients that 42% had delayed the uptake of treatment at the hospital and 20% had missed 
two or more consecutive sessions during their treatment [11]. In a study among childhood 
leukemia patients, approximately 25% of patients refused or abandoned therapy (12), and 
another study in retinoblastoma patients found that 31.5% of patients temporarily refused 
medical treatment, whereas 18.2% of patients refused treatment permanently (13). 
A conceptual review study about psychosocial factors underlying breast screening 
and breast cancer treatment adherence by Magai et al.,[12] suggested that in principle, 
non-adherence to treatment recommendation is a behavioral problem. They argued that 
there are at least two reasons to focus on psychological factors in the study of patients’ 
adherence; First, psychosocial factors have been known to play significant roles in health 
protective and health maintenance behaviors, and second, psychosocial factors are 
relatively modifiable and can potentially be targeted by an intervention program compared 
to demographic and structural factors. 
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In general, psychosocial factors of non-adherence to treatment can be differentiated 
into two groups, namely: cognitive variables and socio-emotional variables. Cognitive 
variables include patients’ knowledge, risk perception, beliefs and attitude to breast cancer 
treatment, whereas socio-emotional variables include social networks and social support, 
and patients’ emotions [12]. Previous studies among breast cancer patients found that 
greater knowledge of the disease and treatment are associated with better adherence 
[13-15]. How patients’ perceive and respond to their illness (i.e. illness perceptions) and 
the degree to which a person believes that he/she controls the events in his/her life have 
also been assumed to be predictors of non-adherence. A review study of patients’ illness 
perceptions and medication adherence found that negative illness perceptions were 
directly or indirectly associated with poor adherence to medication [16]. A review study 
about adherence to therapy with oral anti-neoplastic agents suggested that people with 
a strong belief that their behavior played a large role in determining their circumstances 
(internal locus of control) are more likely to adhere to a prescribed treatment regimen [17]. 
With regard to socio-emotional variables, a meta-analysis study about social support and 
patient adherence to medical treatment found that better social support was associated 
with better adherence [18]. Another meta-analysis found that high levels of psychological 
distress was associated with poor adherence [19]. 
Our previous qualitative study in Indonesian breast cancer patients identified several 
potential psychosocial factors underlying patients’ adherence to treatment, including: lack 
of awareness and knowledge, cancer beliefs, treatment beliefs, emotional burden and 
unmet information needs [11]. The aim of the present study was to test the association 
between these potential psychosocial factors (i.e. knowledge, illness perception, health 
locus of control, satisfaction with information and distress) and non-adherence to treatment 
in Indonesian breast cancer patients in a quantitative way. 
Methods
Participants
This study was part of a larger investigation in which the psychosocial aspects of Indonesian 
breast cancer patients undergoing medical treatment (i.e. surgery, chemotherapy and 
radiotherapy) were explored. Seventy consecutive patients were recruited between June-
October 2011 at the outpatient surgical oncology clinic at Hasan Sadikin Hospital (HSH) 
Bandung. The study included: patients aged eighteen years or older; patients who had 
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received a first diagnosis of breast cancer; patients who had no psychiatric treatment 
history, and patients who had an adequate command of the Indonesian language. 
Measures
Socio-demographic characteristics
A standard socio-demographic form was used to collect self-report data on age, marital 
status, education, employment status, family income, insurance status, travel time to 
hospital, time since diagnosis, family history of cancer and use of traditional healer. The 
patients’ medical records were also reviewed to obtain data on type and stage of cancer 
and type of treatment. 
Adherence to Treatment
Patients’ adherence to treatment was assessed using a self report. We evaluated 2 forms 
of non-adherence; (1) treatment delay, and (2) not attending treatment appointments. As 
there is a strong association between delaying breast cancer treatment by three months or 
more and lower survival [20], we adopted a three-month interval as our gold standard for 
treatment delay. A patient was categorized as a non-adherer according to the first definition 
if the period between the first diagnosis and the first admission at HSH was >3 months. A 
patient was categorized as a non-adherer according to the second definition if they were 
absent from two or more consecutive treatment sessions at HSH [21].  
Breast Cancer Knowledge
Patient knowledge was assessed using the Breast Cancer Knowledge Test (BCKT) [22]. 
This instrument comprises 2 sections; the first section consists of 12 items to assess 
individual breast cancer general knowledge, and the second section consists of 8 items to 
assess individual knowledge about the curability of breast cancer. For each item, patients 
are asked to mark whether the statement is ‘true’ or ‘false’. Items correctly answered are 
given a score of 1, and items answered incorrectly are given a score of 0. The BCKT was 
translated to the Indonesian language using the forward- and back-translation method. In 
the first section, item number 3 about the breast cancer prevalence was adjusted with 
the actual Indonesian prevalence rate. The total score ranged from 0 to 20, with higher 
scores indicating higher breast cancer knowledge. The BCKT has an acceptable reliability 
coefficient (α=0.69).    
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Illness Perceptions
Patient’s cognitive and emotional representation of illness was assessed using the Brief 
Illness Perception Questionnaire (BIPQ) [23]. This instrument was constructed based on 
the Common Sense Model of Illness Cognition which assumes that illness perceptions 
will have an effect on patients’ coping behaviors and psychological outcomes [24]. Illness 
perceptions consists of 8 dimensions, namely: (1) consequences which reflect the expected 
effects and outcome of the illness; (2) time line which refers to the perceived duration of the 
illness; 3) personal control which reflects the beliefs about personal abilities to control the 
illness; (4) treatment control which reflects the beliefs about the efficacy of the treatment to 
cure or manage the illness; (5) identity which refers to the label the person uses to describe 
the illness and the symptoms; (6) illness concern which refers to how much the person 
worries about his/her illness; (7) coherence which refers to how well the person understands 
his/her illness; and (8) emotional representation which reflects a person’s evaluation of the 
potential emotional impact of the illness [23]. Each dimension is measured by a single item 
using a continuous linear 0-10 point scale. Answer scales of items about personal control, 
treatment control and coherence were reversed to elicit the same response directions with 
the other five items. The overall score was obtained by summing the eight item scores 
where a higher score indicates a more threatening view of the illness. This instrument was 
translated into the Indonesian language using the forward- and back-translation method. 
Internal Health Locus of Control 
The Internal Health Locus of Control (HLC) was assessed using the Internal HLC subscale 
of the Multidimensional Health Locus of Control (MHLC) Scales [25]. The MHLC was 
developed as a generic medical condition-specific measurement of locus of control that 
assesses individuals’ feelings of control over their illness or disease, including the internal, 
chance, doctors and powerful others subscales. This measure is an 18-item scale using a 
6-point Likert format, ranging from 1 = ‘strongly disagree’ to 6 = ‘strongly agree’. A higher 
score on each subscale is indicative of a stronger influence of the dimension in health 
behaviors. The MHLC scales were translated into Indonesian through the forward- and 
back-translation method. Cronbach’s alpha coefficients were ranged from 0.48 to 0.77. For 
content validity, the scales were assessed by three psychologists. 
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Satisfaction with Cancer Information 
Patient satisfaction with the information provided was assessed using the Satisfaction with 
Cancer Information Profile (SCIP) [26]. This measure comprises 2 subscales: Subscale 1 
consists of 14 items which measures patient satisfaction with the amount and content of 
information. Patients are asked to rate each item using the following response scale: ‘too 
much’, ‘about right’, ‘too little’ and ‘none wanted’. Patients who rate the items with either ‘about 
right’ or ‘none wanted’ are given score of 1, whereas patients who rate the items with either 
‘too much’ or ‘too little’ are given score of 0. A subscale total score is obtained by summing 
the score for each item, which ranged from 0 to 14. High scores indicating a high degree of 
satisfaction with the amount and content of information received. Subscale 2 consists of 7 
items which measure patient satisfaction with the type and timing of information received. 
Patients are asked to rate each item on a 5-response scale ranged from ‘very satisfied’=5 
to ‘very dissatisfied’=0. The total subscale score ranged from 7 to 35, with higher scores 
indicating higher levels of satisfaction with the form and timing of information. The SCIP was 
translated to the Indonesian version using the forward- and back-translation method. The 
reliability coefficient for the Indonesian version of the SCIP was good (subscale 1 α= 0.77 
and subscale 2 α= 0.81).
Psychological Distress
Psychological distress was assessed using the Distress Thermometer (DT) [27]. The DT 
was developed by the NCCN and is a 1-item self-report measure of psychological distress 
in patients with cancer. Patients are asked to report their distress in the past week on a 
thermometer-like 11-point visual analogue scale, with scores ranging from 0 (no distress) 
to 10 (extreme distress). We prepared an Indonesian version of the Distress Thermometer 
using the forward- and back-translation method. 
Procedures
This study was approved by the Indonesian medical ethical committee and the Board of 
Directors of HSH. Eligible patients were approached by a member of the administration 
staff from the surgical oncology clinic. They asked patients for initial consent and referred 
patients who were willing to participate in the study to the research assistants. One of the 
research assistants followed up and arranged an appointment with the patients on their 
next visit. All data collections were conducted by 10 master´s students in clinical psychology 
who were trained as research assistants and were supervised by AI (first author) and SS 
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(fifth author). After signing the informed consent, patients were asked to complete a socio-
demographic form, the non-adherence questionnaire, the BCKT, the BIPQ, the MHLC, the 
SCIP, and the DT. For those who were unable to complete the questionnaires unassisted (i.e. 
seven patients were illiterate), the research assistants read the questionnaires aloud and 
recorded the patients’ answers on the questionnaires. Patients filled in the questionnaires 
in the waiting room of the clinic before their consultation with the physicians. 
 
Data Analysis
All data analyses were performed using the IBM® SPSS® Statistics version 20. Descriptive 
statistics were used to describe the demographic and clinical information, the mean scores of 
the questionnaires (i.e. the BCKT, the BIPQ, the MHLC, the SCIP and the DT), and the non-
adherence status. To explore the association between non-adherence and the demographic, 
clinical and psychological variables, Chi-square analyses were conducted for categorical 
variables and t-test analyses were conducted for continuous variables. Backward stepwise 
logistic regression analyses were performed to analyze the association between psychosocial 
variables and non-adherence. The BCKT, the BIPQ, the Internal HLC, the SCIP and the DT 
scores were the predictors whereas treatment delay and not attending treatment appointment 
were the outcomes. In addition, backward stepwise logistic regression analyses were 
performed to explore the association between demographic and clinical characteristics and 
non-adherence. Age, marital status, education level, employment status, family incomes, travel 
time to hospital, consult a traditional healer before and after diagnosis were the predictors 
whereas treatment delay and not attending treatment appointment were the outcomes. For 
the logistic regression of not attending treatment appointments, current stage of cancer was 
also included as a predictor. A power calculation for 70 cases with 6 predictors in a linear 
regression analysis turns out that a medium effect (f²=0.21) should exist in the population to 
find a significant effect [28].
Results
Demographic and clinical characteristics 
The mean age of participants was 45.6 years (SD=7.88, range=28-66). Fifty-seven (81%) 
participants were married and forty-six (66%) participants were unemployed/housewives. 
The majority of participants had a lower education level (junior high school=16% and 
elementary school=51%) and seven (10%) had no education. Fifty-three (76%) participants 
had a low monthly income (<USD$200) and twenty-eight (40%) had a travel time from 
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home to the hospital >3 hours. Almost half of participants had an advanced stage of cancer 
(stage III=23% and stage IV=20). The mean number of months since diagnosis was 22.6 
(SD=19.7; range=1-84 months, median=15 months). Ninety-four percent of the participants 
had health insurance provided by the government to poor people. Demographic and clinical 
variables are summarized in Table 1. 
Table 1. Demographic and clinical characteristics of study participants
Variable n (%)
Age (M±SD) 45.60 ± 7.88
Marital Status
Married 57 (81%)
Single 2 (3%)
Widowed 11 (16%)
Education (highest)
None 7 (10%)
Elementary school 36 (51%)
Junior high school 11 (16 %)
Senior high school 10 (14 %)
College or university 6 (9%)
Employment
Housewife/unemployed 46 (66%)
Laborer/irregular job 18 (26%)
Private employee 1 (2%)
Government officer 5 (7%)
Family income (monthly)
< USD$ 200 53 (76%)
USD$200 - USD$300 13 (18%)
> USD$300 4 (6%)
Travel time to hospital
< 1 hour 22 (31%)
2-3 hours 20 (29%)
> 3 hours 28 (40%)
Months since diagnosis (M±SD) 22.6 ± 19.7
Range (months) 1-84
Current stage of cancer
1 3 (4%)
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2 37 (53%)
3 16 (23%)
4 14 (20%)
Treatment modality
Mastectomy 32 (46%)
Chemotherapy 51 (73%)
Radiotherapy 12 (17%)
Health insurance 
Yes 66 (94%)
No 4 (6%)
Family history of breast cancer
Yes 14 (20%)
No 56 (80%)
Consult a traditional healer
Before diagnosis 33 (47%)
After diagnosis 12 (17%)
Non-adherence to treatment
(1) Treatment delay
Seventeen (24%) out of seventy patients had delayed initiating treatment at HSH with a 
time delay ranging from 3 to 27 months, except for the two participants who had delayed 
treatment for four years. The median time of treatment delay was seven months. In regard to 
demographic and clinical characteristics, we found that the stage of cancer and consulting 
a traditional healer before diagnosis was associated with treatment delay. Patients who 
delayed initiating treatment were more likely to be at an advanced cancer stage (stage 
III and IV) (χ² = 9.244, df = 3, p= 0.03) and had more frequently consulted a traditional 
healer before their diagnoses (χ² = 4.953, df = 1, p= 0.03). Means, standard deviations and 
range of the psychological variable scores are detailed in Table 2. T-test results showed no 
significant differences on any of the psychological variables between patients who delayed 
initiating treatment and who did not. Backward stepwise logistic regression analyses found 
that consulting a traditional healer before diagnosis was the only significant predictor of 
treatment delay (χ=1.27, p=0.04).
(2) Not attending treatment appointments
Nine (13%) out of seventy patients reported that they had missed two or more consecutive 
treatment sessions. In regard to demographic and clinical characteristics, we found that 
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only consulting a traditional healer after diagnosis was associated with missing two or more 
consecutive treatment sessions (χ² = 5.420, df = 1, p= 0.02). Means, standard deviations 
and range of the psychological variable scores are detailed in Table 2. T-test results showed 
that patients who had missed two or more consecutive sessions had lower satisfaction 
with the type and timing of information provided (t=2.247, p= 0.03) and higher illness 
perceptions scores (t=-2.520, p= 0.01) than patients who had not missed two or more 
consecutive sessions. Backward stepwise logistic regression analyses found that illness 
perception (β=0.10, p=0.02) was the only significant psychological predictor of missing two 
or more consecutive treatment sessions. In addition, consulting a traditional healer after 
diagnosis (β=1.67, p=0.03) was a significant demographic predictor of missing two or more 
consecutive treatment sessions. 
Table 2. Means, standard deviations and t-test results of the psychological variables of 
the non-adherers and the adherers group 
Measure Initiating a recommended treatment Attending appointments
Adherers
(n=53)
Non-
adherers
(n=17)
Adherers
n=61
Non-
adherers
n=9
Mean 
(SD)
Mean 
(SD)
t-test p-value Mean 
(SD)
Mean 
(SD)
t-test p-value
Distress 4.58 (2.76) 4.82 (2.60) -0.315 0.75 4.46 (2.66) 5.89 (2.80) -1.495 0.14
Internal Health 
locus of control
24.57 (4.18) 23.59 (4.53) 0.823 0.41 23.97 (4.08) 26.78 (4.84) -1.885 0.06
Satisfaction 
with the amount 
and content of 
information
5.40 (3.50) 4.76 (2.75) 0.679 0.50 5.34 (3.28) 4.56 (3.75) 0.662 0.51
Satisfaction 
with the form 
and timing of 
information 
23.23 (4.07) 21.47 (4.11) 1.544 0.13 23.21 (3.89) 20 (4.72) 2.247 0.03
Illness perception 38.51 (9.35) 39.94 
(13.25)
-0.414 0.68 37.70 
(10.26)
46.67 (7.35) -2.520 0.01
Breast cancer 
knowledge
9.42 (4.16) 8.82 (4.16) 0.582 0.56 9.18 (3.63) 9.89 (3.79) -0.544 0.59
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Discussion
Findings from the present study showed that 24% of breast cancer patients reported that 
they had delayed initiating treatment at the hospital and 13% of breast cancer patients 
had missed two or more consecutive treatment sessions. In the bivariate analyses, we 
found no significant differences on any of the psychological variables between patients 
who delayed initiating treatment and those who did not.  Patients who had missed two or 
more consecutive sessions had lower satisfaction with the type and timing of information 
provided and more negative illness perceptions than patients who had not. In multivariate 
regression analyses, consulting a traditional healer before diagnosis was associated with 
treatment delay. Having negative illness perceptions and consulting a traditional healer 
after diagnosis were associated with missing two or more consecutive treatment sessions. 
Of the seventy patients who were currently receiving treatment for their breast cancer, 
24% reported that they delayed initiating treatment after their diagnosis which is lower 
than our previous study that found 40% delayed initiating treatment [11]. One possible 
explanation for this difference may be related to the clinical characteristics of the patients. 
We found that the majority of patients (57%) in the current study were at stage I and II 
and, therefore probably had more positive expectations, whereas in the previous study 
the majority of patients (64%) were at stage III and IV. This difference indicates also that 
patients in the current study came earlier to the hospital compared with patients in the 
previous study. Nevertheless, the non-adherence rate in this study was higher than a recent 
study in South-East Asian breast cancer patients which adopted a similar gold standard 
(i.e. 3 months delay) that found 7% of patients delayed initiating treatment at the hospital 
[29]. Thirteen percent of patients were non-adherent to treatment by missing two or more 
consecutive treatment sessions. This percentage is lower than previous studies in Asian 
and Western breast cancer patients. For example, a study among Malaysian breast cancer 
patients found that 29% of patients were non-adherent to chemotherapy and 13% of patients 
were non-adherent to radiotherapy [30]. A study among American breast cancer patients 
found that 31% of patients discontinued therapy and 28% were non-adherence to adjuvant 
hormone therapy [10], and a study among Canadian breast cancer patients found that 22% 
of patients discontinued adjuvant endocrine therapy within 2 years [31]. This difference 
may be attributed to the operational definition of non-adherence. In the current study, the 
non-adherence rate refers to the percentage of breast cancer patients who had missed two 
or more consecutive treatment sessions, whereas the non-adherence rate in the previous 
literature refers to several outcomes, such as non-adherence to adjuvant endocrine therapy 
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or other medical regiments. In addition, non-adherence was measured by patients’ self 
report in a retrospective way; therefore patients’ responses were vulnerable to recall and 
social desirability bias which may have resulted in an underestimation of non-adherence.  
Having negative illness perceptions was associated with missing two or more 
consecutive treatment sessions in both bivariate and multivariate analyses. These results 
are in concordance with the result of a recent review study that found a negative association 
between illness perception and adherence to medication [16]. According to the Common 
Sense Model (CSM) of illness, patients create cognitive and emotional representations 
of the illness as responses to symptoms and signs of illness, and those perceptions will 
lead to their coping responses [23]. For example, previous studies among diabetes and 
hypertension patients found that patients who felt treatment could control their illness 
were more likely to take their medication as prescribed [32-33]. This finding identifies a 
potential target for intervention to improve patients’ adherence to treatment. Provision of 
appropriate and adequate information about illness and treatment may eliminate patients’ 
misunderstanding and negative conceptualization of the illness and may lead to better 
adherence [34]. 
In bivariate analyses, lower satisfaction with information provided was found to be 
associated with missing two or more consecutive treatment sessions. This finding is in line 
with previous literature which found that greater satisfaction with information was associated 
with higher adherence to medical recommendations and treatments [35-36]. However, this 
association was not significant in multivariate analyses. One possible explanation for this 
result is a high collinearity between illness perception and satisfaction with information 
(r=-0.35, p=0.01), therefore multivariate analyses showed only the strongest predictor (i.e. 
illness perception) of missing two or more consecutive treatment sessions.  
We found that consulting a traditional healer before diagnosis was a risk factor for 
treatment delay and consulting a traditional healer after diagnosis was a risk factor for 
missing treatment sessions. This finding supports the results of our previous study that 
identified a strong belief in traditional healers as one of the main barriers of non-adherence 
to treatment [11]. As a strong belief in traditional healers has been confirmed as a factor 
influencing patients’ adherence to treatment, it implies that it is important to understand 
patients’ attitudes towards, and perceptions of, traditional healers. Better knowledge about 
this topic may assist health professionals to give more appropriate information about cancer 
and its treatment. Improving patient knowledge may help to reduce the unrealistic reliance 
of patients on traditional healers. 
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Contrary to our expectations, none of psychological variables was associated with 
treatment delay, and illness perception was the only psychological factor that significantly 
associated with missing two or more consecutive treatment sessions. Our finding that 
patients’ level of knowledge was not associated with non-adherence is in contrast with 
previous breast cancer studies that found greater knowledge was associated with greater 
adherence [13-15]. A possible explanation for this divergence is that patients’ knowledge 
was measured after the time period of non-adherence in our study; therefore patients’ 
knowledge may have changed. According to a review study about common factors 
underlying breast cancer treatment adherence by Magai et al., [12] literature on the impact 
of knowledge on breast cancer treatment adherence is still limited, therefore the role of 
patients’ knowledge on adherence to treatment is still indecisive and more research is 
required. As internal HLC has been known to be positively associated with health behavior 
[37], we expect that patients with a high internal HLC will be more likely to adhere to 
treatment. This was not supported by our results which were similar to a previous study 
in breast cancer patients [38]. As cancer is chronic and has an uncontrollable nature, it 
leaves only a little personal control. Therefore, having an internal HLC is not necessarily 
associated with better adjustment in cancer patients. In regard to the emotional variables, 
the current study found that distress was not associated with non-adherence which is in 
contrast with previous literature that found that a higher level of distress was associated 
with poor adherence to medical recommendations [19]. This non-significant association 
might be explained by the possible changes in patients’ distress between the time of non-
adherence and the psychological measurements.
Several methodological limitations should be noted. First, this study is based on 
consecutive patients where the majority has low socio-economic status because HSH is a 
referral hospital for the poor people. The relatively small sample size and homogeneity of 
the current sample could have some influence on the results. For example, a review study 
of 50 years of research about adherence to medical recommendations found that studies 
with smaller sample sizes reported higher adherence than larger samples [7]. Therefore, 
the adherence rate obtained in this study should be interpreted with caution and may not 
represent the general Indonesian cancer patient population. Lastly, the cross-sectional 
design of the study limits the causal association between psychological factors and non-
adherence to treatment. Moreover, the psychological variables were measured after the 
occurrence of non-adherence, thus further prospective studies are needed to ascertain the 
current study findings.  In conclusion, we found that an alarming number of breast cancer 
patients delayed initiating treatment at the hospital. We found indications for a difference 
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among non-adherence and adherence groups on illness perceptions and satisfaction with 
information provided, and having negative illness perceptions was associated with missing 
treatment sessions. Finally, as consulting a traditional healer was associated with treatment 
delay and also missing treatment sessions, health professionals’ awareness about this 
issue is important and the provision of sufficient information about illness and its treatment 
is urgently needed from the first medical consultation in order to reduce patients’ unrealistic 
beliefs in traditional healers and improve their adherence to medical recommendations.
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The case fatality of women with breast cancer in Indonesia is increasing [1]. It is therefore 
important for health care professionals, including oncologists, nurses and medical 
psychologists to understand psychological adjustment and potential psychosocial factors 
that relate to non-adherence to medical recommendations in women with breast cancer. 
The main aim of this thesis was to identify possible psychosocial risk factors for non-
adherence to treatment and for psychological adjustment in Indonesian women with breast 
cancer. Considering the pioneering character of the present study in this population, we 
also developed and validated an Indonesian version of the measurement instruments to 
be used in daily cancer care in Indonesia. This chapter consists of 3 sub-sections; the 
first section presents the summary of the main findings and a synthesis of the evidence 
from our studies. The second section discusses the strengths and limitations of the current 
study and also presents recommendations for future research directions. The final section 
describes potential implications of the findings for clinical practice. 
7.1 Main findings 
7.1.1 Psychological adjustment to breast cancer
In Indonesia, breast cancer is the most prevalent  cancer among women and has a relatively 
high mortality rate [1]. Therefore, women who receive a breast cancer diagnosis are facing 
multiple stressors throughout their illness trajectory, including experiencing treatment side 
effects, coping with financial, family and social problems, and facing the risk of recurrence 
and/or death. Understanding the psychological adjustment and its related factors in women 
with breast cancer seems to be an important aspect in cancer care, as poor psychological 
adjustment to cancer has been reported to be associated with several negative outcomes. 
For example, patients with a high level of distress were more likely to have a low adherence 
to treatment recommendations, poor satisfaction with care and poor quality of life [2-4].
In our study described in Chapter 3, we investigated the Indonesian version of the 
’Distress Thermometer’ (DT) in order to know its psychometric properties. It showed a good 
concurrent validity with the Hospital Anxiety and Depression Scales (HADS), which is a 
well-established screening tool for distress. A cutoff score of 5 on the DT yielded optimal 
sensitivity and specificity for the current population, which is in concordance with the results 
of a  meta-analysis study looking at the accuracy of the DT to detect possible distress, 
anxiety and depression in cancer settings [5]. Using a HADS cutoff score of 15, more 
than a half of the Indonesian women with breast cancer in our population were identified 
as experiencing clinically significant distress. The proportion of women who experienced 
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significant levels of distress in the current sample is higher than results of previous studies 
which found that 20-40% of cancer patients experience a significant level of distress. 
These studies were mainly performed in Western countries [6-7]. We found that patients 
who had significant distress were more likely to report more problems in the practical, 
family, emotional, spiritual/religious and physical domains. Interestingly, patients who had 
clinically significant distress were more likely to experience spiritual/religious concerns 
which included concerns about the meaning of life and trust in God. This finding is similar 
to the result of a study in Korean cancer patients [8], however it is in contrast with the results 
of studies in Western cancer patients that found that clinically significant distress was not 
or only weakly associated with spiritual/religious concerns [9-12]. The positive association 
between high distress and spiritual/religious concerns is possibly due to cultural factors. 
Indonesian people are generally religious1  and have a strong belief in God to heal their 
disease. We assume that women who do not  experience progress in their illness, will 
be more convinced that their cancer is the will of God and they therefore cannot change 
their destiny which  might trigger higher levels of distress. We also found that distress, 
as measured with the DT, was negatively correlated with patients’ quality of life, which is 
in concordance with previous studies among Turkish, Norwegian, Germany and Spanish 
cancer patients [11, 13-15].
With regard to psychological adjustment, Health Locus of Control (HLC) has been 
recognized as a potential predictor of a better adjustment to cancer. Theoretically, internal 
HLC (i.e. an individual’s belief that what happens to his/her health condition is a result of his/
her own actions) is considered to be associated with better health outcomes and emotional 
adjustment [16]. Our study presented in Chapter 4 revealed that Indonesian women with 
breast cancer had higher external HLC (i.e. chance, doctors, powerful others and God) 
and lower internal HLC than healthy women which is concordance with the previous 
studies in chronically ill patients and breast cancer patients in other countries [17-20]. One 
possible explanation for this finding may involve the uncontrollable nature of cancer and the 
uncertainty of treatment outcomes which could reduce patients’ beliefs in personal control 
over their illness. In addition, many patients in our study had an advanced stage of cancer 
which required a long-term cancer treatment. Such a condition may increase patients’ belief 
that external sources are determining their health condition, such as physicians, powerful 
others (e.g. family members), chance and God. In this study, only God LHC explained 
1. It is obliged to have a religion in Indonesia, which is also registered in each identification card. 
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a significant amount of the variance of anxiety, other HLC dimensions did not show any 
association with anxiety and depression symptoms, This seems in concordance with a 
previous study among Rheumatoid Arthritis and Systemic Sclerosis patients [21], whereas 
none of the HLC orientations was related to depressive symptoms. Our results on God HLC 
suggest that a strong belief in an external source of control, i.e. God, might be negatively 
associated with patients’ emotional adjustment. However, another explanation might be 
possible too; patients who experienced higher anxiety level may get a greater belief in 
God’s control over their health conditions. For example, a previous study in the UK cancer 
patients found that religious control was positively associated with the hospital anxiety 
and depression scale scores and expression of a fatalistic attitude to cancer, therefore it 
suggests a link that anxiety and depression feelings coupled with fatalistic perception of 
cancer may increase patient’s belief that religious control (i.e. God and religion) has an 
influence on the course of their disease [22]. 
Improving patients’ quality of life is considered the ultimate goal of cancer care service 
in both clinical practice and research. Satisfaction with information and positive illness 
perception were factors that have been found to be associated with patients’ quality of life 
[23]. The study presented in Chapter 5 showed that a considerable number of patients who 
were treated at the outpatient surgical oncology clinic, were dissatisfied with the information 
provided by the health care professionals (i.e. oncologist and nurses). With regard to the 
amount and content of the information many patients were dissatisfied with information 
about social/financial support, namely; access to a patient support group, how treatment 
may influence the ability to work and how to ask for possible financial support. The lack of 
information about social/financial support may be attributed to a high number of patients 
and limited practice hours, and the unbalanced ratio between doctors and patients in the 
Indonesian health care services which results in a short consultation time [24]. Doctors 
seem to focus their information primarily on the physical aspects of illness and treatment. 
Although several patient support groups (e.g. the Indonesian Palliative Community) as well 
as government financial support for the poor people are available (e.g. ASKESKIN and 
JAMKESDA), this information is rarely provided during consultation time. In regard to the 
type and timing of information provided, the majority of patients were dissatisfied with the 
amount of written information provided. Patients reported that most of the information was 
delivered orally by the physicians, whereas written information was seldom provided. As the 
provision of written information has been considered to be beneficial to increase patient’s 
knowledge and to empower patients during a consultation session [25], providing clear, 
concise, easy to understand and attractive leaflets may be beneficial. The current study 
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also found that higher satisfaction with the received information was associated with more 
positive illness perceptions, i.e. stronger beliefs in personal control, less concerns about 
their health condition, better understanding of the illness, and less emotionally affected by 
the illness, which is in concordance with previous studies among cancer patients in the 
Netherlands and the UK [23, 26]. According to the Common Sense Self-Regulatory Model, 
patients form cognitive and emotional representations of the illness by comparing their 
own ideas and information received [27]. Misconceptions about cancer and inappropriate 
information provision prior to and during treatment may lead to incorrect patients’ perceptions 
toward their illness, which might lead to a maladaptive response to the illness. 
In regard to quality of life, we found that only patient satisfaction with the type and timing 
of provided information was associated with more positive perceptions about their general 
health and psychological health condition, whereas satisfaction with the amount and content 
of provided information was not associated with quality of life. Overall, these results show that 
patient satisfaction with information is associated with illness perceptions, whereas only the 
aspects of type and timing seem to have an effect on patients’ quality of life.
7.1.2 Psychological factors associated with non-adherence to 
treatment 
In Chapter 2 we explored psychosocial factors related to delay in seeking medical help 
and non-adherence to treatment in Indonesian women with breast cancer qualitatively. Our 
results showed that a considerable number of patients had delayed in seeking medical help 
and initiating their treatment at Hasan Sadikin Hospital (HSH). We found 8 themes related 
to delay in seeking medical help and non-adherence to treatment which can be categorized 
into 3 clusters, namely: (1) factors related to patients (i.e. lack of awareness and knowledge, 
cancer beliefs and treatment beliefs), (2) factors related to treatment (i.e. financial problems, 
emotional burden and severe side effects), and (3) factors related to patient-health provider 
relationships (i.e. paternalistic style of communication and unmet information needs). Our 
findings indicated that lack of breast cancer awareness and inadequate knowledge about 
signs and symptoms of breast cancer influenced patients’ delay in seeking medical help 
negatively, which is similar to the results of previous studies that found lack of breast cancer 
knowledge was associated with women’s ability to recognize breast cancer symptoms 
and the perceived necessity of seeking medical help [28-31]. Several programs could be 
introduced to improve breast cancer awareness and knowledge that may contribute to 
lowering the number of delay in seeking medical help. Considering the demographic and 
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infrastructure factors in Indonesia, we suggest the use of media campaigns, including public 
service announcements on television, radio and newspapers. The use of media campaigns 
have been found to be an effective way to improve breast health knowledge, to teach 
women how to conduct breast self-examination and to increase breast health practices 
in Chinese population [32]. Besides the lack of knowledge, incorrect cancer beliefs (e.g. 
cancer is incurable and a shameful disease) and negative treatment beliefs influenced 
women’s perception of the necessity to seek medical help and to start their treatment in the 
referral hospital. In the same way, a previous study in Malaysian women found that negative 
perceptions of breast cancer were the main reason for delay in the presentation of breast 
cancer [31]. Many women had negative perceptions of medical treatment of breast cancer; 
in contrast, they had a great belief in traditional healers. They believed that traditional 
therapy was an alternative solution for their health problem or a complement to medical 
treatment, which influenced patients’ behaviors and treatment decisions.
Although most patients in our study had government insurance for poor people, 
which covers all medical expenses, financial problems (e.g. financial difficulties in paying 
transportation costs to the hospital, accommodation and other logistical costs) were the 
most reported reason to skip two or more consecutive treatment session. This result is 
similar to previous studies in Indonesian child leukemia and retinoblastoma patients [33-
34]. Furthermore, we found that patients who experienced severe side effects were more 
likely to miss their treatment because they were too ill to come to the hospital or felt that the 
side effects of the treatment were worse than cancer itself. This finding is in concordance 
with the results of a review study about adherence rates in long-term hormonal therapy, 
which included European, African and Asian breast cancer patients [35]. In addition, 
dissatisfaction with the information provided at consultations was also a factor related to 
patients’ non-adherence to treatment. Some participants reported that they received either 
too little or too complicated and incomprehensive information, leaving their informational 
needs unmet. This condition seems to influence patients’ understanding and belief about 
treatment efficacy, which may decrease their treatment adherence.
To confirm the findings from our qualitative study, we conducted a quantitative study 
aimed to evaluate the association between potential psychosocial factors (i.e. knowledge, 
illness perception, health locus of control, satisfaction with information and distress) and 
non-adherence to treatment in Indonesian women with breast cancer, which was presented 
in Chapter 6. Our results showed that a lower percentage of breast cancer patients delayed 
initiating treatment at the hospital (24%) than we found in our previous study in which 40% 
of patients had delayed initiating treatment. Differences in clinical characteristics of both 
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sample groups were associated with this difference; the majority of patients (57%) in the 
latter study were in the early stages (stage I and II), whereas in the former study the majority 
of patients (64%) were in an advanced stage (stage III and IV). Therefore, the sample in 
the quantitative may have had more positive expectations about the medical treatment of 
breast cancer. Notwithstanding, the percentage of non-adherence in this study was higher 
than in a recent study in South-East Asian breast cancer patients which adopted a similar 
gold standard (i.e. 3 months delay) and found that only 7% of the patients delayed initiating 
treatment at the hospital [36]. The authors of a comparison study between breast cancer 
patients in Indonesia and Malaysia that found that patients in Indonesia were more likely to 
present at advance stages and metastatic breast cancer suggested several barriers of early 
presentation of breast cancer in Indonesia, namely: (1) the referral hospital in Indonesia is 
situated in the capital city, whereas a large percentage of Indonesian population resides 
in the rural area; therefore, some women who reside in the rural area may not present to 
the referral hospital, (2) the lack of a population-based breast cancer screening program, 
(3) financial problems, and (4) cancer and treatment beliefs (e.g. fatalism, shame, belief in 
traditional medicine) [37]. 
In regard to treatment non-adherence, we found that 13% of the patients were non-
adherent to treatment by missing two or more consecutive treatment sessions, which is 
lower than results of previous studies in Asian and Western breast cancer patients. In a 
study among Malaysian breast cancer patients, 29% of the patients were non-adherent 
to chemotherapy and 13% of the patients were non-adherent to radiotherapy [38]. 
Similarly, a study among American breast cancer patients found that 31% of the patients 
discontinued therapy and 28% were non-adherent to adjuvant hormone therapy [39]. We 
assume that the operational definition of non-adherence which we used (i.e. had missed 
two or more consecutive treatment sessions) may have led to different results compared to 
previous literature which adopted various outcomes, such as non-adherence to adjuvant 
endocrine therapy or other medical regiments. In addition, the use of patients’ self report 
in a retrospective way may have caused recall and social desirability bias which may 
have resulted in an underestimation of non-adherence. Our results showed a difference 
among non-adherence and adherence groups in illness perceptions and satisfaction with 
information provided, and having negative illness perceptions was associated with missing 
treatment sessions. We again found that consulting a traditional healer was associated with 
treatment delay and also with missing treatment sessions. In contrast, knowledge, health 
locus of control, and distress were not associated with treatment delay and non-adherence 
to treatment. 
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In comparison with the results of our qualitative study, we found an inconsistency 
concerning the association between breast cancer knowledge and non-adherence to 
treatment. One possible explanation for this difference may be related to the measurement 
that was used to assess women’s knowledge about breast cancer. In the first study, we 
determined that patients had a lack of awareness and knowledge based on qualitative 
judgment of their answers during the interview (e.g. named the diagnosis wrongly, didn’t 
know the symptoms of breast cancer, didn’t know the cause of breast cancer), whereas in 
the second study, patients’ general knowledge about breast cancer and their knowledge of 
breast cancer curability was measured objectively by the Breast Cancer Knowledge Test.
7.2 Methodological considerations
7.2.1 Strengths of the current study
The studies presented in this thesis have several strengths as well as limitations. The strengths 
of the studies were: Firstly, the studies formed a series of investigations that explored the 
factors associated with non-adherence to treatment in Indonesian women with breast cancer, 
and the use of both qualitative and quantitative methods were likely to obtain richer and deeper 
information about potential psychological factors of non-adherence. Secondly, the relatively 
high response rate (91%) in all studies promotes confidence in the accuracy of our study 
results. Thirdly, the use of healthy women as a comparison group for the health locus of control 
study provided a more comprehensive knowledge about health locus of control of Indonesian 
women with breast cancer (and of healthy women (Chapter 4)).
7.2.2 Limitations of the current study
Particular limitations of the studies were the cross-sectional design, the specificity (i.e. the 
referral area of the Hasan Sadikin Hospital) and the size of the sample, and the availability 
of validated Indonesian version of some measurements. Firstly, the cross-sectional design 
used in these studies limits the possibility to establish a causal association among variables 
that were investigated. Further prospective studies are needed to give an insight into the 
direction of these associations. 
Concerning the specificity, the studies that were presented in this thesis were 
conducted in Hasan Sadikin Hospital (HSH) which is a referral hospital that provides 
health services to patients who have middle to low socio-economic and educational level. 
Therefore, multi-center studies with a larger sample of various patient groups are needed 
to be able to extrapolate these results of the present study to other groups. The relatively 
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small sample size in the study about satisfaction with information (Chapter 5) and the study 
about psychological factors associated with non-adherence to treatment (Chapter 6) may 
have led to a limited statistical power. In the latter study, the problem with sample size was 
due to the low non-adherence rate. Our post-hoc power analyses based on the number of 
tests yielded power rates in the range of 0.47 and 0.83 for the significant analyses which 
implies that the findings should be interpreted with caution. However, several associations 
that were found in these studies also appear in other studies. For example, the finding 
that negative illness perceptions are associated with non-adherence to treatment was 
similar with the results of a review study about patients’ illness perceptions and medication 
adherence [40]. 
Thirdly, some measurement instruments were not available in the Indonesian 
language and were translated by our research group. The unavailability of their psychometric 
properties, population norms and the cutoff scores may raise some issues. For example, 
the use of the general cut-off score of the HADS, which has been obtained from Western 
populations, may have led to an overestimation or underestimation of the depression and 
anxiety levels of our Indonesian samples. We addressed these issues by using the forward 
and back translation method as suggested by the experts [41] to translate the Distress 
Thermometer (Chapter 3), the C form of the Multidimensional Health Locus of Control 
Scales (Chapter 4), the Satisfaction with Cancer Information Profile and the Brief Illness 
Perception Questionnaire (Chapter 5), and the Breast Cancer Knowledge Test (Chapter 
6). We used the general cutoff score suggested by the HADS authors for the determination 
of distress and explored its psychometric properties (Chapter 3). Factor analysis of the 
Indonesian version of the HADS demonstrated a two factor solution in good accordance 
with the HADS-A and HADS-D subscales. A final limitation is that we used patients’ self 
report to measure treatment delay and non-adherence to treatment in a retrospective way 
which may have been susceptible to recall and social desirability bias. Therefore, the non-
adherence rates reported in our studies should be interpreted with caution, and future 
prospective research using standardized medical record information is required to confirm 
and extend the current findings.
7.3 Implications for clinical practice and future research
Information about patients’ psychological problems and psychological adjustment during 
their treatment (e.g. depressive symptoms and anxiety), risk perceptions, beliefs and 
attitudes is important to provide to health care professionals. They could use this knowledge 
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to develop appropriate psychosocial care and symptom management, and to provide 
information that matches with patients’ individual needs.
As suggested by The National Comprehensive Cancer Network, distress among 
cancer patients should be screened, monitored and treated promptly at all stages of the 
disease [42]. Our findings suggest that the Indonesian version of Distress Thermometer 
is a brief, easy to administer and valid screening tool for distress that can be used in 
daily cancer care in Indonesia (Chapter 3). Considering the high number of patients at the 
Outpatient Surgical Oncology Clinic, nurses and/or administration staffs could administer 
the DT while patients are waiting for their appointment in the waiting room. Findings of our 
study showed that more than half of the patients reported a significant level of distress. The 
use of the DT in daily cancer care may help oncologists and other health professionals to do 
a quick distress screening, which may help them to prevent potential severe psychological 
problems in cancer patients and to provide additional interventions to patients who need 
it. For example, patients who have higher distress levels could receive cognitive behavioral 
stress management training which aims to help patients to manage their stress effectively. 
In particular, and given the scarcity in psycho-medical help in Indonesia, we suggest that 
patients in an advanced stage of cancer with a high level of distress should be given priority 
for psychological intervention. Accordingly, monitoring patients’ distress and investigating 
the efficacy of a particular intervention for patients’ distress is also a required topic for future 
research. 
People’s perceptions of factors controlling their health (i.e. Health Locus of Control) 
may lead to an understanding of health or illness-related behaviors. In comparison to healthy 
women, women with breast cancer had higher external HLC (i.e. chance, doctors, powerful 
others and God) and lower internal HLC, and God LHC was associated with a higher level 
of anxiety (Chapter 4). Knowledge about the tendency of patients’ health locus of control 
may help health care professionals to identify patients’ emotional adjustment problems during 
their illness trajectory. The high external HLC among women with breast cancer indicates the 
importance to assess women’s feelings of the lack of self control over their illness, and provide 
interventions to help women gain a sense of control over their illness.
In cancer care services, the provision of sufficient and adequate information about the 
disease and its treatment is important to add to appropriate medical treatment. A significant 
gap between individual informational needs and information provided by the health care 
professionals may not only influence patients’ satisfaction with information but also influences 
patients’ illness perceptions by not receiving the correct information about disease and its 
treatment. We found that a considerable number of patients were dissatisfied with several 
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aspects of information provided by the health care professionals, especially with information 
about social/financial support and the provision of written information. In addition, having 
negative illness perceptions was associated with missing treatment sessions (Chapter 5). 
Therefore, the provision of appropriate and adequate information about disease and its 
treatment is urgently needed to help patients reformulate their illness perceptions which in 
turn enables them to cope more adequately during and after treatment [43]. Considering the 
imbalance ratio between health care professionals and cancer patients in the oncology clinic 
in Indonesia, some practical issues emerged, such as limited consultation time and the fact 
that consultation focuses primarily on physical aspects of cancer. Therefore, the provision 
of clear, concise and easy to understand written information about illness and its treatment 
(e.g. leaflets) can be a cost-effective and efficient source of information supplementing the 
vis-à-vis information. In addition, the improvement of verbal information provided by the 
physicians is needed, too. Future research to investigate physicians’ perceptions about 
the provision of verbal and written information for breast cancer patients will be fruitful to 
confirm the current study results.
Our qualitative and quantitative studies identified several psychosocial factors that 
were associated with non-adherence (Chapter 2 and Chapter 6). Having negative illness 
perceptions was associated with missing treatment sessions, whereas a strong belief in 
traditional healers was associated with treatment delay and missing treatment sessions. 
This also emphasizes the relevance of provision of clear information to the patients about 
their illness and its treatment, taking into account what traditional healers tell and do. At 
this moment, we are developing a psycho-education intervention program that aims to 
diminish delay in seeking help and treatment delay, and increase treatment adherence in 
Indonesian women with breast cancer. However, poor adherence might not only be related 
to patients’ behavior, but also to health care providers’ behavior. Further investigation of 
health care providers’ health beliefs and adherence with breast cancer protocols in Hasan 
Sadikin Hospital in Bandung is needed. In addition, a retrospective medical records study 
to investigate the rates of treatment refusal and abandonment, the most severe types of 
non-adherence among Indonesian women with breast cancer is necessary to ascertain the 
current study findings.
In conclusion, our results show several important issues related to the psychological 
adjustment of Indonesian patients with breast cancer, namely: more than half of women 
with breast cancer reported a significant level of distress, had a high external HLC and 
low internal HLC, and were dissatisfied with several aspects of information provided by 
the health care professionals (e.g. information about social/financial support and the 
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provision of written information). God LHC was associated with a higher level of anxiety. 
We also found that non-adherence to treatment was associated with a lack of awareness 
and knowledge, negative illness perceptions and a strong belief in traditional healers, and 
was not associated with Health Locus of Control, satisfaction with information provided 
and distress. Future research should be focuses on the development and evaluation of an 
information package, based on these outcomes.
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Summary
Chapter 1 provides the background, aims and outline of this thesis. It presents changes 
in the prevalence and the unfavorable direction of the case fatality rate among Indonesian 
women with breast cancer. The recent data showed that breast cancer has emerged as the 
most frequent cancer and the leading cause of death among Indonesian women. Although 
the incidence rate is lower than in developed countries, the case fatality rate from breast 
cancer is remarkably high. Similar with others South East Asian countries, the poorer 
survival among Indonesian breast cancer patients is largely due to late presentation of the 
disease. This is caused by many factors, such as a lack of facilities for early detection and 
a poor access to primary treatment. As cancer is a chronic and frequently terminal disease, 
women who are diagnosed with breast cancer are confronted with multiple stressors 
throughout their illness trajectory. Therefore, understanding psychological adjustment and 
potential psychosocial factors that related to non-adherence to medical recommendation in 
women with breast cancer is urgently needed. 
The objective of this thesis was to identify possible psychosocial risk factors for non-
adherence to treatment and psychological distress in Indonesian women with breast cancer. 
To answer the objective of this thesis, first we explored potential determinants of non-
adherence qualitatively, subsequently we conducted several validations and exploratory 
studies to better comprehend the nature of psychological problems and adjustment related 
to breast cancer, and finally we explored the psychological factors that might be associated 
with non-adherence to treatment quantitatively.
Chapter 2 presents the results of a qualitative study about psychosocial and cultural 
reasons for delay in seeking help and non-adherence to treatment in Indonesian women 
with breast cancer. Consecutive fifty breast cancer patients who were treated at the 
Outpatient Surgical Oncology Clinic were interviewed. The interview included participants’ 
demographic characteristics and the following topics: knowledge of the disease, perceived 
disease severity, information provided by the patient’s physician, use of health services 
and alternative treatment, attitudes towards western and traditional medicine particularly 
in relation to the patient’s disease, the perceived benefits of, and barriers to, treatment 
and non-adherence to medical recommendations. Interviews were recorded, transcribed 
verbatim and coded using qualitative software program ATLAS.ti version 5.2. Eight 
main themes concerning reasons for delay in seeking medical help and treatment non-
adherence emerged, namely: lack of awareness and knowledge, cancer beliefs, treatment 
beliefs, financial problems, emotional burden, severe side effects, paternalistic style 
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of communication and unmet information needs. This study found several modifiable 
psychosocial and cultural factors that may be used to develop interventions to reduce 
non-adherence behavior in this population. These findings suggest that the provision of 
extensive information through media campaigns, treatment decision aids, and caregiver 
and patient education are needed to change the illness behaviors of Indonesian breast 
cancer patients.
In Chapter 3, we aimed to translate the Distress Thermometer (DT) into Indonesian, 
test its validity in Indonesian women with breast cancer and determine norm scores of the 
Indonesian DT for clinically relevant distress. We translated the original version of the DT 
into Indonesian version using a forward and backward translation procedure according to 
the guidelines. Therefore, one-hundred and twenty breast cancer patients at the Outpatient 
Surgical Oncology Clinic completed a standard socio-demographic form, the DT and the 
Problem List, the Hospital Anxiety and Depression Scale (HADS) and the WHO Quality 
of Life (WHOQOL-Bref). The receiver operating characteristic curve analysis identified a 
good discrimination (AUC=0.81) of the DT cutoff score relative to the established cutoff 
score of the HADS >15, and  a cutoff score of 5 on the DT had the best sensitivity and 
specificity. Patients who reported distress above this cutoff experienced more problems 
in the practical, family, emotional, spiritual/religious and physical domains than patients 
below the cutoff score. In addition, patients at advanced stages of cancer experienced 
more emotional and physical problems. Patient’s distress level was negatively correlated 
with overall quality of life, general health and all quality of life domains. We conclude that 
the DT was a valid tool for screening distress in Indonesian breast cancer patients, and we 
recommend using a cutoff score of 5 in this population. A particular finding of this study 
was the positive association between clinically significant distress and spiritual/religious 
concerns, which is similar to the results of a study conducted in Korea, but in contrast 
to most studies conducted in Western countries that found no association or only weak 
association. We conclude that patients in an advanced stage of cancer should be given 
priority for psychological intervention.
Chapter 4 investigates whether Indonesian women with breast cancer have higher 
external Health Locus of Control (HLC) than healthy women, and explores the association 
between HLC and symptoms of anxiety and depression. In this study, one-hundred and 
twenty consecutive women with breast cancer who were recruited at the outpatient surgical 
oncology clinic completed a standard demographic form, Form C of the Multidimensional 
Health Locus of Control, as well as the Hospital Anxiety and Depression Scale. As a 
comparison group, one hundred and twenty two healthy women who were recruited 
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from the Bandung area completed a standard demographic form and the Form C of the 
Multidimensional Health Locus of Control. Women with breast cancer had higher scores on 
all external HLC subscales, i.e. chance, doctor, powerful others and God, and lower internal 
HLC compared to healthy women. Lower education level was associated with higher 
chance HLC scores in women with breast cancer, and was associated with lower internal 
HLC and higher chance HLC in healthy women. Time since diagnosis was significantly 
negatively correlated with God LHC scores. High God LHC scores were associated with a 
high level of anxiety, whereas none of the HLC subscales were associated with depression. 
Our results suggest that a strong belief in an external source of control, i.e. God, might be 
negatively associated with patients’ emotional adjustment. Further research is needed to 
give an insight into the direction of this association.  
In Chapter 5, breast cancer patients’ level of satisfaction with information on illness and 
treatment and its association with illness perceptions and quality of life were studied. Seventy 
consecutive breast cancer patients at the Outpatient Surgical Oncology Clinic completed 
a demographic form, the Satisfaction with Cancer Information Profile, the Brief Illness 
Perception Questionnaire and the World Health Organization Quality of Life. A considerable 
number of patients (41%-86%) reported that they received insufficient information regarding 
several aspects related to their illness and treatment, particularly information about access 
to patient support groups and the impact of their treatment on long-term quality of life. In 
regard to the type and timing of information, the majority of patients were dissatisfied with 
the amount of written information provided. Patients’ satisfaction with the type and timing 
of information was positively associated with stronger beliefs in personal control, less 
concerns about their health condition, better understanding of their illness, and satisfied 
patients were less emotionally affected by their illness. Satisfaction with the type and timing 
of information was also associated with a more positive perception of their general health 
and a better psychological health condition. On the other hand, satisfaction with the amount 
and content of information was not associated with illness perception and quality of life. 
Our study results suggest that satisfaction with information provided is associated with 
better health outcomes, including more positive illness perceptions; therefore it highlights 
the importance of providing adequate and sufficient information that meets the needs 
of patients. Even though, longitudinal studies are needed to determine whether there is 
support for this interpretation.
The study in Chapter 6 evaluates the association between psychosocial factors 
(i.e. knowledge, illness perceptions, health locus of control, satisfaction with information 
and distress) and non-adherence to treatment in Indonesian women with breast cancer. 
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Seventy consecutive breast cancer patients participated in this study. They completed a 
demographic form, the non-adherence questionnaire, the Breast Cancer Knowledge Test, 
the Brief Illness Perception Questionnaire, the Multidimensional Health Locus of Control 
Scales, the Satisfaction with Cancer Information Profile and the Distress Thermometer. 
Seventeen (24%) out of seventy patients reported that they had delayed initiating treatment 
at the hospital, and nine (13%) out of seventy patients had missed two or more consecutive 
treatment sessions. The multivariate regression analyses showed that having a negative view 
of cancer (i.e. a view with the emphasis on its threatening character) was associated with 
missing treatment sessions, whereas having consulted a traditional healer was associated 
with both treatment delay and missed treatment sessions. Contrary to our expectations, 
patients’ knowledge, health locus of control and satisfaction with information was not 
associated with treatment delay and missed treatment sessions. We suggest that health 
professionals need to be aware of patients’ negative illness perceptions and unrealistic 
beliefs in traditional healers, and provide them with clear information about their illness and 
its treatment. However, the relative importance of these factors should be studied in future 
prospective studies, also considering the exploratory character of this study.
Finally, Chapter 7 provides a general discussion of the findings, discusses the 
accumulated results which related to our research aims, and presents implications for 
clinical practice and future research. The studies presented in this thesis identified several 
cultural differences in psychological factors associated with non-adherence to treatment and 
psychological adjustment compared to the Western cancer population, namely: Indonesian 
women with breast cancer had higher belief that God determines their health conditions, 
were more dissatisfied with several aspects of information provided by the health care 
professionals (e.g. information about social/financial support and the provision of written 
information) and had a stronger belief in traditional healers. 
Screening for psychological distress among women with breast cancer is needed in 
daily cancer care services to prevent potential severe psychological problems and provide 
additional psychological interventions to patients who need it. Health professionals need to be 
aware of patients’ negative illness perceptions and a strong belief in traditional healers, factors 
which were associated with treatment delay and non-adherence to treatment. Provision of 
clear, concise and easy to understand written information about illness and its treatment (e.g. 
leaflets) can be a cost-effective and efficient source of information supplementing the verbal 
information in the busy setting of the oncology clinic in Indonesia. At this moment, we develop 
a psycho-education intervention program that aims to diminish delay in seeking help and 
treatment delay, and increase treatment adherence in Indonesian women with breast cancer.
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Determinanten van therapie-ontrouw bij Indonesische vrouwen 
met borstkanker
Samenvatting
Hoofdstuk 1 bevat de achtergrond, doelstellingen en de grote lijnen van dit proefschrift. 
Veranderingen in de prevalentie en de ongunstige trend in het letaliteitspercentage bij 
Indonesische vrouwen met borstkanker worden erin gepresenteerd. Recente gegevens 
tonen aan dat borstkanker zich heeft ontpopt tot de meest voorkomende soort kanker en 
de voornaamste doodsoorzaak onder Indonesische vrouwen. Hoewel de incidentie lager 
ligt dan in ontwikkelde landen is het letaliteitspercentage bij borstkanker opmerkelijk hoog. 
Zoals ook in andere Zuidoost-Aziatische landen het geval is, is de kleinere overlevingskans 
bij Indonesische borstkankerpatiënten voornamelijk te wijten aan late onderkenning van 
de ziekte. Dit wordt veroorzaakt door verschillende factoren, waaronder een gebrek aan 
faciliteiten voor vroege detectie en slechte toegang tot primaire zorg. Aangezien kanker 
een chronische en vaak terminale ziekte is, hebben vrouwen bij wie borstkanker is 
vastgesteld met meerdere stressoren te kampen tijdens hun ziektetraject. Om deze reden 
is het dringend nodig een beter inzicht te krijgen in de psychologische adaptatie en de 
psychosociale factoren die verband kunnen houden met falende therapietrouw  bij vrouwen 
met borstkanker.
Het doel van dit proefschrift was om mogelijke psychosociale risicofactoren voor 
therapieontrouw en distress bij Indonesische vrouwen met borstkanker op te sporen. 
Ten behoeve van dit doel hebben wij ten eerste de potentiële bepalende factoren voor 
therapieontrouw kwalitatief verkend; vervolgens hebben wij verschillende validaties en 
verkennende studies uitgevoerd om beter te begrijpen wat de aard is van de psychische 
problemen en psychologische adaptatie in relatie tot borstkanker; tenslotte hebben wij de 
psychische factoren die mogelijk verband houden met therapietrouw/-ontrouw kwantitatief 
verkend.
In hoofdstuk 2 worden de resultaten besproken van een kwalitatieve studie naar 
de psychosociale and culturele redenen voor uitstel bij het zoeken van hulp en voor 
therapietrouw/-ontrouw bij Indonesische vrouwen met borstkanker. Vijftig opeenvolgende 
borstkankerpatiënten die behandeld werden bij de polikliniek oncologie en chirurgie zijn 
ondervraagd. Het gesprek betrof, naast de demografische kenmerken van de deelnemers, 
de volgende onderwerpen: kennis van de ziekte, ernst van de ziekte in de beleving van de 
patiënt, door de behandelend arts verstrekte informatie, het gebruik van de gezondheidszorg 
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en alternatieve behandelingen, attitude ten opzichte van westerse en traditionele 
geneeskunde met name in relatie tot de ziekte van de patiënt, door de patiënt ervaren 
voordelen van, en drempels voor, de behandeling en ten slotte therapietrouw/-ontrouw. De 
interviews zijn opgenomen, woordelijk uitgeschreven en gecodeerd middels het kwalitatieve 
softwareprogramma ATLAS.ti, versie 5.2. Bij de redenen voor het uitstellen van het zoeken 
van medische hulp en voor therapieontrouw, zijn acht overkoepelende thema’s aan het licht 
gekomen, te weten: gebrek aan kennis en inzicht, opvattingen over kanker, opvattingen 
over behandelingen, financiële beperkingen, emotionele belasting, zware bijwerkingen, 
een paternalistische communicatiestijl en het niet voorzien in de informatiebehoefte. Deze 
studie heeft een aantal veranderbare psychosociale en culturele factoren aan het licht 
gebracht, waarvan gebruik gemaakt kan worden voor het ontwikkelen van interventies om 
therapieontrouw in deze populatie terug te dringen. Uit de resultaten komt naar voren dat 
er om het ziektegedrag van Indonesische borstkankerpatiënten te veranderen behoefte 
is aan uitgebreide voorlichtingscampagnes in de media, hulpmiddelen ten behoeve van 
beslissingen over de behandeling, evenals voorlichting voor zorgverleners en patiënten.
Hoofdstuk 3 betreft de vertaling van de Distressbarometer (DB) in het Indonesisch, 
toetsing van de validiteit ervan bij Indonesische vrouwen met borstkanker en vaststelling 
van de normscores van de Indonesische DB voor klinisch relevante distress. De 
oorspronkelijke versie van de DB werd naar het Indonesisch vertaald met behulp van 
een terugvertaalprocedure, zoals voorgeschreven in de richtlijnen. In dit verband vulden 
honderdtwintig borstkankerpatiënten bij de polikliniek chirurgie en oncologie een standaard 
sociaaldemografisch formulier in, evenals de DB en de klachtenlijst, de Hospital Anxiety 
and Depression Scale (HADS) en de WHO Quality of Life (WHOQOL-Bref). Analyse van de 
ROC-curve toonde een goede discriminatie aan (AUC=0.81) van de DB-drempelwaarde in 
relatie tot de drempelwaarde van de HADS >15; een drempelwaarde van 5 op de DB leverde 
de beste sensitiviteit en specificiteit op. Patiënten die aangaven dat hun distress boven deze 
drempelwaarde lag, ervoeren meer praktische, emotionele, levensbeschouwelijke en fysieke 
problemen en meer gezinsproblematiek dan patiënten die onder deze waarde uitkwamen. 
Bovendien hadden patiënten met kanker in vergevorderde stadia meer emotionele en 
fysieke problemen. Er was een negatieve correlatie tussen de mate van distress van de 
patiënt en de algehele kwaliteit van leven, de algemene gezondheidstoestand en alle 
domeinen van de kwaliteit van leven. Hieruit concluderen wij dat de DB een valide middel 
was voor het signaleren van distress bij Indonesische borstkankerpatiënten, en wij bevelen 
aan dat er een drempelwaarde van 5 wordt gehanteerd bij deze populatie. Een opvallend 
resultaat van dit onderzoek was het positieve verband tussen klinisch significante distress 
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en levensbeschouwelijke problemen, een resultaat dat vergelijkbaar is met de resultaten van 
een onderzoek in Korea, maar niet overeenkomt met de meeste onderzoeken in Westerse 
landen, waarbij geen of slechts een zwak verband werd vastgesteld. Wij concluderen hieruit 
dat patiënten in een vergevorderd stadium van kanker met voorrang psychologische hulp 
zouden moeten krijgen.
Hoofdstuk 4 onderzoekt of Indonesische vrouwen met borstkanker een meer externe 
Health Locus of Control (HLC) hebben dan gezonde vrouwen, en verkent het verband tussen 
HLC en symptomen van angst en depressie. Voor dit onderzoek vulden honderdtwintig 
vrouwen met borstkanker, opeenvolgend geworven bij de polikliniek chirurgie en oncologie, 
een standaard demografisch formulier, Formulier C van de Multidimensional Health Locus 
of Control en tevens de Hospital Anxiety and Depression Scale in. Ter vergelijking vulde een 
groep van honderdtweeëntwintig gezonde vrouwen, geworven in Bandoeng en omstreken, 
een standaard demografisch formulier en Formulier C van de Multidimensional Health 
Locus of Control in. Vrouwen met borstkanker hebben op alle subschalen voor externe HLC 
hogere waarden, d.w.z. voor toeval, dokter, invloedrijke derden en God, en lagere interne 
HLC-waarden dan gezonde vrouwen. Een lager opleidingsniveau hield bij vrouwen met 
borstkanker verband met hogere waarden op de toeval-schaal, en bij gezonde vrouwen 
met een lagere interne HLC en hogere waarden op de toeval-schaal. De tijd die sinds de 
diagnose was verstreken, vertoonde een significant negatieve correlatie met de waarden 
op de God-schaal. Hogere waarden op de God-schaal hielden verband met een hoger 
angstniveau; geen van de HLC-subschalen hield echter verband met depressie. Onze 
resultaten lijken uit te wijzen dat een sterk geloof in een externe bron van beheersing, d.w.z. 
God, mogelijk negatief verband houdt met de emotionele adaptatie van de patiënten. Er is 
verder onderzoek nodig om inzicht te krijgen in de richting van dit verband.
In hoofdstuk 5 komt aan de orde hoe tevreden borstkankerpatiënten waren met de 
informatie over de ziekte en de behandeling, evenals het verband tussen tevredenheid en 
percepties van ziekte en kwaliteit van leven. Zeventig opeenvolgende borstkankerpatiënten 
bij de polikliniek chirurgie en oncologie  vulden een demografisch formulier in, evenals het 
Satisfaction with Cancer Information Profile, de Brief Illness Perception Questionnaire en 
de World Health Organization Quality of Life. Een aanzienlijk deel van de patiënten (41%-
86%) liet weten onvoldoende informatie te hebben ontvangen over verschillende aspecten 
van hun ziekte en behandeling, met name informatie over toegang tot steungroepen 
voor patiënten en de impact van de behandeling op de kwaliteit van leven op de lange 
termijn. Wat betreft de aard en de timing van de informatie was een meerderheid van de 
patiënten ontevreden met de hoeveelheid schriftelijke informatie die was aangeboden. 
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De tevredenheid van patiënten met de aard en de timing van informatie hield positief 
verband met een sterker gevoel van persoonlijke beheersing, minder zorgen over hun 
gezondheidstoestand en een beter begrip van de ziekte. Tevreden patiënten waren minder 
emotioneel geraakt door hun ziekte. Tevredenheid met de aard en de timing van de informatie 
hield ook verband met een positievere perceptie van hun algehele gezondheidstoestand 
en een betere psychische gezondheid. Tevredenheid met de hoeveelheid en de inhoud 
van de informatie hield daarentegen geen verband met de perceptie van de ziekte en 
van de kwaliteit van leven. Onze onderzoeksresultaten suggereren dat tevredenheid met 
de informatie die aangeboden wordt verband houdt met betere gezondheidsresultaten, 
waaronder een positievere perceptie van de ziekte; zij onderstrepen dus het belang van 
adequate en voldoende informatieverstrekking die voorziet in de behoefte van de patiënt. 
Toch is er longitudinaal onderzoek nodig om vast te stellen of deze interpretatie wordt 
ondersteund. 
Het onderzoek in hoofdstuk 6 evalueert het verband tussen psychosociale factoren 
(bijv. kennis, perceptie van de ziekte, health locus of control, tevredenheid met informatie 
en distress) en therapietrouw bij Indonesische vrouwen met borstkanker. Zeventig 
opeenvolgende patiënten met borstkanker namen deel aan het onderzoek. Zij vulden een 
demografisch formulier in, de therapieontrouw-enquête, de Breast Cancer Knowledge 
Test, de Brief Illness Perception Questionnaire, de Multidimensional Health Locus of 
Control Scales, het Satisfaction with Cancer Information Profile en de Distressbarometer. 
Zeventien (24%) van de zeventig patiënten meldden dat zij het begin van de behandeling 
in het ziekenhuis hadden uitgesteld, en negen (13%) van de zeventig patiënten hadden 
twee of meer opeenvolgende behandelsessies gemist. De multivariate regressieanalyses 
toonden aan dat een negatief beeld van kanker (een beeld waarbij de nadruk ligt op 
het bedreigende karakter) verband hield met het missen van behandelsessies, terwijl 
voorafgaande raadpleging van een traditionele genezer verband hield met zowel uitstel 
van de behandeling als het missen van behandelsessies. Tegen de verwachting in werd 
er geen verband gevonden tussen de kennis van de patiënten, de health locus of control 
en tevredenheid met de informatie enerzijds, en het uitstellen van de behandeling en het 
missen van behandelsessies anderzijds. Naar onze mening moeten zorgprofessionals zich 
bewust worden van de negatieve ziektepercepties onder de patiënten en hun onrealistische 
geloof in traditionele genezers, en moeten zij patiënten duidelijke informatie over hun ziekte 
en hun behandeling verschaffen. Het relatieve belang van deze factoren moet echter in 
toekomstig prospectief onderzoek worden getoetst, ook gezien het verkennende karakter 
van het onderhavige onderzoek.
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Hoofdstuk 7 bevat ten slotte een algemene discussie van de resultaten, bespreekt het 
totaal van de resultaten in relatie tot onze onderzoeksdoelen en beschrijft enkele implicaties 
voor de klinische praktijk en toekomstig onderzoek. De onderzoeken die in dit proefschrift 
zijn besproken leggen een aantal culturele verschillen bloot in de psychologische factoren 
die verband houden met therapietrouw/-ontrouw en psychologische adaptatie vergeleken 
met de Westerse kankerpopulatie, te weten: Indonesische vrouwen met borstkanker hadden 
een vastere overtuiging dat God hun gezondheidstoestand bepaalt; zij waren minder 
tevreden met verschillende aspecten van de informatieverstrekking door zorgprofessionals 
(bijv. informatie over sociale/financiële ondersteuning en schriftelijke informatie) en hadden 
een sterker geloof in traditionele genezers.
 Distress onder vrouwen met borstkanker moet in de reguliere kankerzorg worden 
gesignaleerd om eventuele ernstige psychische problemen te voorkomen en aanvullende 
psychische hulp te bieden aan patiënten die daar behoefte aan hebben. Zorgprofessionals 
dienen zich bewust te zijn van negatieve ziekteperceptie bij patiënten en een sterk geloof 
in traditionele genezers, factoren die verband hielden met uitstel van de behandeling en 
therapieontrouw. Het bieden van heldere, bondige en makkelijk te begrijpen schriftelijke 
informatie over ziekte en behandeling (bijv. folders) kan een kosteneffectieve en efficiënte 
bron van informatie zijn die de mondelinge informatieverstrekking aanvult in de drukke setting 
van een oncologiekliniek in Indonesië. Op het moment zijn wij bezig een psychologisch-
educatief interventieprogramma te ontwikkelen om waar mogelijk te voorkomen dat 
Indonesische vrouwen met borstkanker het zoeken van hulp en de behandeling uitstellen 
en om de therapietrouw te vergroten.
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Faktor yang menentukan ketidakpatuhan terhadap pengobatan 
pada wanita Indonesia yang menderita Kanker Payudara
Ringkasan
Bab 1 memberikan gambaran tentang latar belakang, tujuan dan kerangka dari disertasi 
ini. Bab ini menunjukkan adanya perubahan dalam prevalensi dan semakin memburuknya 
angka kematian pada wanita Indonesia yang menderita kanker payudara. Data terbaru 
menunjukkan bahwa kanker payudara tampil sebagai jenis kanker yang paling sering 
terjadi dan penyebab kematian utama pada wanita Indonesia. Meskipun angka kejadian 
masih lebih rendah daripada negara-negara maju, angka kematian dari kanker payudara 
tergolong cukup tinggi. Seperti halnya negara-negara Asia Tenggara lainnya, buruknya angka 
harapan hidup pada pasien kanker payudara di Indonesia sebagian besar disebabkan oleh 
keterlambatan presentasi dari penyakit. Hal ini disebabakan oleh berbagai faktor, diantaranya 
kurangnya fasilitas untuk deteksi dini dan keterbatasan akses kepada sarana pengobatan 
primer. Oleh karena kanker adalah suatu penyakit kronis dan seringkali menyebabkan 
kematian, wanita yang didiagnosa kanker payudara akan dihadapkan dengan berbagai 
stresor selama pengalaman sakitnya. Maka dari itu, memahami penyesuaian psikologis 
dan faktor-faktor psikososial potensial yang berhubungan dengan ketidakpatuhan terhadap 
rekomendasi medis pada wanita yang menderita kanker payudara sangatlah dibutuhkan. 
Tujuan dari disertasi ini adalah untuk mengidentifikasi faktor-faktor psikososial yang 
mungkin menjadi faktor risiko untuk ketidakpatuhan terhadap pengobatan dan distress 
psikologis pada wanita Indonesia yang menderita kanker payudara. Untuk menjawab 
tujuan dari disertasi ini, pertama kami melakukan ekplorasi secara kualitatif terhadap 
determinan-determinan yang potensial dari ketidakpatuhan, selanjutnya kami melakukan 
beberapa studi validasi dan ekplorasi untuk bisa memahami secara lebih baik jenis masalah 
psikologis dan penyesuaian diri yang berhubungan dengan kanker payudara, dan akhirnya 
kami melakukan eklorasi secara kuantitatif terhadap faktor-faktor psikologis yang mungkin 
berhubungan dengan ketidakpatuhan terhadap pengobatan.  
Bab 2 menyajikan hasil dari studi kualitatatif tentang faktor-faktor psikososial dan 
kultural untuk penundaan dalam mencari pertolongan dan ketidakpatuhan terhadap 
pengobatan pada wanita Indonesia yang menderita kanker payudara. Secara berurutan 
limapuluh pasien kanker payudara yang sedang menjalani pengobatan di klinik rawat jalan 
bagian bedah onkologi diwawancara. Wawancara meliputi karakteristik demografis dari 
partisipan dan topik-topik sebagai berikut: pengetahuan akan penyakit, persepsi tentang 
tingkat keparahan penyakit, informasi yang disediakan oleh dokter, penggunaan layanan 
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kesehatan dan pengobatan alternatif, sikap terhadap pengobatan barat dan pengobatan 
tradisional khususnya berkaitan dengan penyakit pasien, persepsi mengenai keuntungan-
keuntungan dan hambatan-hambatan terhadap pengobatan dan ketidakpatuhan terhadap 
rekomendasi medis. Wawancara direkam, dicatat secara verbatim dan dikode dengan 
menggunakan program perangkat lunak kualitatif ATLAS.ti versi 5.2. Diperoleh delapan 
tema utama yang berkaitan dengan alasan menunda untuk mencari pertolongan medis 
dan ketidakpatuhan terhadap pengobatan, yaitu: kurangnya kesadaran dan pengetahuan, 
kepercayaan mengenai kanker, kepercayaan mengenai pengobatan, masalah keuangan, 
beban emosional, efek samping yang parah, gaya komunikasi paternalistik dan kebutuhan 
akan informasi yang tidak terpenuhi. Studi ini menemukan beberapa faktor-faktor 
psikososial dan kultural yang dapat diubah untuk bisa digunakan dalam mengembangkan 
intervensi untuk mengurangi perilaku tidakpatuh dalam populasi ini. Temuan-temuan ini 
memberi kesan bahwa penyediaan informasi yang ekstensif melalui media kampanye, 
bantuan untuk memutuskan pengobatan, dan pendidikan terhadap pemberi bantuan dan 
pasien sangatlah dibutuhkan untuk merubah perilaku sakit dari pasien kanker payudara di 
Indonesia.     
Pada Bab 3, kami bertujuan untuk menterjemahkan Distress Thermometer (DT) ke 
dalam bahasa Indonesia, menguji validitasnya pada wanita Indonesia yang menderita 
kanker payudara dan menentukan norma dari DT versi Indonesia untuk distress klinis. 
Kami menterjemahkan versi asli dari DT ke dalam bahasa Indonesia dengan menggunakan 
cara forward and backward translation yang mengacu pada pedoman yang ada. Maka 
dari itu, seratus duapuluh pasien kanker payudara di klinik rawat jalan bagian bedah 
onkologi  mengisi lembar isian sosio-demografis standar, DT dan daftar permasalahan, 
Hospital Anxiety and Depression Scale (HADS) dan WHO Quality of Life (WHOQOL-Bref). 
Analisa kurva receiver operating characteristic menunjukkan suatu diskriminasi yang 
baik (AUC=0.81) dari nilai batas DT terhadap nilai batas HADS >15 yang telah ajeg, dan 
nilai batas 5 pada DT memiliki sensitifitas dan specificitas yang paling baik. Pasien yang 
melaporkan distress di atas nilai batas mengalami lebih banyak masalah dalam domain 
praktis, keluarga, emosional, spiritual/kepercayaan dan fisik dibanding dengan pasien 
yang memiliki distress di bawah nilai batas. Sebagai tambahan, pasien dengan kanker 
tingkat lanjut mengalami lebih banyak masalah emosional dan fisik. Tingkat distress pasien 
berkorelasi negatif dengan kualitas hidup secara keseluruhan, kondisi kesehatan umum 
dan semua domain kualitas hidup. Kami menyimpulkan bahwa DT adalah alat ukur yang 
valid untuk pemeriksaan distress pada pasien kanker payudara di Indonesia, dan kami 
merekomendasikan untuk menggunakan nilai batas 5 pada populasi ini. Temuan yang 
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khusus dari studi ini adalah adanya hubungan positif antara distress klinis dengan masalah 
spiritual/agama, yang serupa dengan hasil studi yang dilakukan di Korea, namun berbeda 
dengan kebanyakan studi yang dilakukan di negara-negara Barat yang tidak menemukan 
adanya hubungan ataupun hanya menemukan hubungan yang lemah. Kami menyimpulkan 
bahwa pasien dengan kanker tingkat lanjut harus diprioritaskan untuk memperoleh 
intervensi psikologis.         
Bab 4 meneliti apakah wanita Indonesia yang menderita kanker payudara memiliki 
eksternal Health Locus of Control (HLC) yang lebih tinggi daripada wanita yang sehat, dan 
mengekplorasi hubungan antara HLC dengan simptom-simptom kecemasan dan depresi. 
Pada studi ini, secara berurutan seratus dua puluh wanita yang menderita kanker payudara 
yang di rekrut dari klinik rawat jalan bagian bedah onkologi mengisi lembar isian demografis 
standar,  Multidimensional Health Locus of Control bentuk C, dan juga Hospital Anxiety and 
Depression Scale. Sebagai kelompok pembanding, seratus dua puluh dua wanita sehat yang 
direkrut dari daerah Bandung mengisi lembar isian demografis standar dan Multidimensional 
Health Locus of Control bentuk C. Wanita yang menderita kanker payudara memiliki nilai 
lebih tinggi pada semua skala eksternal HLC, yaitu chance, doctor, powerful others dan God, 
dan nilai yang lebih rendah dalam internal HLC dibandingkan dengan wanita sehat. Tingkat 
pendidikan yang rendah berhubungan dengan nilai chance HLC yang tinggi pada wanita 
yang menderita kanker payudara, dan berhubungan dengan nilai internal HLC yang rendah 
dan nilai chance HLC yang tinggi pada wanita sehat. Waktu semenjak menerima diagnosis 
secara signifikan berkorelasi negatif dengan nilai God LHC. Nilai God LHC yang tinggi 
berhubungan dengan tingkat kecemasan yang lebih tinggi, sementara itu tidak ada sub-skala 
HLC yang berhubungan dengan depresi. Hasil kami menunjukkan bahwa kepercayaan yang 
kuat terhadap sumber kendali eksternal, misalnya Tuhan, bisa berhubungan negatif dengan 
penyesuaian emosional pasien. Penelitian lebih lanjut tentunya diperlukan untuk memperoleh 
keterangan mengenai arah dari hubungan ini. 
Pada Bab 5, tingkat kepuasan terhadap informasi mengenai penyakit dan pengobatan, 
dan hubungannya dengan persepsi terhadap penyakit dan kualitas hidup pasien kanker 
payudara diteliti. Tujuh puluh pasien kanker payudara yang direkrut secara berurutan 
dari klinik rawat jalan bagian bedah onkologi mengisi lembar isian demografis standar, 
Satisfaction with Cancer Information Profile, Brief Illness Perception Questionnaire dan 
World Health Organization Quality of Life. Cukup banyak pasien (41%-86%) melaporkan 
bahwa mereka tidak menerima informasi yang cukup mengenai beberapa aspek penyakit 
dan pengobatan mereka, terutama informasi mengenai akses terhadap kelompok-kelompok 
pendukung pasien dan akibat dari pengobatan terhadap kualitas hidup jangka panjang 
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mereka. Dalam hal jenis dan waktu pemberian informasi, sebagian besar pasien merasa 
tidak puas dengan jumlah informasi tertulis yang disediakan. Kepuasan pasien terhadap 
jenis dan waktu pemberian informasi berhubungan secara positif dengan kepercayaan 
atas kendali pribadi yang lebih kuat, kehawatiran terhadap kondisi kesehatan yang lebih 
rendah, pemahaman terhadap penyakit yang lebih baik, dan pengaruh emosional dari 
penyakit yang lebih rendah. Kepuasan terhadap jenis dan waktu pemberian informasi 
juga berhubungan dengan persepsi terhadap kondisi kesehatan umum yang lebih positif 
dan kondisi kesehatan psikologis yang lebih baik. Di sisi yang lain, kepuasan terhadap 
jumlah dan isi dari informasi tidak lah berhubungan dengan persepsi terhadap penyakit 
dan kualitas hidup. Hasil studi kami menunjukkan bahwa kepuasan terhadap informasi 
yang diberikan berhubungan dengan hasil kesehatan yang lebih baik, meliputi persepsi 
terhadap penyakit yang lebih positif; dengan demikian hal ini menunjukkan pentingnya 
penyediaan informasi secara memadai dan mencukupi yang sesuai dengan kebutuhan-
kebutuhan pasien. Meskipun demikian, dibutuhkan studi longitudinal untuk menentukan 
apakah ada dukungan untuk interpretasi ini.     
Studi di Bab 6 mengevaluasi hubungan antara faktor-faktor psikososial (yaitu: 
pengetahuan, persepsi terhadap penyakit, health locus of control, kepuasan terhadap 
informasi dan distress) dengan ketidakpatuhan terhadap pengobatan pada wanita Indonesia 
yang menderita kanker payudara. Tujuh puluh pasien kanker payudara yang direkrut 
secara berurutan berpartisipasi dalam studi ini. Mereka mengisi lembar isian demografis, 
Breast Cancer Knowledge Test, Brief Illness Perception Questionnaire, Multidimensional 
Health Locus of Control Scales, Satisfaction with Cancer Information Profile dan Distress 
Thermometer. Tujuh belas (24%) dari tujuh puluh pasien melaporkan bahwa mereka 
telah menunda untuk memulai pengobatan di rumah sakit, dan sembilan (13%) dari 
tujuh puluh pasien pernah absen dua atau lebih sesi pengobatan secara berurutan. Hasil 
analisis regresi multivariate menunjukkan bahwa memiliki pandangan negatif terhadap 
kanker (yaitu pandangan yang menekankan pada karakter penyakit yang mengancam) 
berhubungan dengan absen dari sesi pengobatan, sedangkan berkonsultasi dengan 
penyembuh tradisional berhubungan dengan penundaan untuk memulai pengobatan 
dan absen dari sesi pengobatan. Kami menyarankan bahwa para professional kesehatan 
perlu mengetahui persepsi negatif pasien terhadap penyakit dan kepercayaan yang tidak 
realistis terhadap penyembuh tradisional, dan menyediakan informasi yang jelas mengenai 
penyakit dan pengobatannya bagi mereka. Meskipun demikian, pentingnya hubungan 
antara faktor-faktor tersebut haruslah diteliti pada studi prospektif di masa datang, dan 
juga mempertimbangkan karakter eksploratif pada penelitian ini.     
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Akhirnya, Bab 7 menyajikan diskusi umum atas temuan-temuan yang diperoleh, 
mendiskusikan hasil akumulasi yang berhubungan dengan tujuan dari penelitian kami, 
dan menyajikan implikasi untuk praktek klinis dan penelitian yang akan datang. Studi-studi 
yang disajikan dalam disertasi ini mengidentifikasi beberapa perbedaan budaya dalam 
faktor-faktor psikologis yang berhubungan dengan ketidakpatuhan terhadap pengobatan 
dan penyesuaian psikologis dibandingkan dengan populasi kanker negara-negara Barat, 
yaitu: wanita Indonesia yang menderita kanker payudara memiliki kepercayaan yang lebih 
tinggi bahwa Tuhan menentukan kondisi kesehatan mereka, kurang merasa puas terhadap 
beberapa aspek informasi yang disediakan oleh para professional kesehatan (misalnya: 
informasi mengenai dukungan sosial/keuangan dan ketersediaan informasi tertulis) dan 
memiliki kepercayaan yang lebih kuat terhadap penyembuh tradisional.
Pemeriksaan untuk distress psikologis pada wanita yang menderita kanker payudara 
adalah diperlukan dalam pelayanan perawatan kanker sehari-hari untuk mencegah 
adanya masalah-masalah psikologis yang berat dan menyediakan intervensi psikologis 
tambahan untuk pasien yang membutuhkannya. Para professional kesehatan perlu 
mengetahui persepsi negatif pasien terhadap penyakit dan kepercayaan yang kuat 
terhadap penyembuh tradisional, dimana merupakan faktor-faktor yang berhubungan 
dengan penundaan pengobatan dan ketidakpatuhan terhadap pengobatan. Ketersediaan 
informasi tertulis yang jelas, ringkas dan mudah untuk difahami mengenai penyakit dan 
pengobatannya (misal: leaflet) dapat menjadi sumber informasi yang hemat biaya dan 
efisien untuk melengkapi informasi lisan di klinik onkologi yang sibuk di Indonesia. Pada 
saat ini, kami sedang mengembangkan program intervensi psiko-edukatif yang bertujuan 
untuk menghilangkan penundaan dalam mencari pertolongan dan penundaan pengobatan, 
dan juga meningkatkan kepatuhan terhadap pengobatan pada wanita Indonesia yang 
menderita kanker payudara.  
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